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  1  
SUMMARY
 
A significant part of this dissertation has already been published (see the detail list of 
publication at the end) and submitted. Each chapter contains the content of a publication or 
shortcommunication and full paper. Text, tables and synthetic schemes from these 
publications were directly used while writing thesis. The work presented in this dissertation 
was divided into two parts as following: 
 
Part one: Regioselective Palladium(0)-catalyzed cross-coupling reactions of 
bromosubstituted furan, pyrrole, selenophene and thiophene 
 
1. Synthesis of 2-(2-Arylethenyl)-5-arylfurans by Regioselective Palladium(0)-Catalyzed 
Coupling Reactions of 2-(2-Bromo-2-nitroethenyl)-5-bromofuran. The Suzuki reaction of 2-
(2-bromo-2-nitroethenyl)-5-bromofuran, readily available from furfural, resulted in 
regioselective attack onto the furan moiety. The first regioselective suzuki cross-coupling 
reactions occurs at the bromo substituted furan to give 2-(2-bromo-2-nitroethenyl)-5-
arylfuran. The alkenyl moiety could be functionalized in a second Suzuki reaction. These 
reactions represent a valuable synthetic method for the synthesis of pharmacologically 
relevant products and of useful intermediates for further synthetic transformations. 
 
2. Regioselective Synthesis of Functionalized Pyrroles based on the first Palladium(0)-
Catalyzed Cross-Coupling Reactions of N-Methyltetrabromopyrrol. Pyrrole is the core of 
many natural products having a rich pharmacological and medicinal potential, such as 
Ningaline A, Lamellarin, Lukianol A, and Storniamide. In this chapter I report a new 
methodology for the functionalization of pyrroles. Regioselective Suzuki cross-coupling 
reactions of 2,3,4,5-tetrabromo-1-methylpyrrole allow a convenient synthesis of 
functionalized pyrroles.  
 
3. Regioselective Sonogashira Reactions of N-Methyltetrabromo-pyrrole. First Synthesis 
of Tri- and Tetra(1-alkynyl)pyrroles. Hydrocarbons bearing multiple alkynyl groups have 
received considerable attention due to their interesting physicochemical properties, as 
synthetic building blocks of new and interesting arenes, and due to their æsthetic attraction. 
Recently, studies related to the synthesis and characterization of hexaethynylbenzene and 
tetra(1-alkynyl)thiophene based on Sonogashira coupling reactions were published. In this 
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chapter, N-methyl-2,3,4,5-tetrabromopyrrole is transformed into a variety of alkylnyl-
substituted pyrroles by regioseletive Sonogashira cross-coupling reactions. In addition, the 
synthesis of the first tri-, and tetra(1-alkylnyl)pyrrole is reported. 
 
4. Efficient Synthesis of Substituted Selenophenes based on the First Palladium(0)-
Catalyzed Cross-Coupling Reactions of Tetrabromoselenophene. Selenium represents an 
essential element for higher organisms and is of considerable pharmacological relecance. This 
includes antiviral activity, inhibitory activity against human myelogenous leukemia K562 
cells, cytotoxicity against HT-29, HeLa, ACHN and 5637 cells, and muscarinic antagonist 
activity. Therefore, the synthesis of functionalized selenophenes is important for 
pharmacological and medicinal applications. Regioselective Suzuki cross-coupling reactions 
of tetrabromoselenophene allow a convenient synthesis of various aryl-substituted 
selenophenes. High yields were obtained using a novel biaryl monophosphine ligand. The 
first tetra(1-alkynyl)selenophene was prepared in one step by a Sonogashira reaction of 
tetrabromoselenophene. 
 
5. Regioselective Palladium(0)-Catalyzed Cross-Coupling Reactions and Metal-Halide 
Exchange Reactions of Tetrabromothiophene. Thiophenes possess many applications in 
medicinal chemistry and in material sciences (light-emission, electroluminescenc, redox 
activity etc.). The Suzuki reaction of tetrabromothiophene with arylboronic acids provides a 
regioselective approach to various 5-aryl-2,3,4-tribromothiophenes, symmetrical 2,5-diaryl-
3,4-dibromothiophenes, and tetraarylthiophenes. Unsymmetrical 2,5-diaryl-3,4-
dibromothiophenes are prepared by Suzuki reaction of 5-aryl-2,3,4-tribromothiophenes. 
Tetraarylthiophenes containing two different types of aryl groups are obtained by Suzuki 
reactions of 2,5-diaryl-3,4-dibromothiophenes. During the optimization of the conditions of 
each individual reaction, the solvent, the catalyst and the temperature played an important 
role. In several cases, classical conditions (use of Pd(PPh3)4 as the catalyst) gave excellent 
yields. The yields of those transformations which failed or proceeded sluggishly could be 
significantly improved by application of a new biaryl monophosphine ligand developed by 
Buchwald and coworkers. Regioselective metal-halide-exchange reactions of 
tetrabromothiophene provide a convenient approach to various 2,5-substituted 3,4-
dibromothiophenes. 5-Alkyl-2-trimethylsilyl-3,4-dibromothiophenes could be prepared in a 
one-pot protocol by sequential addition of trimethylchlorosilane and alkyl bromides. The 
reaction of tetrabromothiophene with methyl chloroformiate and subsequent Suzuki reactions 
  3  
afforded 3,4-diaryl-2,5-bis(methoxycarbonyl)thiophenes. These products were transformed 
into sulphur-analogues of pyrrole natural products, such as ningaline A. 
 
Part two: Oriented Synthesis of  N,O-Heterocycles by Cyclization Reactions of 
Hydrazone with Diethyl Acetate and Arylkenyl-Oxime 
 
6. Synthesis of Pyrazole-3-carboxylates and Pyrazole-1,5-Dicarboxylates by One-Pot 
Cyclization of Hydrazone Dianions with Diethyl Oxalate. Pyrazole-5-carboxylic acid 
derivatives represent important building blocks in organic and medicinal chemistry due to 
their pharmacological properties. For example, pyrazole-5-carboxylic acids and pyrazolo[1,5-
c]quinazoline-2-carboxylates are nicotinic acid receptor agonists and excitatory amino acid 
antagonists, respectively. Ethyl 5-propyl-1H-pyrazole-3-carboxylate is a key intermediate for 
the synthesis of viagra. Herein I reported a new and convenient approach to synthesize 
pyrazole-3-carboxylates and pyrazole-1,5-dicarboxylates by one-pot cyclization of hydrazone 
dianions with diethyl oxalate. 
 
7. Regioselective Synthesis of 6-Halomethyl-5,6-dihydro-4H-1,2-oxazines based on 
Cyclizations of Arylalkenyl-oximes. 1,2-Oxazines are of pharmacological relevance and 
represent useful synthetic building blocks as intermediates during the synthesis of glycosidase 
inhibitor analogues and of functionalized pyrroles. They have been prepared by other 
methods, for example, hetero-Diels-Alder reactions of alkenes with ene-nitroso compounds 
derived from -haloximes, hetero-Diels-Alder reactions of dienes with nitroso compounds 
and base-mediated cyclizations of -chloroximes and -sulfonyloximes. In this chapter I report 
that 6-iodo- and 6-bromomethyl-5,6-dihydro-4H-1,2-oxazines were prepared by condensation 
of dilithiated acetophenone-oximes with allylbromide and subsequent regioselective iodine- 
or NBS-mediated cyclization. 
 
Experimental section 
Experimental section. The experimental procedures and spectrocopic data and full 
characterization of all new products are described. 
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P Part 1   1      Regioselective Palladium(0)-Catalyzed Coupling Reactions 
of Bromosubstituted Furans, Thiophenes, Pyrroles, Selenophenes 
Introduction 
The formation of carbon-carbon and carbon-heteroatom bonds is always of interest for 
chemists from past until now. It provides a convenient approach to construct complicated 
molecules from simple precusors. Up to date there are many useful methodologies for making 
bonds. One of them relies on transition metal-catalyzed reactions, particularly palladium(0)-
catalyzed carbon-carbon bond forming reactions.1 The application of palladium-catalyzed 
cross-coupling reactions is tremendously successful in chemistry such as total synthesis, 
nanotechnology, synthesis of advanced materials, biological, medicinal and pharmacological 
chemistry. The cross-coupling bond forming reactions between sp2 carbon atom with various 
hybridized carbon (sp, sp2, sp3) 2,3 are well-know as the Heck, Stille, Suzuki, Sonogashira, 
Tsuji-Trost and Negishi reactions (Scheme 1). 
 
  
 
 
Scheme 1: The most commonly utilized palladium-catalyzed cross-coupling reactions. (This 
scheme was copied from Angew. Chem. Ind. Ed. 2005, 44, 4442) 
 
A short look at the mechanistic picture1 for a typical cross-coupling reactions reveals three 
key steps in generally catalytic cycle (Scheme 2). Different substrates and reagents lead to the 
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particularly useful reactions. The first step is the oxidative addition of organic halides or 
pseudo-halides to the Pd(0) complex to form organopalladium halides. The following step is 
transmetallation with nucleophilic compounds to give a diorganopalladium complex. This 
complex undergoes a reductive elimination to create carbon-carbon bond and regeneration of 
the catalyst. 
 
 
 
Scheme 2. General mechanism for palladium-catalyzed cross-coupling reaction (This scheme 
was copied from Tetrahedron, 2005, 61, 2245) 
 
Suzuki reaction 
 
In 1981, a very useful palladium-catalyzed carbon-carbon formation was reported by Suzuki 
and Miyaura which involves the palladium-mediated coupling of aryl or akenyl halides and 
triflates with organoboron compounds in the presence of base, a process known today as 
Suzuki reaction.4 The success of the Suzuki reaction relies on its cheracteristic features. 1) 
commercial availability of a large number of boronic acids and esters, 2) the stability to heat, 
air and moisture, 3) the tolerance to a broad range of functional groups, 4) mild reaction 
conditions, 5) low toxicity of the reagents, 6) and easy separation of inorganic by-products 
from the reaction mixture. 
 
A general catalytic cycle for the cross-coupling of organic halides or triflates with 
organometallic reagents is shown in (Scheme 3).1 It involves the oxidative addition of organic 
halides or triflates to the Pd(0) complex to form a organopalladium halide (R1-Pd(II)-X). This 
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step is followed by transmetallation with a boronic acid derivative or a borane to give a 
diorganopalladium complex (R1-Pd-R2). This complex undergoes a reductive elimination with 
carbon-carbon bond formation and regeneration of the catalyst. 
Pd(0)
Transmetallation
Oxidative additionReductive elimination
R2-B(OH)2  +  baseXB(OH)2
R1-Pd(II)-X
R1X
R1-Pd(II)-R2
R1-R2
 
Scheme 3. Catalytic cycle in Suzuki reaction  
The rate of Suzuki reaction mainly relies on the oxidative addition and transmetallation. The 
oxidative addition step is dependent on the reactivity of the substrate according to the order 
Ar-I> Ar-Br > Ar-Cl > Ar-OTf. The transmetalation is accelerated by the presence of base. 
This can be explained by the increase of the nucleophilicity of the organoborane compound 
by formation of an organoborate containing a tetravalent borom atom. The solvent plays an 
important role in Suzuki reaction. Often the use of DMF gives good results.  
 
The choice of the catalysts is also very important for the success of the reaction. The common 
palladium sources employed include, for example, Pd(OAc)2, PdCl2, Ph(PPh3)2Cl2, and 
Pd(dba)2. The use of bulky electron-rich ligands is often the key for a successful 
transformation. The ferrocenylphosphine5, N-heterocyclic carbenes6, P(t-Bu)3 7, P(Cy)3 often 
give a good yield. Recently the innovation of ligands has been developed strongly by Prof. 
Mathias Beller. He has developed some nowadays comercially available ligands, such as 
dibutyl-1-adamatylphosphine8 and phosphino subsituted N-aryl pyrroles.9 These ligands are 
applied in the palladium-catalyzed coupling of variety of aryl and heteroaryl chlorides with 
arylboronic acid showing high turnover numbers at mild reaction temperatures. Another 
famous ligand was reported by Prof. Buchwald and co-workers.10 They have developed 
electron-rich, bulky biphenylphosphine ligands, such as S-Phos (2,6-dimethoxybiphenyl-
dicyclohexylphosphine), X-Phos, Dave-Phos, and others. The application of these ligands 
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gave excellent yields for aryl chlorides and heteroaryl chlorides with arylboronic and 
heteroarylboronic acids. In my research, S-Phos ligand was employed for most of the Suzuki 
reactions.  
 
 
 
Scheme 4. Structural features of the dialkylbiarylphosphines and their impact on the efficacy 
of catalysts using these ligands.11 (This scheme was copied from Acc. Chem. Res. 2008, 41 
(11) 1461) 
 
Sonogashira reaction 
 
The palladium-catalyzed coupling of terminal akynes with vinyl or aryl halides was first 
reported independently and simultaneously by the groups of Cassar12 anh Heck13 in 1975. A 
few months later, Sonogashira and co-workers demonstrated that, in many cases, this cross-
coupling reaction could be accelerated by the addition of cocatalytic CuI salts to the reaction 
mixture.14,15 The protocol for Sonogashira reaction has been improved a lot. Nowadays, the 
Sonogashira reaction proceeds under mild conditions, sometimes even at room temperature, 
with high turnover number. The classical conditions of the Sonogashira coupling relies on the 
use of copper salts as cocatalysts. Modern variants can be carried out under copper-free 
conditions. 
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Scheme 5. Two mechanisms of the Sonogashira reaction (This scheme was copied from 
Chem. Rev. 2007, 107, 874) 
 
The different mechanism of different variants of the Sonogashira reaction leads to different 
invidual protocols. The in situ generation of  copper alkylides under the reaction conditions 
often generates homocoupling products (so-called Glaser coupling).16 This side reaction is an 
important problem. The addtion of copper salts as cocatalysts have drawbacks. The 
mechanism of the copper-free Sonogashira reaction is not well-known. The oxidative addtion 
of R1-X to the palladium(0) complex is the initial step. The second step is still under debate. 
Some authors supposed that the alkyne replaces one ligand to give an intermediate complex 
and the ligated alkyne would be more easily deprotonated by the amine to form a new 
complex R1Pd(-CCR2)L2, which subsequently gives rise to the formation of the coupling 
product by reductive elimination. In this copper-free mechanism, the way of adding the 
alkyne plays an important role. Buchwald and cowoker have reported that a slow addition of 
the alkyne at 70-90 °C using a syringe pump in a pressure tube gives best results.17  
 
The general reactivity order of the sp2 species is vinyl iodide > vinyl triflate > vinyl bromide 
> aryl iodide > aryl triflate > aryl bromide >> aryl chloride; therefore the Sonogashira process 
usually runs smoothly when the more expensive and unstable aryl or vinyl iodides are used.1 
 
Several catalysts and ligands for Sonogashira reaction have been developed. Typical reactions 
are performed using a palladium(0)-phosphane complex in the presence of a cocatalytic 
amount of a copper (I) salt and an amine (used as a solvent or in large excess) under 
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homogeneous conditions. The classically used catalysts are triphenylphosphane-related 
complexes, such Pd(Ph3)4, Pd(Ph3)2Cl2, Pd(dppe)Cl2, Pd-(dppp)Cl2 or Pd(dppf)Cl2. Most 
frequently used loadings of palladium are in the range of 5 mol-%. Larger amounts of the 
copper(I) salt are often employed and the use of THF as the solvent18 was highly 
recommended. For copper-free Sonogashira reactions more electron-rich phosphane ligands 
are used because of the easier oxidative insertion of the palladium(0) species to the aryl 
halides. The palladium sources1 mainly employed are Pd(OAc)2, Pd2(PhCN)2, Pd2(CH3CN)2, 
Pd2(dba)3 and Pd(3-C3H5)Cl2,19 and ligands, such as, P(t-Bu)3,20 P(Cy)3, electron-rich o-
biphenylphosphane (X-Phos)17, multidentate ferrocenyl phosphane21b, and tetraphosphanes. 
The Sonogashira reaction provides a valuable method for synthesis of conjugated acetylenic 
systems, which are used in a diverse array of important applications from natural products and 
pharmaceutical to designed molecules of interest in biotechnology and nanotechnology.1 
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1.1 Synthesis of 2-(2-Arylethenyl)-5-arylfurans by Regioselective Palladium(0)-
Catalyzed Coupling Reactions of 2-(2-Bromo-2-nitroethenyl)-5-bromofuran  
1.1.1 Introduction  
 
Furans are of considerable pharmacological relevance and occur in a variety of natural 
products.22,23 Some natural products containing the furan ring have an intense odour, e.g. 2-
furylmethanethiol, a component of coffee aroma, Rose furan, a component of rose oil, 
Menthofuran, which occurs in peppermint oil.24 Recently, (+)-(Z)-Deoxypukalide25 was 
isolated from the Pacific Octocoral  Leptogorgia sp.  and Saurufuran A, B26 isolated from the 
Saururus chinenesis (Scheme 6). 
O
(+)-(Z)-Deoxypukalide
COOMe
O
O
O
Me
COOH
Saurufuran A  
 
Scheme 6. Some natural products containing furan moieties. 
 
A number of synthetic approaches to furans have been reported.27 Bach and coworkers 
reported an interesting approach to 2,3-disubstituted furans by regioselective palladium(0)-
catalyzed coupling reactions of 2,3-dibromofurans.28 The success of these transformations 
relies on the fact that the oxidative addition of the palladium(0) complex onto carbon atom C-
2 of the furan is faster than onto C-3 (Scheme 7).29 Herein, I wish to report what are, to the 
best of my knowledge, the first regioselective palladium(0)-catalyzed coupling reactions of 2-
(2-bromoalkenyl)-5-bromofurans which contain both a furyl and an alkenyl bromide function 
(Scheme 7). A similar idea of 2-(2-bromophenyl)-2-bromopyridine5 was published later than. 
The oxidative addition of the palladium(0) complex to the C-Br bond attached to carbon C-2 
of pyridine is faster than to the C-alkenyl moiety. However, if there are two bromine atoms 
located at the alkenyl group, the oxidative addition of the palladium(0) complex was reversed 
(Scheme 7). These reactions should be of considerable interest, since the starting materials are 
readily available and the products are pharmacologically relevant and represent useful 
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intermediates for further synthetic transformations (e. g. electrocyclic ring-closure 
reactions).30 
 
O
Br
BrOBr
Br
1st attack
2nd attack
1st attack
2nd attack
N Br
Br
Br
N Br
Br
1st attack
1st attack
2nd attack
2nd attack
3rd attack
 
Scheme 7. Regioselectivity of palladium(0)-catalyzed coupling reactions 
1.1.2 Results and Discussion  
 
As a starting point for my studies I chose (Z)-2-(2-bromo-2-nitroethenyl)-5-bromofuran 3 
which is readily available by Henry reaction of furfural with nitromethane and subsequent 
bromination (Scheme 8).31 It has been shown that compound 3 possesses interesting biological 
activity and its derivatization is, therefore, of considerable interest.31e Furfural represents an 
inexpensive, green starting material which is produced in large scale by acid-mediated 
hydrolysis of plant-derived polysaccharides (sustainable development). 
 
O CHO O NO2
O
NO2
Br
Br
1 2 3
i ii
Biomass
 
 
Scheme 8. Synthesis of (Z)-2-(2-bromo-2-nitroethenyl)-5-bromofuran (3); conditions: i, 
CH3NO2, NaOH, H2O; ii, 1) Br2, AcOH; 2) pyridine   
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Ar1 B(OH)2
O
NO2
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Ar1
O
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Ar1
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Scheme 9. Suzuki reactions of 3; conditions: i, 3 (1.2 equiv.), Ar1B(OH)2 (1.0 equiv.), 
Pd(PPh3)4 (3 mol-%), K3PO4 (2.0 equiv.), solvent (see Table 1); ii, 3 (1.0 equiv.), Ar1B(OH)2 
(2.0 equiv.), Pd(PPh3)4 (5 mol-%), K3PO4 (4.0 equiv.), solvent (see Table 2); iii, 4a-i (1.0 
equiv.), Ar2B(OH)2 (1.0 equiv.), Pd(PPh3)4 (3 mol-%), K3PO4 (2.0 equiv.), solvent (see Table 
3) 
 
The Suzuki reaction of 3 (1.2 equiv.) with various boronic acids (1.0 equiv.) resulted in 
regioselective coupling of the furan rather than the alkenyl moiety to give the 2-(2-bromo-2-
nitroethenyl)-5-arylfurans 4a-i (Scheme 9). The reaction proceeded without E/Z-isomerization 
of the double bond. The structure and configuration of the products was proved by 
spectroscopic methods and by X-ray crystal structure analyses. During the optimization, the 
stoichiometry, temperature, solvent, and the presence of water played an important role (Table 
1). The reaction of 3 (1.0 equiv.) with 2.0 equiv. of boronic acids resulted in double coupling 
and formation of the 2-(2-aryl-2-nitroethenyl)-5-arylfurans 5a-e containing two identical aryl 
groups (Table 2). The Suzuki reaction of 4a (1.0 equiv.) with various arylboronic acids (1.0 
equiv.) allowed the synthesis of 2-(2-aryl-2-nitroethenyl)-5-phenylfurans 6a-f which contain 
two different aryl groups (Table 3). The formation of 5a-e and 6a-f proceeded, as expected for 
Suzuki reactions, without E/Z-isomerization of the double bond. 
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Table 1. Synthesis of 2-(2-bromo-2-nitroethenyl)-5-arylfurans 4a-i 
entry 4 Ar1 Solvent/H2O (6:1) T (°C) % (4)a 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
a
a
a
a
a
b
b
b
c
d
d
e
f
f
g
h
i
Ph 
Ph 
Ph 
Ph 
Ph 
4-(HO)C6H4 
4-(MeO)C6H4 
4-(MeO)C6H4 
2-(MeO)C6H4 
3,5-Me2C6H3 
3,5-Me2C6H3 
4-(EtO)C6H4 
1-Naphtyl 
1-Naphtyl 
3,4,5-(MeO)3C6H2 
2-Thienyl 
4-MeC6H4 
Toluene 
Toluene 
THF 
1,4-Dioxane b 
1,4-Dioxane 
1,4-Dioxane 
1,4-Dioxane 
Toluene 
1,4-Dioxane 
Toluene 
1,4-Dioxane 
1,4-Dioxane 
1,4-Dioxane 
Toluene 
1,4-Dioxane 
1,4-Dioxane 
Toluene 
90 
20 
20 
90 
90 
90 
90 
90 
90 
90 
90 
90 
90 
90 
90 
90 
90 
90 
76 
73 
70 
78 
83 
69 
38 
64 
93 
56 
67 
52 
75 
77 
87 
84 
 
a Isolated yields; b without addition of H2O.  
 
Figure 1. X-Ray crystal structure of compound 5e 
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Table 2. Synthesis of 2-(2-aryl-2-nitroethenyl)-5-arylfurans 5a-g 
5 Ar1 Solvent/H2O (6:1) % (5) a 
a
b
c
d
e
f
g
Ph 
4-(MeO)C6H4 
2-(MeO)C6H4 
3,5-Me2C6H3 
4-(EtO)C6H4 
4-MeC6H4 
2-Thienyl 
Toluene 
1,4-Dioxane 
1,4-Dioxane 
1,4-Dioxane 
Toluene 
Toluene 
1,4-Dioxane 
67 
69 
64 
86 
87 
82 
42 
 
a Isolated yields (all reactions were carried out at 90 °C) 
 
Table 3. Synthesis of 2-(2-aryl-2-nitroethenyl)-5-arylfurans 6a-e 
6 Ar1 Ar2 Solvent/H2O (6:1) % (6) a 
a
b
c
d
e
Ph 
Ph 
Ph 
Ph 
Ph 
1-Naphthyl 
3,5-Me2C6H3 
4-MeC6H4 
4-(MeO)C6H4 
2-Thienyl 
Toluene 
Toluene 
Toluene 
1,4-Dioxane 
Toluene 
63 
74 
79 
75 
57 
 
a Isolated yields (all reactions were carried out at 90 °C) 
1.1.3 Conclusion
 
The Suzuki reaction of 2-(2-bromo-2-nitroethenyl)-5-bromofuran, readily available from 
furfural, resulted in regioselective attack onto the furan moiety. The first regioselective 
Suzuki cross-coupling reaction occurs at the bromo-substituted furan to give 2-(2-bromo-2-
nitroethenyl)-5-arylfuran. The alkenyl moiety could be functionalized in a second Suzuki 
reaction. The products are formed without E/Z-isomerization of the double bond. 
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1.2 Regioselective Suzuki Cross-Coupling Reactions of 2,3,4,5-Tetrabromo-1-
methylpyrrole 
1.2.1 Introduction  
 
Pyrroles are of considerable pharmacological relevance. They occur in a number of synthetic 
drugs (e. g. zomepirac and atorvastatin) and natural products (e. g. in the tetrapyrrole 
pigments Porphobilinogen, Bilirubin, Polycitone A, Lamellarin D, Sventrin, etc.) (Scheme 
10).32,33,34 Oligopyrroles proved to be important as organic materials (e. g. as synthetic 
metals).35 Heterocycles have been widely functionalized by palladium(0)-catalyzed cross-
coupling reactions.36 In recent years, it has been shown that polyhalogenated heterocycles 
may be regioselectively functionalized in such reactions by selective activation of a single 
halogen atom – a process which is controlled by electronic and steric parameters.37 Recently, I 
reported the synthesis of tetraarylthiophenes based on regioselective Suzuki reactions of 
tetrabromothiophene.38 Despite their potential synthetic utility, regioselective 
functionalization reactions of polyhalogenated pyrroles have only scarcely been reported to 
date. Bach and Schröter recently reported regioselective Suzuki reactions of ethyl 2,3,4-
tribromopyrrole-5-carboxylate and of 2,3-dibromo-5-nitropyrrole.39 Herein, I disclose my 
preliminary results related to Suzuki cross-coupling reactions of 2,3,4,5-tetrabromo-1-
methylpyrrole. Palladium(0)-catalyzed cross-coupling reactions of tetrahalopyrroles have, to 
the best of my knowledge, not been reported to date. In general, reactions of tetrahalogenated 
pyrroles are rather rare which can be explained by the unstable nature of these compounds.40 
 
N
NBr
Br
O
O
HO
MeO
MeO
OH
HO
MeO
Lamellarine D
H
N
O
NH
N
NH2
Sventrin
N
HO
HO
Br
Br
OH
Br
BrHO Br
Br
OH
Br
Br
OO
Polycitone A Me  
Scheme  10. Some natural products containing pyrrole moieties. 
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1.2.2 Results and Discussion  
 
2,3,4,5-Tetrabromo-1-methylpyrrole (7) was prepared by NBS-mediated bromination of N-
methylpyrrole. The published procedure41 for the synthesis of 7 was modified, as I were not 
able to isolate the pure product by the original protocol.  The reaction was carried out at 78 
°C for 8 h. It proved to be helpful for the separation of succinimide to add heptane to the 
reaction mixture which results in precipitation of succinimide and of side-products. The 
yellowish crude product was purified by repeated washing with cold ethyl acetate to give the 
pure material in the form of colourless crystals. Noteworthy, impure product fails to undergo 
the desired Suzuki reactions and also more rapidly decomposes. The solid can be stored under 
argon at 18 °C for a few weeks. After a few weeks the compound starts to become slightly 
yellow and the quality is not sufficient anymore for Suzuki reactions.  
 
The Suzuki reaction of 7 with various boronic acids (1.1 equiv.) afforded the 5-aryl-2,3,4-
tribromopyrroles 8a-f in good yields and with very good regioselectivity (Scheme 4, Table 4). 
During the optimization, it proved to be important to suppress the formation of 2,5-diaryl-3,4-
dibromopyrroles, as their separation from the desired products proved to be difficult and 
tedious. The stoichiometry, temperature, solvent, and the presence of water proved to play an 
important role in terms of yield (Table 4). Noteworthy, the employment of benzyl-, 
carbamate-, and sulfonyl-protected pyrroles was unsuccessful (decomposition). The reaction 
of 8e with 1.1 equiv. of (3-chlorophenyl)- and (4-methoxyphenyl)boronic acid resulted in 
regioselective formation of 2,5-diaryl-3,4-dibromopyrroles 9a and 9b, respectively (Scheme 
11).  
 
The Suzuki reaction of 7 with 2.5 equiv. of various arylboronic acids afforded the 2,5-diaryl-
3,4-dibromopyrroles 10a-f in good yields and with very good regioselectivity (Scheme 12, 
Table 5).12 The solvent proved again to be a very important parameter during the optimization 
of the yield. The reaction of 10c with (4-methoxyphenyl)- and (4-chlorophenyl)boronic acid 
gave tetraarylpyrroles 12a and 12b, respectively, containing two different types of aryl 
groups. Tetraarylpyrroles 11a,b, containing four identical aryl groups, were prepared by 
reaction of 7 with (4-ethylphenyl)- and (3.chlorophenyl)boronic acid (5.0 equiv.). The best 
yields of 11a,b and 12a,b were obtained when the reactions were carried out using a ternary 
solvent mixture (toluene/EtOH/H2O = 5:1:1) and an increased amount of catalyst and 
reagents. Considerable amounts of 2,3,5-triaryl-4-bromopyrroles were formed when the 
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amounts of reagents and catalyst were too low. Noteworthy, the bromide groups of 2,5-diaryl-
3,4-dibromopyrroles 10a-f proved to be considerably less reactive than those of 2,5-diaryl-
3,4-dibromothiophenes.38 This must be explained by electronic reasons, as the steric 
hindrance is similar for both types of substrates. The conditions developed for the synthesis of 
11a,b,c and 12a,b could be successfully applied to the synthesis of related tetraarylpyrroles. 
  
N BrBr
Ar1 B(OH)2
N BrAr
1
7 8a-f
i
Br Br Br Br
Me Me
Ar2 B(OH)2
N Ar
2Ar1
9a (45%)
ii
Br Br
Me
Ar1 = 4-MeC6H4; Ar2 = 3-ClC6H4
9b (51%) Ar1 = 4-MeC6H4; Ar2 = 4-(MeO)C6H4
9a,b
 
 
Scheme 11. Synthesis of 5-aryl-2,3,4-tribromopyrroles 8a-f and of 2,5-diaryl-3,4-
dibromopyrroles 9a,b; conditions: i, 7 (1.0 equiv.), Ar1B(OH)2 (1.1 equiv.), Pd(PPh3)4 (6 mol-
%), K3PO4 (4.0 equiv.), solvent (see Table 4), 90 °C, 12 h; ii, 2c (1.0 equiv.), Ar2B(OH)2 (1.1 
equiv.), Pd(PPh3)4 (10 mol-%), K3PO4 (4.0 equiv.), DMF/toluene/EtOH/H2O (4:1:1:1), reflux, 
48 h 
 
Table 4. Synthesis of 8a-f  
8 Ar solvent a % b 
a 3-PhC6H4 Toluene/H2O 66 
b 3-ClC6H4 Toluene/H2O 71 
c 4-EtC6H4 Toluene/H2O 75 
d 2-(MeO)C6H4 1,4-Dioxane/H2O 70 
e 4-MeC6H4 1,4-Dioxane/H2O 81 
f 3,5-Me2C6H3 1,4-Dioxane/H2O 72 
 
a Solvent/H2O = 4:1; b yields of isolated products 
 
All products were characterized by spectroscopic methods. The structure of 8e and 10b was 
independently confirmed by X-ray crystal structure analysis (Figure 2, 3). 
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Scheme 12. Synthesis of 2,5-diaryl-3,4-dibromopyrroles 10a-f and of tetraarylpyrroles 11a,b
and 12a,b; conditions: i, 7 (1.0 equiv.), Ar1B(OH)2 (2.5 equiv.), Pd(PPh3)4 (6-10 mol-%), 
K3PO4 (4.0 equiv.), solvent (see Table 5), 90 °C, 12 h; ii, 10c (1.0 equiv.), Ar2B(OH)2 (3.0 
equiv.), Pd(PPh3)4 (20 mol-%), K3PO4 (4.0 equiv.), DMF/toluene/EtOH/H2O (4:1:1:1), reflux, 
(12a: 48 h, 12b: 96 h); iii, 7 (1.0 equiv.), ArB(OH)2 (5.0 equiv.), Pd(PPh3)4 (20 mol-%), 
K3PO4 (5.0 equiv.), DMF/toluene/EtOH/H2O (4:1:1:1), reflux, 96 h  
Table 5. Synthesis of 10a-f 
10 Ar1 solvent % a 
a 3-ClC6H4 Toluene/H2O (5:1) 57 
b 4-EtC6H4 Toluene/H2O (5:1) 52 
c 4-MeC6H4 Toluene/H2O (5:1) 79 
d 4-ClC6H4 1,4-Dioxane/H2O (5:1) 67 
e 4-(MeO)C6H4 1,4-Dioxane /H2O (5:1) 79 
f Thien-2-yl Toluene/MeOH/H2O (2:2:1) 50 
 
a Yields of isolated products 
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Figure 2. Ortep plot of 8e (50% probability level) 
 
Figure 3. Ortep plot of 10b (50% probability level) 
1.2.3 Conclusion
 
In conclusion, I have reported a new strategy for the synthesis of 5-aryl-2,3,4-
tribromopyrroles, 2,5-diaryl-3,4-dibromopyrroles and tetraarylpyrroles based on 
regioselective Suzuki cross-coupling reactions of N-methyltetrabromopyrrole. 
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1.3 Regioselective Sonogashira Reactions of N-Methyl-Tetrabromopyrrole. First 
Synthesis of Tri- and Tetra-(1-alkynyl)pyrroles 
1.3.1 Introduction  
 
Hydrocarbons bearing multiple alkynyl groups have received considerable attention, due to 
their interesting physicochemical properties, as synthetic building blocks of new and 
interesting arenes, and because of their æsthetic attraction (Scheme 13).42 For example, 
Vollhardt and coworkers reported the synthesis and characterization of hexaethynylbenzene A 
and its application to the first synthesis of the so-called archimedanes containing only benzene 
and cyclobutane moieties.43 In contrast to their hydrocarbon counterparts, multiple-
alkynylated heterocycles are relatively rare. Whitesides et al. reported the synthesis of tetra(1-
alkynyl)thiophenes B based on regioselective Sonogashira couplings of tetraiodothiophene.44 
Later, related reactions of tetrabromothiophene were reported.45 
 
Pyrroles constitute an important class of heterocycles which are present in natural products (e. 
g. in the tetrapyrrole pigments porphobilinogen and bilirubin)46 and in various synthetic drugs 
(e. g. zomepirac and atorvastatin).34 Pyrroles and oligopyrroles show promising properties as 
new materials (e.g., as synthetic metals).35 In recent years, syntheses of 2,5-47 and 3,4-di(1-
alkynyl)pyrroles48 have been reported. These molecules have been used for the synthesis of 
polymers and fused heterocycles. The synthesis of tri- and tetra(1-alkynyl)pyrroles C has, to 
the best of my knowledge, not been reported to date.  
 
SeS N
R
A B C D  
 
Scheme 13. Molecules with multiple alkynyl groups 
 
Heterocycles have been widely functionalized by palladium(0)-catalyzed cross-coupling 
reactions.49 In recent years, it has been shown that polyhalogenated heterocycles may be 
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regioselectively functionalized in such reactions by selective activation of a single halogen 
atom – a process which is controlled by electronic and steric parameters.37 Bach and Schröter 
reported regioselective Sonogashira reactions of ethyl 2,3,4-tribromopyrrole-5-carboxylate 
and of 2,3-dibromo-5-nitropyrrole.39 Recently, I reported the synthesis of aryl-substituted 
thiophenes38 and pyrroles50 by Suzuki reactions of tetrabromothiophene and tetrabromo-N-
methylpyrrole, respectively. Herein, I disclose my preliminary results related to what are, to 
the best of my knowledge, the first Sonogashira cross-coupling reactions of tetrabromo-N-
methylpyrrole. These reactions allow a convenient synthesis of a variety of novel alkynylated 
pyrroles. In this context, I report what are, to the best of my knowledge, the first syntheses of 
tri- and tetra(1-alkynyl)pyrroles. 
1.3.2 Results and Discussion  
 
The reaction of N-methylpyrrole with N-bromosuccinimide (NBS) afforded tetrabromo-N-
methylpyrrole (7). The synthesis was carried out following the procedure of Gilow and 
Burton,51 but with some variations (related to the temperature, reaction time, and amount of 
NBS). Notably, I observed that it is crucial to isolate 7 in analytically pure form as colourless 
crystals. The oily form is generally slightly impure, tends to be considerably less stable and 
decomposes within a few days. The presence of impurities results in a failure of Pd(0)-
catalyzed cross-coupling reactions. In contrast, the crystalline solid can be stored under argon 
atmosphere at 18 °C (in the dark) for a few weeks. Then, the compound starts to slightly 
darken and it cannot be successfully used anymore in Pd(0)-catalyzed reactions.  
 
In general, the Sonogashira cross-coupling reactions reported herein only proved to be 
possible when tetrabromo-N-methylpyrrole was employed. The employment of benzyl-, 
carbamate-, and sulfonyl-protected tetrabromopyrroles was unsuccessful and resulted in the 
formation of complex mixtures and decomposition. In most of the Sonogashira reactions 
reported herein, the best yields were obtained when (freshly prepared) PdCl2(CH3CN)2 (10 
mol-%), CuI (10 mol-%), PPh3 (20 mol-%), and (rigorously dried and freshly distilled) 
iPr2NH were employed. The yields dramatically decrease when traces of water are present. 
The temperature and the reaction time also proved to be important parameters (vide infra). 
The yields of most products reported herein could be slightly increased when 20 rather than 
10 mol-% of catalyst was employed. The best yields were generally obtained for non-volatile 
alkynes, due to the high reaction temperatures. 
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The Sonogashira reaction of 7 with various alkynes (1.1 equiv.) regioselectively afforded the 
novel 5-(1-alkynyl)-2,3,4-tribromopyrroles 13a-e (Scheme 14, Table 6). The formation of a 4-
(1-alkynyl)-2,3,5-tribromopyrrole was not observed. The relatively low yields of 13a-e can be 
explained by the formation of considerable amounts of 2,5-di(1-alkynyl)-3,4-
dibromopyrroles. Therefore, it proved to be important during the optimization to use not more 
than 1.1 equiv. of the alkyne and to stirr the solution at 90 °C for not more than 1 h. Stirring 
for 3 h resulted in the formation of a mixture of 2,5-di(1-alkynyl)-3,4-dibromopyrroles and 
starting material (7). Likewise, the yields of 13a-e decreased when the reactions were carried 
out at temperatures lower than 90 °C. The yields could be slightly increased when 20 rather 
than 10 mol-% of catalyst was employed. 
 
The Sonogashira reaction of 7 with two different alkynes (1.05 equiv. each) afforded the 
unsymmetrical 2,5-(1-alkynyl)-3,4-tribromopyrroles 3a-e (Scheme 14, Table 7). During the 
optimization, it proved to be important that alkynes of considerably different reactivity are 
employed. In addition, it was crucial to add both alkynes at the same time to avoid the 
formation of symmetrical 2,5-di(alkynyl)pyrroles.  
 
The reaction of 7 with 2-methylbut-3-yn-2-ol and phenylacetylene (1.05 equiv. each) and, 
subsequently, with phenylacetylene (1.05 equiv.) afforded the 2,4,5-tri(1-alkynyl)-3-
bromopyrrole 4.  
 
Table 6. Synthesis of 13a-e  
13 R1 % a 
a nPr 30 
b CMe2OH 32 
c (CH2)3OH 30 
d CH2CH(OH)Me 35 
e 4-MeC6H4 40 
 
a yields of isolated products 
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N BrBr
R1
N Br
7
13a-e
i
Br Br Br Br
Me Me
N
14a-e
ii
Br Br
Me
R1
R1 R2
R2
N
15 (41%)
(R1 = CMe2OH, R2 = Ph)
Br
Me
R1 R2
R2
iii
(see Table 7)
(see Table 6)
R1
R1
R2
 
 
Scheme 14. Synthesis of 13a-e, 14a-e, and 15; conditions: i, 7 (1.0 equiv.), R1CCH (1.2 
equiv.), PdCl2(CH3CN)2 (10 mol-%), CuI (10 mol-%), PPh3 (20 mol-%), iPr2NH, 90 °C, 1 h; 
ii, 7 (1.0 equiv.), R1CCH and R2CCH (1.05 equiv. each, addition at the same time), 
PdCl2(CH3CN)2 (10 mol-%), CuI (10 mol-%), PPh3 (20 mol-%), iPr2NH, 90 °C, 6-8 h; iii, 1) 
7 (1.0 equiv.), R1CCH and R2CCH (1.05 equiv. each, addition at the same time), 
PdCl2(CH3CN)2 (10 mol-%), CuI (10 mol-%), PPh3 (20 mol-%), iPr2NH, 100 °C, 6-8 h; 2) 
R2CCH (1.05 equiv.), 12-16 h 
Table 7. Synthesis of 14a-e
14 R1 R2 % a 
a 4-MeC6H4 CH2CH(OH)Me 40 
b 4-MeC6H4 (CH2)3OH 40 
c 4-MeC6H4 CMe2OH 44 
d 4-MeC6H4 nHex 41 
e CMe2OH nHex 37 
 
a yields of isolated products 
 
The Sonogashira reaction of 7 with 2.5 equiv. of various alkynes afforded the symmetrical 
2,5-di(1-alkynyl)-3,4-dibromopyrroles 16a-k in good yields and with very good 
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regioselectivity (Scheme 15, Table 8). Products 16a,b,d,g-k were obtained in good yields 
when the reaction was carried out using PdCl2(CH3CN)2, PPh3 and HNiPr2 (procedure A). The 
best yields were obtained when the reaction mixture was stirred at 100 °C for 6-8 h. Longer 
and shorter reaction times resulted in a decrease in yield, due to decomposition and 
uncomplete conversion, respectively. However, product 16b could be isolated in equally good 
yield after stirring for only 3 h when the reaction was carried out in an autoclave (at 90 °C). 
The yields of products 16a,b could be improved when Pd(OAc)2, the novel ligand L and 
Cs2CO3 were employed (procedure C). This method was also successfully applied to the 
synthesis of 16c,e,f. The yields of 16a,b,i considerably decreased when the (freshly prepared) 
carbene-ligated catalyst 7 (5 mol-%) was employed (procedure B).  
 
The structure of 16b was independently confirmed by X-ray crystal structure analysis (Figure 
4).73  
 
 
Figure 4. Ortep plot of 16b (50% probability level) 
 
N
N
Me
MeO2C
Pd
N
N
Me
CO2Me
Cl
Cl
7
PCy2
iPr Cy = CyclohexylPrL  =
iPr
i
 
 
The Sonogashira reaction of 16a,b with 2-methylbut-3-yn-2-ol (4.0 equiv.) afforded the 
tetra(1-alkynyl)pyrroles 17a,b containing two different types of alkynyl substituents. 
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R
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7 16a-h 17a (R = Ph): 33%
17b (R = 4-Tol): 15%
ii
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Me Me
RR N
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Me
MeHO Me
Me
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Me
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HO
(see Table 8)  
 
Scheme 15. Synthesis of 16a-h and 17a,b; conditions: i, procedure A: 7 (1.0 equiv.), RCCH 
(2.5 equiv.), PdCl2(CH3CN)2 (10 mol-%), CuI (10 mol-%), PPh3 (20 mol-%), iPr2NH, 100 °C, 
6-8 h; procedure B: 7 (1.0 equiv.), 7 (5 mol-%, structure see below), PPh3 (5 mol-%), CuI (10 
mol%), Cs2CO3 (1.5 equiv.), DMF; procedure C: Pd(OAc)2 (5 mol-%), L (15 mol-%), 
Cs2CO3 (3.0 equiv.), CH3CN, reflux, 6 h; ii, 16a,b (1.0 equiv.), RCCH (4.0 equiv.), 
PdCl2(CH3CN)2 (10 mol-%), CuI (10 mol-%), PPh3 (20 mol-%), iPr2NH, 100 °C, 20 h 
 
Table 8. Synthesis of 16a-h 
16 Ar % (A) a % (B) a % (C) a 
a Ph 59 17 84 
b 4-MeC6H4 71 19 79 
c 4-FC6H4   47 
d nPr 45   
e nPent   67 
f nOct   72 
g nUndec 65   
h (CH2)3OH 61   
i CH2CH(OH)Me 70 15  
j CMe2OH 74   
k SiMe3 67   
 
a yields of isolated products using procedures A, B, and C (see Scheme 14) 
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2,4,5-Tri(1-alkynyl)-3-bromopyrroles 18a-e, containing three identical alkynyl groups, were 
selectively prepared by Sonogashira reaction of 7 with 3.3 equiv. of various alkynes (Scheme 
16, Table 9).16,21 The best yields were obtained when the reaction mixture was stirred at 100 
°C for 12-16 h. The success of these transformations relies on the fact that the formation of 
the fourth carbon-carbon bond is significantly slower than the formation of the third one. In 
fact, no competing formation of a tetra(1-alkynyl)pyrrole was observed. 
 
N BrBr
R
i
7 18a-e
Br Br
N
Br
Me Me
RR
R
(see Table 9)  
 
Scheme 16. Synthesis of 18a-e; conditions: i, 7 (1.0 equiv.), RCCH (3.3 equiv.), 
PdCl2(CH3CN)2 (10 mol-%), CuI (10 mol-%), PPh3 (20 mol-%), iPr2NH, 100 °C, 12-16 h 
 
Table 9. Products and yields  
18 R % a 
a Ph 36 
b 4-MeC6H4 42 
c CMe2OH 40 
d (CH2)3OH 40 
e CH2CH(OH)Me 44 
 
a yields of isolated products 
 
Tetra(1-alkynyl)pyrroles 19a and 19b, containing four identical alkynyl groups, were 
prepared by reaction of 7 with an excess (6.0 equiv.) of phenylacetylene and 4-tolylacetylene, 
respectively (Scheme 17). The best yields were obtained when the reaction mixture was 
stirred at 100 °C for 20 h. Although the yields of 19a,b are relatively low, it should be taken 
into account that four carbon-carbon bonds are formed in one reaction. A theoretical yield of 
71% for each C-C bond formation would result in a 25% overall yield. Notably, products 
derived from alkyl-substituted alkynes proved to be rather unstable and could not be isolated 
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in pure form. We have not yet tried to prepare the unsubstituted parent compound, 
tetraethynyl-N-methylpyrrole, as its thiophene analogue has been reported to be highly 
explosive.44 
N BrBr
R
i
7
Br Br
N
Me Me
RR
RR
19a (R = Ph): 25%
19b (R = 4-Tol): 32%  
 
Scheme 17. Synthesis of 19a,b; conditions: i, 7 (1.0 equiv.), RCCH (6.0 equiv.), 
PdCl2(CH3CN)2 (10 mol-%), CuI (10 mol-%), PPh3 (20 mol-%), iPr2NH, 100 °C, 20 h 
1.3.3 Conclusion
 
In conclusion, I have studied the synthesis of a variety of alkynyl-substituted pyrroles based 
on regioselective Sonogashira cross-coupling reactions of tetrabromo-N-methylpyrrole. In this 
context, the synthesis of what are, to the best of my knowledge, the first tri- and tetra(1-
alkynyl)pyrroles has been reported. The Sonogashira reactions of tetrabromo-N-methylpyrrole 
first occur at carbon atoms C2 and C5 which are more electron deficient than C3 and C4. The 
formation of 2,5-di(1-alkynyl)pyrroles is relatively fast. Therefore, the best yields were 
obtained for the synthesis of the symmetrical di(alkynyl)pyrroles 16. In contrast, the synthesis 
of the mono-alkynylated pyrroles 13 was more difficult and required a thorough optimization 
of the reaction time. Unsymmetrical di(alkynyl)pyrroles 14 could be directly prepared from 7 
when two alkynes of different reactivity were employed and added at the same time. The first 
tri(1-alkynyl)pyrroles were prepared. For their successful synthesis it proved to be important 
that the formation of the fourth carbon-carbon bond is significantly slower than the formation 
of the third one. Finally, I reported the synthesis of the first tetra(1-alkynyl)pyrroles.  
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1.4 Efficient Synthesis of Substituted Selenophenes based on the First 
Palladium(0)-Catalyzed Cross-Coupling Reactions of 
Tetrabromoselenophene 
1.4.1 Introduction  
 
Selenium represents an essential element for higher organisms.52 In this context, the selenium 
containing enzymes Glutathioneperoxidase and 5’-Deiodase type 1 play an important role. In 
fact, a number of diseases can result from selenium deficiency.53,54 In addition, selenium 
containing molecules are of considerable pharmacological relevance.55 A prominent example 
is the antitumor and antiviral active C-glycosyl selenazole selenazofurin.56 Selenophenes have 
also been reported to be of considerable pharmacological relevance. For example, they act as 
muscarinic antagonists,57 show antiviral activity,58 inhibitory activity against human 
myelogenous leukemia K562 cells, cytotoxicity against HT-29, HeLa, ACHN and 5637 
cells,59 and in vitro antiproliferative activity against human acute B-lymphoblastic leukemia 
and human acute T-lymphoblastic leukemia.60 In addition, selenophenes promote the 
polymerization of tubulin and stabilize microtubules.61 Selenophene containing porphyrines 
have been shown to possess activity against murine colon carcinoma Colo-26 cells.62 
Selenophenes also exhibit antifungal activity63 and cytotoxic against human cervical cancer 
KB cells and human hepatocellular carcinoma HepG2 cells cells.64 
 
Unfortunately, selenium compounds are in most cases less stable than their corresponding 
sulfur analogues. In addition, the methods and conditions available for the synthesis of 
organosulfur compounds can often not be applied to selenium. Therefore, the development of 
new methods for the synthesis of organoselenium compounds is of considerable current 
interest. Substituted selenophenes65 have been mostly prepared so far based on 
cyclocondensation reactions. For example, 2,5-diarylselenophenes and tetraarylselenophenes 
are available by cyclocondensation of alkynes (2 equiv.) with selenium in the presence of 
lithium metal.66 However, these reactions often suffer from the harsh reaction conditions. 
Kirsch and coworkers reported67 the synthesis of 2,5-diarylselenophes by -Aryl--chloro 
acroleins, easily prepared from substituted acetophenones and Vilsmaier-Haack reagent, are 
condensed with appropriate benzylbromide derivatives to give the title compounds 
Heterocycles have been widely functionalized by palladium(0)-catalyzed cross-coupling 
reactions.68 However, syntheses of functionalized selenophenes by such reactions are 
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relatively rare. 2,5-Diarylselenophenes were prepared by Suzuki reactions of 2,5-
dihaloselenophenes.69 The Sonogashira reaction of 2-bromo- and 2-iodoselenophene with 
alkynes has been reported to give (1-alynyl)selenophenes.70 The reaction of 2,5-
diiodoselenophene with two equivalents of an alkyne has been reported to give 2,5-di(1-
alkynyl)selenophenes. The synthesis of tri- and tetra(1-alkynyl)selenophenes has, to the best 
of my knowledge, not been reported to date. 
 
In recent years, it has been shown that polyhalogenated heterocycles can be regioselectively 
functionalized in palladium(0)-catalyzed cross-coupling reactions by selective activation of a 
single halogen atom. The regioselectivity is controlled by electronic and steric parameters.37 
Recently, I have reported the synthesis of tetraarylthiophenes50 and –pyrroles71 based on 
regioselective Suzuki reactions of tetrabromothiophene and tetrabromo-N-methylpyrrole, 
respectively. Herein, I disclose my preliminary results related to Suzuki reactions of 
tetrabromoselenophene. These reactions allow a convenient and regioselective approach to 
aryl-substituted selenophenes which are not readily available by other methods. In addition, I 
report the synthesis of what is, to the best of my knowledge, the first tetra(1-
alkynyl)selenophene by a Sonogashira reaction of tetrabromoselenophene. 
1.4.2 Results and Discussion  
 
Helmholdt and coworkers have recently reported the synthesis of tetrabromoselenophene (20) 
in 39% yield by reflux of a CHCl3 solution of selenophene with an excess of bromine.72 We 
have been able to improve the yield to 84% by some modifications (Scheme 18). The solvent 
CHCl3 was replaced by CH2Cl2. Due to the lower boiling point of CH2Cl2, the amount of 
bromine present in solution (and not in the gas phase) could be increased. The reaction time 
had to be extended from 12 to 72 h in order to make sure that the bromination is complete. 
Considerable amounts of di- and tribrominated selenophenes were formed when the reaction 
time was too short. Tetrabromoselenophene was isolated as a crystalline solid which can be 
stored under argon at 18 °C for several weeks.  
Se
20 (84%)
i
Se BrBr
Br Br
 
Scheme 18. Synthesis of tetrabromoselenophene (20); conditions: i, 1) Br2 (7.0 equiv.), 0 °C, 
CH2Cl2; 2) reflux, 3 d; 3) NaOH, H2O (2 M), reflux, 6 h 
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The Suzuki reaction of 20 with various boronic acids (1.1 equiv.) afforded the 5-aryl-2,3,4-
tribromoselenophenes 21a-d in good yields and with very good regioselectivity (Scheme 19, 
Table 21). During the optimization, it was important to suppress the formation of 2,5-diaryl-
3,4-dibromoselenophenes, as their separation from the desired products proved to be difficult. 
Therefore, the stoichiometry was an important parameter and only a slight excess of the 
boronic acid should be used. Products 21a,c,d were best prepared using Pd(PPh3)4 (5 mol-%) 
in dioxane/toluene/H2O (2:2:1) (procedure A). For the reaction of 20 with sterically 
encumbered 3,5-dimethylphenylboronic acid (to give product 21b) the application of 
procedure A gave unsatisfactory results (formation of a complex mixture). The problem was 
solved by employment of the new ligand L (Chart 1) which has been recently introduced by 
Buchwald and coworkers. The reaction of a dioxane/toluene solution (1:1) of 20 with 3,5-
dimethylphenylboronic acid, in the presence of  Pd(OAc)2 (5 mol-%) and L (10 mol-%), 
afforded  21b in 85% yield (procedure B). The reaction of 21a,b with 1.2 equiv. of (4-
tolyl)boronic acid, following procedure B, resulted in regioselective formation of the 
unsymmetrical 2,5-diaryl-3,4-dibromoselenophenes 22a,b (Scheme 19).  
 
 
Se BrBr
Ar1 B(OH)2
Se BrAr
1
20 21a-d
i
Br Br Br Br Ar2 B(OH)2
Se Ar
2Ar1
ii
Br Br
22a (Ar1 = 3,5-Me2C6H3; Ar2 = 4-MeC6H4): 76%
22b (Ar1 = 4-EtC6H4; Ar2 = 4-MeC6H4): 80%
22a,b
 
 
Scheme 19. Synthesis of 5-aryl-2,3,4-tribromoselenophenes 21a-d and of 2,5-diaryl-3,4-
dibromoselenophenes 22a,b; conditions: i, procedure A: 20 (1.0 equiv.), Ar1B(OH)2 (1.3 
equiv.), Pd(PPh3)4 (5 mol-%), K3PO4 (4.0 equiv.), dioxane/toluene/H2O (2:2:1), reflux, 8 h; 
procedure B: 20 (1.0 equiv.), Ar1B(OH)2 (1.1 equiv.), Pd(OAc)2 (5 mol-%), L (see Chart 1, 10 
mol-%), K3PO4 (4.0 equiv.), dioxane/toluene (1:1), reflux, 8 h; ii, 21a,b (1.0 equiv.), (4-
MeC6H4)B(OH)2 (1.1 equiv.), Pd(OAc)2 (5 mol-%), L (see Chart 1, 10 mol-%), K3PO4 (4.0 
equiv.), dioxane/toluene (1:1), reflux, 8 h 
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Table 10. Products and yields  
21 Ar1 % (2) a,b 
a 4-EtC6H4 50 (A) 
b 3,5-Me2C6H3 85 (B) 
c 4-(MeO)C6H4 68 (A) 
d 3-PhC6H4 47 (A) 
 
a Isolated yields; in brackets: b procedure (see legend of Scheme 19) 
 
PCy2
OMe Cy = CyclohexylMeOL  =
 
 
Chart 1. Biaryl monophosphine ligand developed by Buchwald and coworkers (ref. 73) 
 
The Suzuki reaction of 20 with 2.5 equiv. of various arylboronic acids afforded the 
symmetrical 2,5-diaryl-3,4-dibromoselenophenes 23a-h in good yields and with very good 
regioselectivity (Scheme 20, Table 11). The best yields of products 23b,c were obtained by 
application of procedure B (using Pd(OAc)2 / L). In contrast, procedure A (using Pd(PPh3)4) 
gave better yields for halogenated arylboronic acids (products 23f,g). This can be explained 
by the assumption that Pd(OAc)2 / L catalyzes a homo-coupling of the halogenated 
arylboronic acid which competes with the desired cross-coupling reaction.  
 
The reaction of 23b with (4-methoxyphenyl)boronic acid (3.0 equiv.) gave 
tetraarylselenophene 25a,b containing two different types of aryl groups (Scheme 12). 
Tetraarylselenophene 24a-e, containing four identical aryl groups, was prepared by reaction 
of 20 with various arylboronic acid (5.0 equiv.) (Table 12). The sterically encumbered 
tetraarylselenophenes 24a-e and 25a,b were isolated in very good yields when a) procedure B 
was employed, b) an excess of the respective boronic acid was employed and c) the amount 
catalyst was increased (10 rather than 5 mol-%). Considerable amounts of 2,3,5-triaryl-4-
bromoselenophenes were formed when the amounts of boronic acid and catalyst were too 
low.  
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Ar1 B(OH)2
Ar B(OH)2
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i
20 23a-h
24a-e 25a,b
iiiii
Br Br Br Br
Se Ar
1Ar1
Ar2 Ar2
Se ArAr
Ar Ar
25a (79%): Ar1 = 4-(MeO)C6H4, Ar2 =  4-EtC6H4
25b (82%): Ar1 = 4-(MeO)C6H4, Ar2 = 3,5-Me2C6H4
Scheme 20. Synthesis of 2,5-diaryl-3,4-dibromoselenophenes 23a-h and 
tetraarylselenophenes 24a-e and 25a,b ; conditions: i, procedure A: 20 (1.0 equiv.), 
Ar1B(OH)2 (2.5 equiv.), Pd(PPh3)4 (5 mol-%), K3PO4 (4.0 equiv.), dioxane/toluene/H2O 
(2:2:1), reflux, 14 h; procedure B: 20 (1.0 equiv.), Ar1B(OH)2 (2.1 equiv.), Pd(OAc)2 (5 mol-
%), L (see Chart 1, 10 mol-%), K3PO4 (4.0 equiv.), dioxane/toluene (1:1), reflux, 8 h; ii, 23b 
(1.0 equiv.), (4-(MeO)C6H4B(OH)2 (3.0 equiv.), Pd(OAc)2 (5 mol-%), L (see Chart 1, 10 mol-
%), K3PO4 (4.0 equiv.), dioxane/toluene (1:1), reflux, 8 h; iii, procedure A: 20 (1.0 equiv.), 
Ar1B(OH)2 (5.0 equiv.), Pd(PPh3)4 (10 mol-%), K3PO4 (4.0 equiv.), dioxane/toluene/H2O 
(2:2:1), reflux, 14 h; procedure B: 20 (1.0 equiv.), Ar1B(OH)2 (5.0 equiv.), Pd(OAc)2 (10 mol-
%), L (see Chart 1, 20 mol-%), K3PO4 (4.0 equiv.), dioxane/toluene (1:1), reflux, 8 h
Table 11. Synthesis of 23a-h
23 Ar1 % (4) a,b 
a 4-MeC6H4 83 (A) 
b 4-EtC6H4 69 (A), 83 (B) 
c 3,5-Me2C6H3 65 (A), 79 (B) 
d 4-(MeO)C6H4 82 (B) 
e 2-(MeO)C6H4 42 (A), 68 (B) 
f 3-ClC6H4 45 (A), 15 (B) 
g 4-BrC6H4 55 (A) 
h 3-PhC6H4 48 (A) 
a Isolated yields; in brackets: procedure (see legend of Scheme 19) 
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Table 12. Synthesis of 24a-e 
24 Ar1 % (5) a 
a Ph 55 (A), 79 (B) 
b 4-MeC6H4 89 (B) 
c 4-EtC6H4 98 (B) 
d 3,5-Me2C6H3 74 (A) 
e 4-(MeO)C6H4 89 (B) 
 
a Isolated yields; in brackets: procedure (see legend of Scheme 19) 
 
All products were characterized by spectroscopic methods. The structures of 23d and 24d 
were independently confirmed by X-ray crystal structure analyses (Figures 5 and 6).74 
 
 
Figure 5. Ortep plot of 24d (50% probability level)  
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Figure 6. Ortep plot of 23d (50% probability level) 
 
Se BrBr Seii
20 27a-f
i
Br Br Br Br
SeBr
Br Br
R R
R
26a (28%): R = C6H5-
26b (38%): R = (Et)3Si-
26b (20%): R = (Me)3Si-
26a,b,c
R
R
 
 
Scheme 21. Synthesis of 7; conditions: i, 20 (1.0 equiv.), alkyne (1.1 equiv.), Pd(PPh3)4 (5 
mol-%), CuI (5 mol-%), iPr2NH, 100 °C, 12 h; ii, 20 (1.0 equiv.), alkyne (2.3 equiv.), 
Pd(CH3CN)2Cl2 (5 mol-%), P(t-Bu)3 (10 mol-%), CuI (5 mol-%), iPr2NH, 100 °C, 12 h 
 
Firstly, the Sonogashira coupling of 20 (1.0 equiv.) with  alkyne (1.1 equiv.) gave the 
products 26a,b,c with low yield when tetrakis was used as catalysts (Scheme 14). The 
optimization of Sonogashira reaction of 20 was screened by some procedures. The 
Sonogashira coupling of 20 with 2.3 equiv. phenylacetylene under different kinds of ligand, 
base, solvent and temperature was shown in table 13. The best yield was obtained when 
procedure (d) was used. The catalytic system (d) was applied for synthesis of di(1-
alkynyl)selenophene. The results of product 27a-f were shown in table 14. The di(1-
alkynyl)selenophene 27d,f were obtained with high yield. 
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The structures of 26a was independently confirmed by X-ray crystal structure analyses 
(Figure 7).74 
 
Table 13. The screening of some procedures a 
C6H5 Catalysts – 5 mol % Solvent - base  T°C % 
a
b
c
d
e
Pd(Ph3)4 
Pd(Ph3)4 
Pd(CH3CN)2Cl2–P(t-Bu)3 
Pd(CH3CN)2Cl2–P(t-Bu)3 
Pd(OAc)2 
DMF – NEt3 
Toluene : EtOH – HN(iPr)2 
1,4-Dioxane - HN(iPr)2 
1,4-Dioxane - HN(iPr)2 
N(C2H5OH)3 
Room temperature 
100°C 
Room temperature 
100°C 
100°C 
- 
53 
86 
91 
66 
 
a : CuI 2 mol-% b: 4 mL Toluene : EtOH (2:2); c, d: ligand P(t-Bu)3 (10 mol-%), 4 mL 1,4-
Dioxane; e: 4 mL N(C2H5OH)3 : acts as ligand, base and solvent. 
 
 
Figure 7. Ortep plot of 26a (50% probability level) 
 
Table 14. Synthesis of 27a-f 
27 R % (27) d 
a
b
c
d
e
f
p-tolyl 
4-(MeO)C6H4 
trimethylsiyl 
m-tolyl 
4-FC6H4 
C6H5 
83 
40 
65 
98 
46 
91 
 
d : procedure d was employed. 
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The Sonogashira coupling of 20 with phenylacetylene afforded tetra(1-alkynyl)selenophene 
28 in 77% yield (Scheme 22). During the optimization, the employment of an excess of 
alkyne (6.0 equiv.), a relatively high temperature (100 °C) and a long reaction time (14 h) 
proved to be important. The best results were obtained when Pd(PPh3)4 (10 mol-%) was used 
as the catalyst. The use of an excess of CuI allowed to significantly improve the yield 
compared to the use of only 10 mol-%. Diisopropylamine was used as the solvent. To the best 
of my knowledge, the synthesis of a tetra(1-alkynyl)selenophene has not been reported to 
date. 
Se BrBr
Ph
i
20
Br Br
Se PhPh
PhPh
28 (77%)
Scheme 22. Synthesis of 28; conditions: i, 20 (1.0 equiv.), PhCCH (6.0 equiv.), Pd(PPh3)4 
(10 mol-%), CuI (4.0 equiv.), iPr2NH, 100 °C, 14 h 
1.4.3 Conclusion
 
In conclusion, I have reported a new strategy for the synthesis of 5-aryl-2,3,4-
tribromoselenophenes, 2,5-diaryl-3,4-dibromoselenophenes, and tetraarylselenophenes based 
on regioselective Suzuki reactions of tetrabromoselenophene. The first tetra(1-
alkynyl)selenophene was prepared by Sonogashira reaction of tetrabromoselenophene with 
phenylacetylene. 
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1.5 Regioselective Palladium(0)-Catalyzed Cross-Coupling Reactions and 
Metal-Halide Exchange Reactions of Tetrabromothiophene 
1.5.1 Introduction 
 
Regioselective functionalizations of polyhalogenated heterocycles play an increasingly 
important role in organic synthesis.37 Such reactions rely on the higher reactivity of more 
electron-deficient carbon atoms while the other reactive positions remain unattacked. This 
concept has been applied to regioselective palladium(0)-catalyzed cross-coupling reactions 
based on different rates of oxidative additions of palladium(0) species to different carbon-
halide bonds of the substrate. Thiophene-containing compounds constitute an important class 
of materials which show intrinsic electronic properties such as luminescence, redox activity, 
nonlinear optical chromism and electron-transport.75 Thiophenes are also present in 
pharmacologically relevant natural products. This includes, for example, dibenzothiophenes,76 
[2,2';5',2'']terthiophenes,77 and thienyl-diynes.78 
 
2,3-Dibromothiophene has been functionalized by regioselective Sonogashira coupling of 
carbon atom C-2.79 A very good C-2 regioselectivity was observed also for the Kumada cross 
coupling of 2,3- and 2,4-dibromothiophene.80 2,5-Disubstituted thiophenes were prepared by 
regioselective Sonogashira coupling reactions of tetraiodothiophene81 and 
tetrabromothiophene.82 Recently, I reported the synthesis of symmetrical 2,3,4,5-tetraaryl- and 
2,5-diaryl-3,4-dibromothiophenes by regioselective Suzuki reactions of 
tetrabromothiophene.38 In my initial study, ‘classical’ conditions (use of 10-20 mol-% of 
Pd(PPh3)4) were employed. Although these conditions gave excellent yields in a number of 
cases, several other reactions failed or proceeded sluggishly in only moderate or low yields. 
Herein, I report that the yields could be significantly improved by application of a new biaryl 
monophosphine ligand developed by Buchwald and coworkers. With respect to my 
preliminary studies, I herein report for the first time the selective synthesis of 5-aryl-2,3,4-
tribromothiophenes and their transformation into unsymmetrical 2,5-diaryl-3,4-
dibromothiophenes. These reactions were not possible at all under classical conditions. In 
addition, I report regioselective metal-halide exchange reactions of tetrabromothiophene. 
Although a few isolated examples of such reactions have been previously reported,83 I studied 
the preparative scope and synthetic applications. For example, the combination of metal-
halide exchange reactions with Suzuki reactions provides a new and convenient strategy for 
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the synthesis of ningaline A analogues and related target molecules. In addition, I report for 
the first time a one-pot protocol for the sequential reaction of tetrabromothiophene with two 
different electrophiles.  
1.5.2 Results and Discussion 
 
Tetrabromothiophene (30) was prepared by bromination of thiophene (following a modified 
literature procedure) (Scheme 23).84 During the optimization, it proved to be important to 
dropwise add an excess of bromine (dissolved in chloroform) to a chloroform solution of 
thiophene at 0 °C. A saturated aqueous solution of NaOH was added and the mixture was 
stirred under reflux for 6 h. The product was recrystallized from a 1:1 solution of chloroform 
and methanol. The crude product (red to brownish crystals) was washed with cold ethyl 
acetate for several times to give pure 30 as colourless crystals (87%). Notably, I observed that 
it is crucial to isolate 30 in analytically pure form as colourless crystals. The oily form is 
generally slightly impure, tends to be considerably less stable and decomposes within a few 
days. The presence of impurities results in a failure of Pd(0)-catalyzed cross-coupling 
reactions. In contrast, the crystalline solid can be stored under argon atmosphere at 18 °C (in 
the dark) for a few weeks. Then, the compound starts to slightly darken and it cannot be 
successfully used anymore in Pd(0)-catalyzed reactions.  
 
S
30 (87%)
i
S BrBr
Br Br
 
Scheme 23. Synthesis of tetrabromoselenophene (30); conditions: i, 1) Br2 (7.0 equiv., slow 
addition), 0 °C, CHCl3, 2) reflux, 3 h; 3) NaOH, H2O (2 M), reflux, 6 h 
The tetraarylthiophenes 31a-g, containing four identical aryl groups, were successfully 
prepared by Suzuki reaction85 of 30 (1.0 equiv.) with 5.0 equiv. of various boronic acids 
(Scheme 24, Table 14). All reactions were carried out based on optimization studies of Suzuki 
reactions carried out in my laboratory.86 The protocol is defined as ‘procedure A’ in the 
present manuscript. Tetrakis(triphenylphoshane)palladium(0) and potassium phosphate were 
used as catalyst and base, respectively. The stoichiometry of the reagents, the temperature, the 
solvent, and the presence of water proved to be important parameters. Oxygen-containing 
boronic acids showed a better solubility in 1,4-dioxane than in toluene. On the other hand, the 
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higher boiling point of toluene proved to be advantageous in many cases. All reactions were 
carried out in the presence of water (solvent/water = 4:1) which proved to be very important 
in order to obtain good yields.87 While products 31b and 31d-g were formed in excellent 
yields, 31a and 31c could be isolated in only moderate yields. The synthesis of tetra(thien-2-
yl)thiophene (31h) completely failed. Products 31a, 31c and 31h were prepared in good yields 
by the application of Pd(OAc)2 as the catalyst and the new biaryl monophosphine ligand L 
(Chart 1) developed by Buchwald and coworkers. 
 
S BrBr
Ar1 B(OH)2
S Ar
1Ar1
30 31a-h
i
Br Br Ar1 Ar1
 
 
Scheme 24. Synthesis of tetraarylthiophenes 31a-h. Conditions: i, procedure A: 17 (1.0 
equiv.), Ar1B(OH)2 (5.0 equiv.), Pd(PPh3)4 (10 mol-%), K3PO4 (8.0 equiv.), solvent/H2O = 
4:1 (solvent see Table 1); procedure B: 17 (1.0 equiv.), Ar1B(OH)2 (6.0 equiv.), Pd(OAc)2 (5 
mol-%), L (10 mol-%, see Chart 1), K3PO4 (8.0 equiv.), dioxane/toluene (1:1), 100 °C, 8 h 
Table 14. Synthesis of 2,3,4,5-tetraarylthiophenes 31a-h
31 Ar1 Solvent % (A) a % (B) b 
a Ph Toluene 37 c 70 
b 4-(MeO)C6H4 1,4-Dioxane 94 d  
c 2-(MeO)C6H4 1,4-Dioxane 38 d 65 
d 1-Naphthyl Toluene 65 d  
e 4-MeC6H4 Toluene 87 c  
f 4-ClC6H4 Toluene 89 d  
g 4-FC6H4 Toluene 93 d  
h 2-Thienyl Toluene 0 81 
 
a Isolated yields, procedure A (see Scheme 24); b isolated yields, procedure B (see Scheme 
24); c reaction time: 12 h; d reaction time: 24 h 
Detailed inspection of the 1H and 13C NMR spectra and dynamic NMR studies (variable 
temperature NMR etc.) of tetrakis(2-methoxyphenyl)thiophene (31c) show that the rotation of 
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the aryl-groups is sterically hindered and that two (out of theoretically possible six) rotamers 
are present at room temperature (Scheme 25). However, the structure of the rotamers could 
not be unambigiously assigned.  
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Scheme 25. Possible rotameric structures of 31c 
 
Since it is not possible to assign the rotational isomers of 31c unambiguously on the basis of 
both 1H and 13C NMR spectra, I (in collaboration with Dr. H. Jiao, Leibniz-Institute of 
Catalysis, Rostock) have carried out B3LYP density functional theory calculations to get the 
energetic order of these six possible isomers (A-F).88 At first I have optimized A-F at the 
B3LYP/6-31G(d) level and they are found to energy minimums by frequency calculations 
(without imaginary frequencies). We also have carried out single-point energy calculations at 
the B3LYP level by using the more flexible 6-311+G(d,p) basis set and the B3LYP/6-31G(d) 
optimized geometries for energetic comparison. As given in Table 15, isomer F is most stable, 
tightly followed by isomers D and E within less than 1 kcal/mol (0.72 and 0.83 kcal/mol, 
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respectively). Isomer B is higher in energy by 1.12 kcal/mol, while isomers A and C are much 
higher in energy by 3.06 2.42 kcal/mol, respectively. These energetic differences indicate that 
F is the most stable isomer, and also major part of the isomeric mixture; D and E are minor 
part of the mixture. Probably isomer B will have some trace contribution, but the contribution 
of isomer A and C could be ruled out. 
 
Table 15. The computed total electronic energies (Etot, au) and relative energies (E, 
kcal/mol) 
Structure Etota Etotb Eb 
A (31c) –1935,29952 –1935.72280 3.06 
B (31c) –1935,30356 –1935.72589 1.12 
C (31c) –1935,30189 –1935.72382 2.42 
D (31c) –1935,30407 –1935.72654 0.72 
E (31c) –1935,30359 –1935.72635 0.83 
F (31c) –1935,30571 –1935.72768 0.00 
G (31b) –1699.90610 –1700.28558 1.22 
  
a B3LYP/6-31G* (full optimization); b B3LYP/6-311+G**//B3LYP/6-31G* (single-point 
energy calculation)  
 
S BrBr Ar1 B(OH)2
S Ar1Ar1 Ar2 B(OH)2
i
30 32a-f 33a-f
iiBr Br Br Br
S Ar1Ar1
Ar2 Ar2
 
 
Scheme 26. Synthesis of symmetrical 2,5-diaryl-3,4-dibromothiophenes 32a-f and of
tetraarylthiophenes 33a-f. Conditions: i, procedure A: 30 (1.0 equiv.), Ar1B(OH)2 (2.2 equiv.), 
Pd(PPh3)4 (6 mol-%), K3PO4 (4.0 equiv.), solvent/H2O = 4:1 (solvent see Table 2); procedure 
B: 30 (1.0 equiv.), Ar1B(OH)2 (2.1 equiv.), Pd(OAc)2 (5 mol-%), L (see Chart 1, 10 mol-%), 
K3PO4 (4.0 equiv.), dioxane/toluene (1:1), reflux, 8 h; ii, 32a,b (1.0 equiv.), Ar2B(OH)2 (3.0 
equiv.), Pd(PPh3)4 (10 mol-%), K3PO4 (4.0 equiv.), solvent/H2O = 4:1 (solvent see Table 17) 
 
The reaction of 30 (1.0 equiv.) with 2.2 equiv. of boronic acids allowed the regioselective 
synthesis of the 2,5-diaryl-3,4-dibromothiophenes 32a-f (Scheme 26, Table 16). The 
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application of procedure A  (Pd(PPh3)4) allowed to prepare the products in moderate yields 
(except for 32b which was isolated in good yield). The yields of 32a and 32c-f were 
significantly improved by application of method B  (Pd(OAc)2, L). Products 32a,b (1.0 
equiv.) could be further functionalized by Suzuki-reaction with 3.0 equiv. of various 
arylboronic acids to give the tetraarylthiophenes 33a-f which contain two different types of 
aryl groups (Scheme 26, Table 17). The products were isolated in good yields. During the 
optimization, the solvent played an important role. For oxygen-containing boronic acids, the 
use of a mixture of toluene and dioxane proved to be advantageous (vide supra). 
 
Table 16. Synthesis of symmetrical 2,5-diaryl-3,4-dibromo-thiophenes 32a-f 
32 Ar1 Solvent % (A) a % (B) b 
a Ph Toluene 32 c 88 
b 4-MeC6H4 Toluene 77 c  
c 4-(MeO)C6H4 1,4-Dioxane 43 d 85 
d 2-(MeO)C6H4 1,4-Dioxane 35 d 79 
e 3,5-Me2C6H3 Toluene 54 d 91 
f 2-Thienyl Toluene 54 d 71 
 
a Isolated yields, procedure A (see Scheme 23); b isolated yields Isolated yields, procedure B 
(see Scheme 23); c reaction time: 12 h; d reaction time: 24 h 
Table 17. Synthesis of tetraarylthiophenes 33a-f
33 Ar1 Ar2 Solvent % (A) a 
a Ph 4-MeC6H4 Toluene 86 b 
b 4-MeC6H4 Ph Toluene 51 b 
c 4-MeC6H4 4-(MeO)C6H4 Dioxane/Toluene (1:1) 76 c 
d 4-MeC6H4 4-(EtO)C6H4 Dioxane/Toluene (1:1) 93 c 
e 4-MeC6H4 4-(HO)C6H4 Dioxane/Toluene (1:1) 82 c 
f 4-MeC6H4 4-ClC6H4 Toluene 91 c 
 
a Isolated yields; b reaction time: 12 h; c reaction time: 24 h 
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The structures of all products were established by spectroscopic methods. The structure of 
32b was independently confirmed by an X-ray crystal structure analysis (Figure 8).89  
 
 
Figure 8. Ortep plot of 32b (50% probability level) 
 
Figure 9. Ortep plot of 32e (50% probability level) 
The Suzuki reaction of 30 with various boronic acids (1.1 equiv.) afforded the 5-aryl-2,3,4-
tribromothiophenes 34a-f in good yields and with very good regioselectivity (Scheme 27, 
Table 18). The reactions were carried out by application of procedure B (Pd(OAc)2, L). The 
application of method A proved to be unsuccessful. During the optimization, it was important 
to suppress the formation of 2,5-diaryl-3,4-dibromothiophenes, as their separation from the 
desired products proved to be difficult. The structure of 34f was independently confirmed by 
an X-ray crystal structure analysis (Figure 9).74 The reaction of 34b with 1.2 equiv. of 
arylboronic acids, following again procedure B, resulted in regioselective formation of the 
unsymmetrical 2,5-diaryl-3,4-dibromothiophenes 35a-c (Scheme 27).  
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Ar1 B(OH)2
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30 34a-f
i
Br Br Br Br Ar2 B(OH)2
S Ar
2Ar1
ii
Br Br
35a (Ar1 = 4-(MeO)C6H4, Ar2 = 4-EtC6H4): 72%
35b (Ar1 = 4-(MeO)C6H4, Ar2 = 3,5-Me2C6H3): 67%
35c (Ar1 = 4-(MeO)C6H4, Ar2 = 3-PhC6H4): 69%
35a,b,c
 
Scheme 27. Synthesis of 5-aryl-2,3,4-tribromothiophenes 34a-f and of unsymmetrical 2,5-
diaryl-3,4-dibromothiophenes 35a-c; conditions: i, 30 (1.0 equiv.), Ar1B(OH)2 (1.2 equiv.), 
Pd(OAc)2 (5 mol-%), L (see Chart 1, 10 mol-%), K3PO4 (4.0 equiv.), dioxane/toluene (1:1), 
reflux, 8 h; ii, 34b (1.0 equiv.), Ar2B(OH)2 (1.2 equiv.), Pd(OAc)2 (5 mol-%), L (see Chart 1, 
10 mol-%), K3PO4 (4.0 equiv.), dioxane/toluene (1:1), reflux, 8 h 
Table 18. Products and yields  
34 Ar1  % (5) a 
a 2-(MeO)C6H4 75 
b 4-(MeO)C6H4 80 
c 3-PhC6H4 77 
d 2-Naph 69 
e 4-EtC6H4 87 
f Ph 61 b 
 
a Isolated yields (procedure B) 
b Isolated yields (procedure A) 
 
Figure 10. Ortep plot of 34f (50% probability level) 
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The addition of n-butyllithium (2.5 equiv.) to a THF solution of tetrabromothiophene (30) 
(1.0 equiv.) and subsequent addition of alkyl halides (3.0 equiv.) afforded the 2,5-dialkyl-3,4-
dibromothiophenes 36a-d (Scheme 28, Table 19). This approach is preparatively useful, since 
the Suzuki reaction of tetrabromothiophene with alkylboronic acids  failed. All attempts to 
prepare 3,4-dibromo-2,5-dihexylthiophene from 30 under Suzuki conditions using a variety of 
different ligands (e. g., dppf, P(tBu)3, PPh3, BINAP) failed. 3,4-Dibromo-2,5-
bis(trimethylsilyl)thiophene (36e) was prepared in good yield from 30 and 
trimethylchlorosilane. The reaction of dilithiated 30 with dimethyl disulfide afforded 
thiophene 36f. Thiophenes 36g and 36h were prepared by reaction of dilithiated 30 with 
methyl chloroformate and benzoyl chloride, respectively. During the optimization of the 
reactions, the stoichiometry (excess of base and electrophile) played an important role. The 
structure of the products was established by spectroscopic methods. The structure of 36g was 
independently confirmed by an X-ray crystal structure analysis (Figure 11).74 
 
S BrBr
R X
S RR
30 36a-h
i
Br Br Br Br
 
 
Scheme 28. Synthesis of symmetrical 3,4-dibromothiophenes 36a-h. Conditions: i, 1) nBuLi 
(2.5 equiv.), 78 °C, 1 h; 2) RX (3.0 equiv.), 78  20 °C, 16 h 
Table 19. Synthesis of symmetrical 3,4-dibromothiophenes 36a-h
36 R X % a 
a Me Br 56 
b nBu I 94 
c isoPent Br 77 
d nDodec Br 89 
e SiMe3 Cl 82 
f SMe SMe 55 
g CO2Me Cl 52 
h COPh Cl 68 
 
a Isolated yields 
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Figure 11. Ortep plot of 36g
 
The addition of n-butyllithium (2.5 equiv.) to a THF solution of tetrabromothiophene (30) 
(1.0 equiv.) and subsequent addition of trimethylchlorosilane (1.0 equiv.) and subsequent 
addition of alkyl bromides (1.2 equiv.) afforded the 5-alkyl-3,4-dibromo-2-
trimethylsilylthiophenes 37a-f in a one-pot protocol (Scheme 29, Table 20). However, the 
application of this strategy to the synthesis of 2,5-dialkylthiophenes containing two different 
alkyl groups proved to be successful.90 
S BrBr
R Br
S SiMe3R
30 37a-f
i
Br Br Br BrMe3SiCl
 
Scheme 29. Synthesis of 5-alkyl-2-trimethylsilyl-3,4-dibromothiophenes 37a-f. Conditions: i, 
1) 30 (1.0 equiv.), nBuLi (2.5 equiv.), TMEDA (2.5 equiv.), 78 °C, 30 min; 2) Me3SiCl (1.0 
equiv., addition during 3 h), 30 min, 78 °C; 4) RBr (1.2 equiv.), 78 °C, 4 h 
 
Table 20. Synthesis of unsymmetrical 3,4-dibromothiophenes 37a-f 
37 R % a 
a Et 65 
b nBu 61 
c iPent 60 
d nHex 60 
e nHept 55 
f nUndec 51 
a Isolated yields 
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The double Suzuki reaction of diester 36g with arylboronic acids afforded the 3,4-
diarylthiophenes 38a-d (Scheme 30, Table 21). Products 38a-c were prepared by application 
of procedure A. The best results were obtained, similar to the experiments outlined above, 
when dioxane was used for boronic acids containing oxygen (products 38b,c). The yield of 9b 
was much improved by application of protocol B. Likewise, product 9d was prepared in good 
yield by application of protocol B. 
 
S CO2MeMeO2C
Br Br
36g
Ar B(OH)2
i S CO2MeMeO2C
Ar Ar
38a-d  
 
Scheme 30. Synthesis of 3,4-diarylthiophenes 38a-d. Conditions: i: Procedure A: 36g (1.0 
equiv.), ArB(OH)2 (3.0 equiv.), Pd(PPh3)4 (5 mol-%), K3PO4 (4.0 equiv.), solvent/H2O = 4:1 
(solvent see Table 19). Procedure B: 7g (1.0 equiv.), ArB(OH)2 (2.5 equiv.), Pd(OAc)2 (5 
mol-%), L (see Chart 1, 10 mol-%), K3PO4 (4.0 equiv.), dioxane, reflux, 8 h
 
Table 21. Synthesis of 3,4-diarylthiophenes 38a-d
38 Ar % (A) a % (B) b 
a 4-ClC6H4 42 c  
b 2-(MeO)C6H4 45 d 85 c 
c 2-(HO)C6H4 49 d  
d 4-(HO)C6H4  71 e 
 
a Isolated yields (procedure A); b isolated yields (procedure B); c solvent: toluene; d solvent: 
toluene / dioxane = 1:1; e solvent: dioxane 
 
Detailed inspection of the 1H and 13C NMR spectra and dynamic NMR studies (variable 
temperature NMR etc.) for 3,4-di(2-methoxyphenyl)thiophene 38b show that two 
atropisomers are present at room temperature, due to the hindered rotation of the aryl groups 
(Scheme 31). In contrast, only one set of signals is observed for 3,4-di(2-
hydroxyphenyl)thiophene 38c. This might be explained by the higher rotation barrier in case 
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of the methoxy derivative 38b (and fast equilibration for 38c at 20 °C) or, alternatively, by the 
selective formation of one atropisomer in case of 38c. 
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38c (R = OH)
H
 
Scheme 31. Possible rotameric structures of 38b,c
 
In addition I have also computed the relative energies of the two isomers (G and H) for 38b 
(R = OMe) and 38c (R = OH). At the same level of theory for 38b, isomer H is more stable 
than isomer G by 1.22 kcal/mol. Therefore, 38b is a mixture of isomers with H as the major 
isomer and G as the minor isomer, and this is in agreement with the experimental observation. 
For 38c (R = OH), the situation becomes somewhat more complicated due to the possibility of 
the formation of hydrogen bonding interaction between the O–H group at the phenyl ring and 
the carboxylic C=O group. For isomer G with two O–H groups at the same side of the 
thiophene ring, there are three possible structures; one (G-1) does not have hydrogen bonding 
interaction (with O–H group in the phenyl ring plane); and the second one (G-2) has one set 
of hydrogen bonding interaction and the B3LYP/6-31G(d) optimized O–H···O=C distance is 
1.791 Å; and the third one (G-3) has two sets of hydrogen bonding interaction with the O–
H···O=C distance of 1.885 Å. For isomer H, due to the appropriate orientation of the O–H 
group at the phenyl ring and the carboxylic C=O group it is possible to form two sets of 
hydrogen bonding interaction, and the B3LYP/6-31G(d) optimized O–H···O=C distance is 
1.803 Å. As given in Table 22, isomer H is most stable, and isomers G-a; G-b and G-c are 
higher in energy by 5.35, 2.99, and 4.88 kcal/mol kcal/mol, respectively. The large energy 
difference between H and G identifies H as the only one isomer in the solution (>99%); and 
this is also in agreement with the experimental finding. Compared this result with that for 
38b, it is interesting to know the driving force for this enhanced stability for isomer H over 
isomer G of 38c. Apart from the hydrogen bonding interaction, the appropriate conrotatory 
orientation of the phenyl groups in isomer H reduces their repulsive interaction and strengths 
at the same time the hydrogen bonding interaction. Although both G-b and G-c also have 
hydrogen bonding interaction, the disrotatory orientation of the phenyl groups will increase 
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the repulsive interaction with the increased hydrogen bonding interaction. Consequently, 
isomer H is considerably more stable than isomer G for 38c. This explains perfectly the 
findings from the 1H and 13C NMR spectra. In case of of 38c, only one atropisomer, namely 
H, is selectively formed. In case of of 38b, both atropisomers are formed and are detetced 
(slow equilibrium at 20 °C on the NMR time scale). 
 
Table 22. The computed total electronic energies (Etot, au) and relative energies (E, 
kcal/mol) 
Structure Etota Etotb Eb 
G (38b) –1699.90610 –1700.28558 1.22 
H (38b) –1699.90772 –1700.28753 0.00 
G-1 (38c) –1621.29328 –1621.66814 5.35 
G-2 (38c) –1621.29880 –1621.67191 2.99 
G-3 (38c) –1621.29659 –1621.66889 4.88 
H (38c) –1621.30484 –1621.67667 0.00 
 
a) B3LYP/6-31G* (full optimization) 
b) B3LYP/6-311+G**//B3LYP/6-31G* (single-point energy calculation) 
 
Recently, 3,4-bis(4-hydroxyphenyl)pyrrole-2,5-dicarboxylic acid was isolated from a new 
marine Halomonas sp. strain.91 This compound shows potent anti-tumor-promoting activities. 
The sulfur analogue 39 of this natural product was prepared by base-mediated hydrolysis of 
38d (Scheme 32). 
 
S CO2MeMeO2C
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Scheme 32. Synthesis of 39. Conditions: i: aq. KOH (30%), EtOH, reflux, 2.5 h 
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Recently, the natural product ningaline A, a pyrrole-based bis-lactone, was isolated.92  This 
compound also exhibits a strong anti-proliferatuve activity. The sulfur analogue 40 of 
ningaline A was prepared by treatment of 38b with BBr3 and subsequent addition of 
potassium tert-butanolate (Scheme 33). 
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Scheme 33. Synthesis of 40. Conditions: i: 1) BBr3 (8.0 equiv.), CH2Cl2, 20 °C, 4 d; 2) 
KOtBu, H2O 
1.5.3 Conclusion
 
In conclusion, I have reported Suzuki reactions of tetrabromothiophene with arylboronic acids 
which provide a regioselective approach to various 5-aryl-2,3,4-tribromothiophenes, 
symmetrical 2,5-diaryl-3,4-dibromothiophenes, and tetraarylthiophenes. Unsymmetrical 2,5-
diaryl-3,4-dibromothiophenes are prepared by Suzuki reaction of 5-aryl-2,3,4-
tribromothiophenes. Tetraarylthiophenes containing two different types of aryl groups are 
obtained by Suzuki reactions of 2,5-diaryl-3,4-dibromothiophenes. During the optimization of 
the reaction conditions, the solvent and the catalyst played an important role. In several cases, 
classical conditions (Pd(PPh3)4) gave excellent yields. The yields of those transformations 
which completely failed or proceeded sluggishly could be significantly improved by 
application of a new biaryl monophosphine ligand developed by Buchwald and coworkers. 
Regioselective metal-halide-exchange reactions of tetrabromothiophene provide a convenient 
approach to 2,5-dialkyl-3,4-dibromothiophenes. 2-Trimethylsilyl-5-alkyl-3,4-
dibromothiophenes could be prepared in a one-pot protocol by sequential addition of 
trimethylchlorosilane and alkyl bromides. The reaction of tetrabromothiophene with methyl 
chloroformiate and subsequent Suzuki reactions afforded 3,4-diaryl-2,5-
bis(methoxycarbonyl)thiophenes. Based on this strategy, sulphur-analogues of the natural 
products ningaline A and 3,4-bis(4-hydroxyphenyl)pyrrole-2,5-dicarboxylic acid were 
prepared. 
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P   Part 2 :    Synthesis of N,O-Heterocycles based on Cyclocondensation 
Reactions of Hydrazone and Oxime Dianions 
 
Introduction 
Besides catalysis, the development of new synthetic strategies and building blocks represents 
an important challenge in organic chemistry.93,94 The development of new cyclization 
reactions of dianions and dianion equivalents, which lead to biologically relevant ring 
systems, is a current field of research in the group of Prof. Langer. In his review about dianion 
chemistry,95 Prof. Langer defined dianions more specifically as species that (a) posses a 
lithium, sodium, potassium or magnesium counterion and (b) undergo at least one carbon-
carbon bond formation in their reaction with electrophiles. The generation of dianions often 
requires the use of a strong base, such as lithium diisopropylamide (LDA) or butyllithium 
(nBuLi). Dianions can be generated by deprotonation, reduction or metal-haldide 
exchange.95,96 
 
The work outlined in the second part of this thesis is a contribution to the chemistry of 1,4-
C,N-dianions. The reactions developed allow a facile synthesis of pyrazole-3-carboxylates 
and pyrazole-1,5-dicarboxylates by cylization of hydrazone dianions with diethyl oxalate 
(chapter 6). In addition, a regioselective synthesis of 6-halomethyl-5,6-dihydro-4H-1,2-
oxazines based on cyclizations of arylalkenyl-oximes is reported (chapter 7). 
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1.6 Synthesis of Pyrazole-3-carboxylates and Pyrazole-1,5-Dicarboxylates by 
One-Pot Cyclization of Hydrazone Dianions with Diethyl Oxalate 
1.6.1 Introduction  
 
Pyrazole-5-carboxylic acid derivatives represent important building blocks in organic and 
medicinal chemistry. In addition, they are of interest in their own right, due to their 
pharmacological properties. For example, pyrazole-5-carboxylic acids and pyrazolo[1,5-
c]quinazoline-2-carboxylates are nicotinic acid receptor agonists97 and excitatory amino acid 
antagonists, respectively.98 It was shown that related bis(benzo[g]indazole-3-carboxamides) 
exhibit antiproliferative activity against various cancer cell lines.99 Ethyl 5-propyl-1H-
pyrazole-3-carboxylate is a key intermediate for the synthesis of viagra.100 Celecoxib is the 
first-to-market drug of a number of selective cyclo-oxygenase 2 (COX-2) inhibitors which are 
promising anti-inflammatory and analgetic agents (without the undesirable side effects 
associated with other non-steroidal anti-inflammatories).101 Recently, Nicolaou et al.102 
reported that a pyrazole-substituted epothilone derivative shows a strong antitumor activity 
through the stabilization of microtubules by binding with tubulin. In fact, it is considered to be 
the most potent epothilone derivative reported to date. The pyrazole moiety is also present in 
many agrochemically important compounds, such as Fenpyroximate, Tebufenpyrad, 
Tolfenpyrad, etc (Scheme 34).103 
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Scheme 34: some natural products containing pyrazole moieties. 
 
Pyrazoles are available by 1,3-dipolar cycloaddition reactions of diazoalkanes with alkynes 
and related transformations.104 Other syntheses rely on cyclizations of 1,3-diketones with 
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hydrazine105 and on Michael reactions of hydrazines with ,-unsaturated ketones.106 An 
interesting approach to pyrazoles relies on the cyclization107 of hydrazone dianions, generated 
by means of nBuLi, with esters,108 acid chlorides109 and nitriles.110 Pyrazolines were prepared 
by cyclization of dilithiated hydrazones with -haloketones.111 Recently, the synthesis of 
pyrazole-3-carboxylates by reaction of hydrazines with propiolates and Weinreb amides was 
reported.112 Ranatunge reported113 the synthesis of 3-aryl-pyrazole-5-carboxylates based on 
the condensation of  hydrazines with 4-aryl-2,4-dioxoesters. The products were transformed 
into nitrate-substituted oximes which represent potent and selective COX-1 and COX-2 
inhibitors. We reported the cyclization of oxime and hydrazone dianions with epibromohydrin 
to give 1,2-oxazines and oxazolo[3,4-b]pyridazin-7-ones, respectively.114 We also reported 
the cyclization of oxime dianions with diethyl oxalate which provides a convenient access to 
isoxazole-5-carboxylates.115 Recently, I reported a new and convenient approach to pyrazole-
3-carboxylates by one-pot cyclizations of hydrazone dianions with diethyl oxalate.116 Herein, 
I report full details of these studies. In addition to my preliminary communication,74 I also 
report the synthesis of pyrazole-1,5-dicarboxylates (protected pyrazole-5-carboxylates) from 
the same starting materials. 
1.6.2 Results and Discussion 
 
The reaction of a THF solution of diethyl oxalate (42) with the dianion of acetophenone 
hydrazone 41a, generated by n-butyllithium (2.5 equiv.), and subsequent reflux of a toluene 
solution of the crude product in the presence of p-toluenesulfonic acid (PTSA) afforded 
pyrazole-3-carboxylate 43a in up to 53% yield (Scheme 35). The best results were obtained 
when the reaction mixture was allowed to slowly warm from 78 to 20 °C. The solvent was 
removed in vacuo without aqueous work-up and a toluene solution of the residue was simply 
refluxed in the presence of PTSA for 8 h. Notably, the use of oxalyl chloride or ethyl oxalyl 
chloride resulted in polymerization. The use of a hydrazone containing a tosyl protective 
group was not successful (formation of complex mixtures).  
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Scheme 35. Mechanism of the formation of pyrazole-5-carboxylate 43a and of pyrazole-1,5-
dicarboxylate 44a
 
The formation of 43a can be explained by attack of the carbon atom of the dianion A onto the 
ester group (intermediate B), subsequent cyclization by attack of the nitrogen atom onto the 
keto group (intermediate C), aromatization upon addition of the acid, and subsequent acid-
mediated decarboxylation. Notably, reflux of a CH2Cl2 solution of the crude product in the 
presence of trifluoroacetic acid (TFA) afforded the pyrazole-1,5-dicarboxylate 44a in up to 
59% yield. Noteworthy, both protected and non-protected pyrazole-carboxylates can be 
prepared from the same starting materials. The results can be explained by the higher acidity 
of PTSA compared to TFA. 
The cyclization of the dianions of hydrazones 41a-j with diethyl oxalate and subsequent 
dehydration with PTSA afforded the aryl-substituted pyrazole-5-carboxylates 43a-j (Table 
23). Likewise, pyrazole-1,5-dicarboxylates 44a-j were obtained  when TFA was employed. 
The cyclization of diethyl oxalate with the dilithiated hydrazone of p-nitroacetophenone was 
unsuccessful. The cyclization of diethyl oxalate with the dianions of hydrazones 41k and 41l, 
prepared from 3-methylbutane-2-one and pentane-2-one, afforded the alkyl-substituted 
pyrazole-5-carboxylates 43k and 43l and pyrazole-1,5-dicarboxylates 44k and 44l in good 
yields, respectively. Pyrazoles 43m and 44m, containing a phenyl and a methyl substituent, 
were prepared based on the cyclization of diethyl oxalate with propiophenone-derived 
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hydrazone 41m. The structure of 43b was independently confirmed by crystal structure 
analysis.117 The cyclization of diethyl oxalate with the dianions of tetralone hydrazone 41n 
and of cycloalkanone-derived hydrazones 41p-r afforded, after dehydration with PTSA, the 
pyrazole-5-carboxylates 43n-r. The pyrazole-1,5-dicarboxylates 44n-r were isolated when the 
dehydration was carried out using TFA. The yields of pyrazole-1,5-dicarboxylates 44 were in 
most cases slightly better than those of pyrazole-5-carboxylates 43. 
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Scheme 36. Synthesis of pyrazole-5-carboxylates 43a-q and pyrazole-1,5-dicarboxylates 44a-
q. i: 1) nBuLi (2.5 equiv.), THF, 45 min, 78 °C, 2) 15 min, 20 °C, 3) 42, 78  20 °C, 16 h, 
4) removal of THF; ii: p-TsOH (4.0 equiv.), toluene, reflux, 8 h; iii: TFA, CH2Cl2, reflux 8 h. 
 
 
Figure 12. Ortep plot of 43b
The structure of products 43b,i were independently confirmed by X-ray crystal structure 
analysis (Figures 12, 13).74  
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Table 23. Synthesis of 43a-q and 44a-q 
43 R1 R2 % (43) a % (44) a 
a C6H5 H 53 59 
b 4-MeC6H4 H 57 61 
c 3-MeC6H4 H 61 48 
d 4-(MeO)C6H4 H 45 47 
e 2-(MeO)C6H4 H - 42 
f 1-Naphthyl H 45 - 
g 2-Naphthyl H 38 - 
h 4-ClC6H4 H 42 54 
i 4-FC6H4 H 47 41 
j iPr H 69 72 
k nPr H 72 70 
l C6H5 Me 62 69 
m        C6H4(CH2)2     54 49 
n           (CH2)4    43 44 
o           (CH2)5 40 47 
p           (CH2)6 38 42 
q           (CH2)10 31 65 
 
a Yields of isolated products 
 
Figure 13. Ortep plot of 43i
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1.6.3 Conclusion
 
In conclusion, I have reported a convenient and regioselective synthesis of pyrazole-3-
carboxylates and pyrazole-1,5-dicarboylates by cyclization of hydrazone dianions with diethyl 
oxalate. 
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1.7 Regioselective Synthesis of 6-Halomethyl-5,6-dihydro-4H-1,2-oxazines based 
on Cyclizations of Arylalkenyl-oximes  
1.7.1 Introduction  
 
1,2-Oxazines are of pharmacological relevance and represent useful synthetic building blocks. 
They have been used, for instance, as intermediates during the synthesis of glycosidase 
inhibitor analogues118 and of functionalized pyrroles.119 1,2-Oxazines have been prepared, for 
example, by hetero-Diels-Alder reactions of alkenes with ene-nitroso compounds derived 
from -haloximes120 and by hetero-Diels-Alder reactions of dienes with nitroso 
compounds.121 1,2-Oxazines are also available by NBS-,122 diphenyldiselenide-,123 acid-,124 
and UV-mediated125 cyclization of alkenyl-substituted oximes. 1,2-Oxazines have also been 
prepared by base-mediated cyclizations of -chloroximes9 and -sulfonyloximes.126 Other 
synthetic approaches to 1,2-oxazines rely on Lewis-acid catalyzed reactions of allenoximes,127 
acid-catalyzed cyclization of cyclopropyloximes,128 and on cyclizations of -nitroketones.129 
Recently, I have reported130 the synthesis of 1,2-oxazines by cyclization131 of oxime dianions 
with epibromohydrin. Herein, I report what are, to the best of my knowledge, the first 
syntheses of 6-iodomethyl-5,6-dihydro-4H-1,2-oxazines by condensation of oxime dianions 
with allylbromide and subsequent O-regioselective iodine-mediated cyclization.   
1.7.2 Results and Discussion 
 
The reaction of the dianions of oximes 45a-k, generated by means of nBuLi (2.5 equiv.), 
afforded the arylalkenyl-oximes 47a-k in good yields (Scheme 37, Table 24). The reaction of 
the latter with iodine afforded the 6-iodomethyl-5,6-dihydro-4H-1,2-oxazines 48a-k in 
moderate to excellent yields. The best yields were obtained when the reaction was carried out 
in dichloromethane using a saturated aqueous solution of sodium bicarbonate as the base. The 
reaction of 47e,f,j,k with N-bromosuccinimide (NBS) afforded the 6-bromomethyl-5,6-
dihydro-4H-1,2-oxazines 48l-o. The tricyclic oxazine 48p was prepared in high yield from 
tetralone (45p) (Scheme 38). The structure of all products was established by spectroscopic 
methods. The structures of 48d, 48f and 48j were independently confirmed by X-ray crystal 
structure analyses (Figures 14-16).74 Products 48j,k and 48n-p were isolated as 1:1 mixtures 
of diastereomers. In case of 48j, one of the two diastereomers could be separated by 
crystallization (Figure 16). 
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The regioselectivity of cyclization requires some discussion. Oximes are ambident 
nucleophiles which can react with electrophiles either at the oxygen or at the nitrogen atom. 
Grigg and coworkers showed that the regioselectivity is controlled by the E/Z-configuration 
of the oxime and by the rate of E/Z-isomerization with respect to the N- or O-nucleophilic 
attack.132,133,134 The intramolecular reaction of oximes with halonium ions has been reported 
to result in N-alkylation and formation of nitrones. For example, treatment of a CH2Cl2-
solution of alkenyl-oxime 49 with iodine and anhydrous potassium carbonate quantitatively 
afforded nitrone 50 which was trapped by a subsequent [3+2] cycloaddition (Scheme 39).134 
Similar results were obtained for the oxime of ethyl 2-homoallyl-cyclohexanone-2-
carboxylate. The N-regioselectivity was explained by a rapid ZE isomerization and 
subsequent attack of the nitrogen atom onto the iodonium ion. The reaction of 5 with N-
bromosuccinimide (NBS) was reported to give a 2:1-mixture of nitrone and 1,2-oxazine 
which reflects the E/Z-ratio of 5.122 In this reaction, the E/Z-isomerization was slow compared 
to the N- and O-cyclization. Similar results have been reported for diphenyl diselenide-
mediated cyclizations.123  
 
In contrast to 49, the aryl-substituted oximes 47a-l contain an E-configured C=N group, due 
to the steric effect of the aryl group.135 The excellent O-regioselectivity of the formation of 
1,2-oxazines 48a-p can be explained by the assumption that the EZ isomerization is slow 
compared to the O-regioselective 1,2-oxazine formation. 
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Scheme 37: Synthesis of 1,2-oxazines 48a-o. Reagents and conditions: i, 1) 45 (1.0 equiv), 
nBuLi (2.5 equiv), THF, 1 h, 78 °C, then 10 min, 20 °C, 2) 2 (2.0 equiv), 78  20 °C, 16 
h; ii, 48a-k: I2 (2.0 equiv), CH2Cl2, NaHCO3 (sat. aqueous solution), 20 °C, 12 h, 48l-o: NBS 
(1.0 equiv), CH2Cl2, 20 °C, 2 h 
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Table 24. Products and yields    
45,47 48 X R Ar % (3) a % (4) a
a a I H Ph 85 95 
b b I H 4-MeC6H5 69 83 
c c I H 3-(MeO)C6H5 68 66 
d d I H 4-(MeO)C6H5 71 67 
e e I H 2-(EtO)C6H5 64 96 
f f I H 4-(EtO)C6H5 69 61 
g g I H 4-FC6H5 67 81 
h h I H 4-ClC6H5 60 52 
i i I H 1-Naphthyl 65 66 
j j I Me Ph 63 50 b 
k k I Me 4-(MeO)C6H5 60 43 b 
e l Br H 2-(EtO)C6H5 64 57 
f m Br H 4-(EtO)C6H5 69 87 
j n Br Me Ph 63 73 b 
k o Br Me 4-(MeO)C6H5 60 25 b 
 
a Yields of isolated product;  b dr = 1:1 
 
 
 
Figure 14. Ortep plot of 48d (50% probability level)  
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Figure 15. Ortep plot of 48f (50% probability level)  
 
Figure 16. Ortep plot of 48j (50% probability level) 
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Scheme 38. Synthesis of 1,2-oxazine 48p. Reagents and conditions: i, 1) 45 (1.0 equiv), 
nBuLi (2.5 equiv), THF, 1 h, 78 °C, then 10 min, 20 °C, 2) 2 (2.0 equiv), 78  20 °C, 16 
h; ii, I2 (2.0 equiv), CH2Cl2, NaHCO3 (sat. aqueous solution), 20 °C, 12 h, dr = 1:1 
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Scheme 39. Synthesis of nitrone 50 by Grigg et al. (ref. 133). Reagents and conditions: i, I2 
(2.0 equiv), CH2Cl2, K2CO3 (anhydrous), 25 °C, 12 h 
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1.7.3 Conclusion
In conclusion, 6-iodo- and 6-bromomethyl-5,6-dihydro-4H-1,2-oxazines were prepared by 
condensation of dilithiated acetophenone-oximes with allylbromide and subsequent 
regioselective iodine- or NBS-mediated cyclization. The results reported herein show that 
oxazines are available from alkenyl-oximes containing sterically demanding substituents.  
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Experimental Section  
1.8 Material and Methods  
1.8.1 General Remarks
Reactions were carried out under inert atmosphere (Argon 4.6) in order to simultaneously 
exclude oxygen and water when appropriate. Schlenck techniques were applied. Solvents for 
reactions were dried and destilled by standard methods or purchased from Merck, Aldrich, 
Acros Organics, and others whenever exclusion of water was desired. Solvents for liquid 
chromatography and extraction were always destilled prior to use and partly reused after 
fractionating destillation (n-heptane, ethyl acetate).  
1.8.2 Methods for Compound Characterization and Analysis  
 
NMR Spectroscopy
Bruker AC 250, Bruker ARX 300, Bruker ARX 500, Bruker Avance 600. For NMR 
characterization the one-dimensional 1H NMR, proton-decoupled 13C NMR, and DEPT 135 
spectra were collected. If necessary, other techniques (APT, NOESY, COSY, HMBC) were 
applied as well. All NMR spectra presented in this work were collected in CDCl3 solution. All 
chemical shifts are given in ppm.  
References (1H NMR): TMS (	 = 0.00) or residual CHCl3 (	 = 7.26) were taken as internal 
standard. When these reference peaks were superimposed by signals belonging to the 
compound under investigation a small amount of CH2Cl2 (	 = 5.30) was added and taken as 
reference instead.  
References (13C NMR): TMS (	 = 0.0) or residual CHCl3 (	 = 77.0) were taken as internal 
standard.  
Multiplicities are given as follows: s = singlet, d = doublet, t = triplet, q = quartet, sep = 
septet, m = multiplet, br = broad signal. More complex coupling patterns are represented by 
combinations of the respective symbols. For example, td indicates a triplet of doublets with 
the larger coupling constant associated with the first symbol (here: triplet).  
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Infrared Spectroscopy (IR)  
Nicolet 205 FT-IR, Nicolet Protége 460 FT-IR. Peaks are given the following assignments: w 
= weak, m = medium, s = strong, br = broad.  
 
Mass Spektrometry (MS)
AMD MS40, Varian MAT CH 7, MAT 731 (EI, 70 eV), Intecta AMD 402 (EI, 70 eV and 
CI), Finnigan MAT 95 (CI, 200 eV).  
 
High Resolution Mass Spectrometry (HRMS)  
Varian MAT 311, Intecta AMD 402.  
 
Elemental Analysis
LECO CHNS-932, Thermoquest Flash EA 1112.  
 
Melting Points
Micro heating table HMK 67/1825 Kuestner (Büchi Apparatus), Leitz Labolux 12 Pol with 
heating table Mettler FP 90. Melting points are uncorrected.  
 
Rotation Angles
L
P (IBZ Meßtechnik, NaD = 589 nm).  
 
X-ray Structures 
Bruker X8Apex diffractometer with CCD camera (Mo K radiation and graphite 
monochromator,  = 0.71073 Å). The space group is determined by the XPREP program and 
the structures were solved via the SHELX-97 program package. Refinements were carried out 
according to the minimum square error method.  
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1.8.3 Chromatographic Methods
 
Thin Layer Chromatography (TLC)
Merck Kieselgel 60 F254 on aluminium foil from Macherey-Nagel. Detection was carried out 
under UV light at 254 nm and 365 nm. As colourizing reagent the following mixtures were 
used: 1-2/100 p-Anisaldehyde or vanillin, 10/100 glacial acetic acid, 5/100 sulphuric acid, 83-
84/100 methanol.  
 
Column Chromatography  
Column chromatography was performed with Merck Silica Gel 60 or Macherey-Nagel Silica 
Gel 60 (0.063-0.200 mm, 70-230 mesh). The finer Merck Silica Gel 60 (0.040-0.063 mm, 
230-400 mesh) was chosen when appropriate.  
 
High Performance Liquid Chromatography (HPLC)  
For separation of enantiomers an analytical column type CHIRALCEL OD-H was used. 
Purification of diastereomers was carried out on a Knauer LiChrosorb RP 18 column.  
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1.9 General Procedures
1.9.1 Synthesis of functionalized furans based on suzuki coupling reactions of 2-(2-
bromoethenyl)-5-furan
 
Synthesis of 2-(2-bromoethenyl)-5-bromofuran (3) 
1H NMR (300 MHz, CDCl3): 	 = 6.53 (d, 3J = 3.8 Hz, 1 H, furan), 
7.28 (d, 3J = 3.8 Hz, 1 H, furan), 8.41 (s, CH). 13C NMR (75 MHz, 
CDCl3): 	 = 114.5 (CH), 120.9, 122.7 (CH, furan), 123.9, 128.4, 147.4 
(C).
1.9.1.1 Synthesis of 2-(2-bromo-2-nitroethenyl)-5-arylfurans  
General procedure for the synthesis of 2-(2-bromo-2-nitroethenyl)-5-arylfurans (4a-i): 
To a toluene solution (3 ml) of 3 (0.356 g, 1.2 mmol) was added Pd(PPh3)4 (0.042 g, 3 mol %)
at 20 °C. After stirring for 30 min, the arylboronic acid (1.0 mmol), K3PO4 (2.0 mmol) and
water (0.5 ml) were added. The mixture was stirred at 90 °C for 8 h. After cooling to ambient
temperature, the mixture was diluted with EtOAc, dried (Na2SO4), and filtered through a short
Celite pad. The solution was concentrated in vacuo and the residue was purified by column
chromatography (silica gel, n-heptane / EtOAc = 20:15:1). 
Synthesis of 2-((Z)-2-bromo-2-nitrovinyl)-5-(1-naphtyl)furan (4f): 
Starting with 3 (0.356 g, 1.2 mmol) and 4-hydroxyphenylboronic 
acid (1.0 mmol), 4f was isolated (0.241 g, 75 %) as a red solid. 
Mp: 122-124 °C. 1H NMR (300 MHz, CDCl3): 	 =  7.05 (d, 3J = 
3.8 Hz, 1 H, furan), 7.52-7.59 (m, 4 H, Ar), 7.86 (d, 3J = 8.7 Hz, 
1 H, Ar), 7.91 (d, 3J = 8.7 Hz, 1 H, Ar), 7.96 (t, 3J = 8.7 Hz, 2 H, Ar), 8,43 (d, 3J = 3.8 Hz, 1 
H, furan), 8.69  (s, CH). 13C NMR (75 MHz, CDCl3): 	 = 113.0 (CH), 122.9, 124.6, 125.3, 
126.4, 127.2, 127.3, 130.5 (CH, Ar), 123.7, 126.6 (CH, furan), 123.5, 126.6, 128.7, 134.0, 
146.1, 159.3 (C). IR (KBr, cm-1): ~  = 3428 (s), 2241 (w), 2111 (w), 1649 (w), 1045 (s), 1017 
(s), 1004 (s), 823(s), 765 (s), 627 (s). MS (EI, 70 eV): m/z (%) = 345 (M+, [81Br], (11), 343 
(M+, [79Br], (15), 85 (100). HRMS (EI, 70 eV): calcd for C16H10O3NBr (M+, [79Br]): 
342.9844; found: 342.9849.  
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Synthesis of 2-((Z)-2-bromo-2-nitrovinyl)-5-(2-thienyl)furan (4h): 
Starting with 3 (0.297 g, 1.0 mmol) and (2-thienyl)boronic acid 
(2.2 mmol), 4h was isolated (0.261 g, 42%) as a red solid. Mp: 70-
71 °C. 1H NMR (300 MHz, CDCl3): 	 =  6.78 (d, 3J = 3.8 Hz, 1 H, 
furan), 7.13 (t, 3J = 4.01 Hz, 1 H, thiophene), 7.38, 7.42, 7.49  (d, 3J = 3.8 Hz, 2 H, furan, d, 3J 
= 4.01 Hz, 1 H, thiophene), 8.57 (s, CH). 13C NMR (75 MHz, CDCl3): 	 = 108.7 (CH), 123.3, 
125.8, 127.4, 128.3 (CH, 4CH, furan and thiophene), 124.2, 131.8, 140.2, 154.6 (C). IR (KBr, 
cm-1): ~  = 3412 (s), 2243 (w), 2131 (w), 1655 (w), 1051 (s), 1019 (s), 1002 (s), 827(s), 768 
(s), 625(s). MS (EI, 70 eV): m/z (%) = 301 (M+, [81Br], 5), 299 (M+, [79Br], (10), 285 (22), 
235 (12), 219 (10), 189 (18), 169 (100), 147 (28), 119 (20). HRMS (EI, 70 eV): calcd for 
C10H6O3NBrS (M+, [79Br]): 289.92518; found: 289.92511. 
 
1.9.1.2 Synthesis of 2-(2-aryl-2-nitroethenyl)-5-arylfurans (5a-g) 
General procedure for the synthesis of 2-(2-aryl-2-nitroethenyl)-5-arylfurans (5a-g). To a 
toluene solution (3 ml) of 3 (0.297 g, 1.0 mmol) was added Pd(PPh3)4 (0.070 g, 5 mol%) at 20 
°C. After stirring for 30 min, the arylboronic acid (2.2 mmol), K3PO4 (2.0 mmol) and water 
(0.5 ml) were added. The mixture was stirred at 90 °C for 8 h. After cooling to ambient 
temperature, the mixture was diluted with EtOAc, dried (Na2SO4), and filtered through a short 
Celite pad. The solution was concentrated in vacuo and the residue was purified by 
columnchromatography (silica gel, n-heptane / EtOAc = 20:15:1).  
Synthesis of 2-((Z)-2-methoxyphenyl-2-nitrovinyl)-5-(2-methoxyphenyl)furan (5c): 
Starting with 3 (0.297 g, 1.0 mmol) and 4-methoxyphenyl 
boronic acid (2.2 mmol), 5c was isolated (0.224 g, 64%) as a 
red solid. Mp: 116-117 °C. 1H NMR (300 MHz, CDCl3): 	 =  
3.74 (s, 3 H, OCH3), 3.89 (s, 3 H, OCH3), 6.68, 6.96 (d, 3J = 3.8 
Hz, 1 H, furan), 6.80, 6.85, 7.05, 7.10 (d, 3J = 8.7 Hz, 4 CH, Ar), 6.94, 7.12, 7.19, 7.53 (t, 3J = 
8.7 Hz, 4 CH, Ar), 8.14 (s, CH). 13C NMR (75 MHz, CDCl3): 	 = 55.4, 55.7 (OCH3), 112,2 
(CH), 111.2, 111.3, 120.5, 120.9, 122.2, 122.5, 131.1, 131.3  (8 CH, Ar), 126.6, 129.4 (CH, 
furan), 118.1, 142.9, 145.6, 145.9, 154.6, 156.1, 157.5 (C). IR (KBr, cm-1): ~  = 3439 (w), 
2826 (w), 2612 (w), 1640 (s), 1503 (s), 1288 (s), 1243 (s), 1021 (s), 965 (s), 748 (s). MS (EI, 
70 eV): m/z (%) = 351 (M+, 83), 321 (19), 293 (93), 290 (31), 247 (24), 202 (40), 189 (100), 
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187 (45), 145 (27), 135 (27). HRMS (EI, 70 eV): calcd for C20H17O5N (M+): 351.11012; 
found: 351.10931.  
Synthesis of 2-((Z)-4-ethoxyphenyl-2-nitrovinyl)-5-(4-ethoxyphenyl)furan (5e): 
Starting with 3 (0.297 g, 1.0 mmol) and (4-
methoxyphenyl)boronic acid (2.2 mmol), 5e was isolated 
(0.242 g, 69%) as a red solid. Mp: 94-96 °C. 1H NMR (300 
MHz, CDCl3): 	 = 1.38, 1.42 (t, 3J = 7.2 Hz, 3 H, CH3), 3.98, 
402 (q, 3J = 7.2 Hz, 2 H, OCH2CH3), 6.45, 7.16 (d, 3J = 3.8 
Hz, 1 H, furan), 6.75, 6.88, 6.98, 7.14 (d, 3J = 8.7 Hz, 4 H, Ar), 8.12 (s, CH). 13C NMR (75 
MHz, CDCl3): 	 = 14.8, 14.9 (CH3), 63.6, 63.7 (CH2), 105.9 (CH), 114.9, 115.0, 125.8, 126.1  
(CH, Ar), 124.0, 131.8 (CH, furan), 123.6, 145.0, 145.1, 146.4, 158.3, 159.7, 160.1 (C). IR 
(KBr, cm-1): ~  = 3441 (w), 2829 (w), 2622 (w), 1645 (s), 1517 (s), 1272 (s), 1252 (s), 1021 
(s), 965 (s), 747 (s). MS (EI, 70 eV): m/z (%) = 379 (M+, 38), 349 (18), 347 (42), 321 (52), 
249 (14), 216 (71), 203 (60), 188 (45), 187 (25), 119 (100), 29 (18). HRMS (EI, 70 eV): calcd 
for C22H21O5N (M+): 379.14142; found: 379.14150.  
Synthesis of 2-((Z)-4-tolyl-2-nitrovinyl)-5-(4-tolyl)furan (5f): 
Starting with 3 (0.297 g, 1.0 mmol) and (4-tolyl)boronic acid 
(2.2 mmol), 5f was isolated (0.262 g, 82%) as a red solid. 
Mp: 111-112 °C. 1H NMR (300 MHz, CDCl3): 	 =  2.23, 
2.40 (s, 3 H, CH3), 6.43, 6.49 (d, 3J = 3.8 Hz, 1 H, furan), 
7.00, 7.04, 7.19, 7.23 (d, 3J = 8.7 Hz, 4 H, Ar), 8.00 (s, CH). 
13C NMR (75 MHz, CDCl3): 	 = 21.4, 21.5 (CH3), 106.9 (CH), 124.3, 125.1, 129.4, 129.7 
(CH, Ar), 122.0, 129.5 (CH, furan), 126.4, 128.2, 139.2, 139.7, 141.4, 146.4, 158.3 (C). IR 
(KBr, cm-1): ~  = 3439 (s), 2250 (w), 2124 (w), 1659 (w), 1056 (s), 1028 (s), 1008 (s), 823(s), 
761 (s), 625(s). MS (EI, 70 eV): m/z (%) = 319 (M+, 24), 261 (54), 229 (21), 215 (28), 186 
(17), 173 (100), 129 (30), 128 (18), 32 (27). HRMS (EI, 70 eV): calcd for C20H17O3N (M+): 
319.12084; found: 319.12069.  
1.9.1.3 Synthesis of 2-(2-aryl-2-nitroethenyl)-5-arylfurans (6a-e) 
 
General procedure for the synthesis of 2-(2-aryl-2-nitroethenyl)-5-arylfurans (6a-e). To a 
toluene solution (3 ml) of 4a (0.294 g, 1.0 mmol) was added Pd(PPh3)4 (0.042 g, 3 mol %) at 
20 °C. After stirring for 30 min, the arylboronic acid (1.2 mmol), K3PO4 (2.0 mmol) and
O
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water (0.5 ml) were added. The mixture was stirred at 90 °C for 8 h. After cooling to ambient
temperature, the mixture was diluted with EtOAc, dried (Na2SO4), and filtered through a short
Celite pad. The solution was concentrated in vacuo and the residue was purified by column
chromatography (silica gel, n-heptane / EtOAc = 20:15:1). 
 
Synthesis of 2-((Z)-3,5-dimethylphenyl-2-nitrovinyl)-5-phenylfuran (6d): 
Starting with 4a (0.294 g, 1.0 mmol) and (3,5-
dimethylphenyl)boronic acid (1.2 mmol), 6d was isolated (0.327 
g, 74%) as a red solid. Mp: 115-117 °C. 1H NMR (300 MHz, 
CDCl3): 	 =  2.31 (s, 6 H, 2CH3), 6.43, 7.35 (d, 3J = 3.8 Hz, 1 H, 
furan), 6.95  (s, 2 H, Ar), 7.06 (s, 1 H, Ar), 7.13 (m, 5 CH, Ar), 
8.01 (s, CH). 13C NMR (75 MHz, CDCl3): 	 = 21.1 (CH3), 108.1 (CH), 124.3, 127.8, 128.4 
(2CH, Ar), 122.6, 128.4 (CH, Ar), 122.2, 130.3 (CH, furan), 138.3, 138.4, 138.7, 147.9, 
156.1, 157.8  (C). IR (KBr, cm-1): ~  = 3439 (s), 2255 (w), 2119 (w), 1661 (w), 1048 (s), 
1018 (s), 1014 (s), 823(s), 761 (s), 627(s). MS (EI, 70 eV): m/z (%) = 319 (M+, 57), 289 (30), 
262 (17), 261 (88), 258 (22), 215 (31), 159 (100), 131 (12), 115 (19). HRMS (EI, 70 eV): 
calcd for C22H17O3N (M+): 319.12029; found: 319.12002.  
Synthesis of 2-((Z)-2-thienyl-2-nitrovinyl)-5-phenylfuran (6e): 
Starting with 4a (0.294 g, 1.0 mmol) and 2-thienyl boronic acid 
(2.2 mmol), 6e was isolated (0.148 g, 57%) as a orange solid. Mp: 
106-108 °C. 1H NMR (300 MHz, CDCl3): 	 =  6.83, 7.39 (d, 3J = 
3.8 Hz, 1 H, furan), 7.17 (t, 3J = 4.01 Hz, 1 H, thiophene), 7.68, 
7.71 (d, 3J = 4.01 Hz , 1 H, thiophene), 7.29-7.37 (m, 5 CH, Ar), 8.50 (s, CH). 13C NMR (75 
MHz, CDCl3): 	 = 108.9 (CH), 123.5, 124.5, 128.7, 128.8, 129.7 (CH, furan & thiophene), 
125.0, 129.1 (2 CH, Ar), 129,6 (CH, Ar), 138.3, 138.4, 138.7, 147.8, 159.8 (C). IR (KBr, cm-
1): ~  = 3427 (s), 2247 (w), 2110 (w), 1648 (w), 1041 (s), 1011 (s), 1001 (s), 823(s), 755 (s), 
622 (s). MS (EI, 70 eV): m/z (%) = 297 (M+, 12), 295 (18), 293 (18), 214 (100), 198 (12), 183 
(14), 168 (55), 139 (63), 115 (62), 77 (24), 63 (18). HRMS (EI, 70 eV): calcd for C16H11O3NS 
(M+): 297.32844; found: 297.32839. 
 
1.9.2 Synthesis of functionalized pyrroles based on suzuki coupling reactions of 
tetrabromopyrrole 
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Synthesis of 2,3,4,5-tetrabromo-1-methylpyrrole (7):  
To a THF solution (700 mL) of 1-methylpyrrole (40.5 g, 44.5 mL, 0.5 mol) 
was added N-bromosuccinimide (504 g, 2.5 mol) at 78 °C and the solution 
was stirred at this temperature for 8 h. To the mixture was added n-heptane 
(500 mL) and the tetrahydrofuran was subsequently removed under reduced 
pressure to give a colourless precipitate of succinimide. The precipitate was filtered off and 
the solvent of the filtrate was removed in vacuo. To the residue added a saturated aqueous 
solution of NaOH and the solution was heated under reflux for 6 h. The aqueous and the 
organic layer were separated. The latter was dired (Na2SO4), filtered, and the filtrate was 
concentrated in vacuo. The residue was recrystallized from a 1:1-solution of chloroform and 
methanol at 18 °C. The crude product (in the form of yellow crystals) was washed with very 
cold ethyl acetate for several times times to give 7 as colourless crystals (174.7 g, 88%). 1H 
NMR (250 MHz, CDCl3): 	 = 3.65 (s, CH3). 13C NMR (75 MHz, CDCl3): 	 = 37.0 (CH3), 
101, 103.5 (CBr).  
 
1.9.2.1 Synthesis of 5-aryl-2,3,4-tribromo-1-methylpyrroles (8a-f) 
  
 
General procedure for synthesis of 5-diaryl-2,3,4-tribromo-1-methylpyrroles: To a 
solution (4 mL) (see table 4 for each individual compounds) of 7 (0.199 g, 0.5 mmol) was 
added Pd(PPh3)4 (0.035 g, 6 mol-%) at 20 °C under argon atmosphere. After stirring for 30 
min, the arylboronic acid (1.1 mmol), K3PO4 (4.0 mmol) and water (1.0 mL) were added. The 
mixture was stirred under relux for 12 h. After cooling to 20 °C, the mixture was diluted with 
EtOAc, dried (Na2SO4), and filtered through a short Celite pad. The solution was concentrated 
in vacuo and the residue was purified by flash column chromatography (fine flash silica gel, 
n-heptane).  
 
Synthesis of 5-(3-bisphenyl)-2,3,4-tribromo-1-methylpyrrole (8a): 
Starting with 7 (0.199 g, 0.5 mmol) and 3-bisphenyl boronic acid 
(0.109 g, 1.1 mmol), 8a was isolated (0.135 g, 66%) as a yellow 
solid, mp = 164165 °C. 1H NMR (250 MHz, CDCl3): 	 = 3.57 (s, 
3 H, CH3), 7.30-7.86 (m, 9 H, Ar). 13C NMR (75 MHz, CDCl3): 	 
= 35.8 (CH3), 98.4, 101.4, 104.7 (CBr), 126.20, 126.24, 127.3, 127.4, 129.2 (CH, Ar), 127.2, 
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128.8 (2 CH, Ar), 131.0, 133.6, 140.3, 141.6 (C). IR (KBr, cm1): ~ = 2951 (w), 2911 (w), 
1661 (m), 1585 (s), 1569 (m), 1518 (s), 1419 (m), 1284 (m), 1254 (s), 1149 (s), 1037 (s), 800 
(s), 743 (m), 699 (m). MS (EI, 70 eV): m/z (%) = 473 (M+, [81Br,81Br,81Br], 49), 471 (M+, 
[81Br,81Br,79Br], 100), 469 (M+, [81Br,79Br,79Br], 45), 467 (M+, [79Br,79Br,79Br], 50). HRMS 
(EI, 70 eV): calcd for C17H12Br3N (M+, [81Br ,81Br ,79Br]): 470.84789; found: 470.84780; (M+, 
[81Br ,79Br ,79Br]): 468.84994; found: 468.84986. 
 
Synthesis of 5-(3-chloro)-2,3,4-tribromo-1-methylpyrrole (8b):
Starting with 7 (0.199 g, 0.5 mmol) and 3-chlorophenyl boronic acid 
(0.080 g, 1.1 mmol), 8b was isolated (0.152 g, 71%) as a yellow solid, 
mp = 139141 °C. 1H NMR (250 MHz, CDCl3): 	 = 3.53 (s, 3 H, 
CH3), 7.26 (t, 3J = 8.2 Hz, 1 H, Ar), 7.35 (s, 1 H, Ar), 7.40 (d, 3J = 8.2 
Hz, 2 H, Ar). 13C NMR (75 MHz, CDCl3): 	 = 35.8 (CH3), 98.8, 101.5, 105.4 (CBr), 128.6, 
128.9, 129.8, 130.4 (CH, Ar), 131.9, 132.0, 134.4 (C). IR (KBr, cm1): ~ = 2956 (w), 2919 
(w), 1669 (m), 1579 (s), 1565 (m), 1519 (s), 1423 (m), 1289 (m), 1259 (s), 1169 (s), 1026 (s), 
801 (s), 768 (m), 695 (m). MS (EI, 70 eV): m/z (%) = 433 (M+, [81Br,81Br,81Br,37Cl], 31), 431 
(M+, [81Br, 81Br,79Br,37Cl], 52), 429 (M+, [81Br,79Br,79Br,37Cl], 45), 427 (M+, 
[79Br,79Br,79Br,37Cl], 47), 425 (M+, [79Br,79Br,79Br,35Cl], 56). HRMS (EI, 70 eV): calcd for 
C11H7Br3ClN (M+, [81Br , 79Br ,79Br,37Cl]): 428.77762; found: 428.77752; (M+, [79Br 
,79Br,79Br,37Cl]): 426.77967; found: 428.77961; (M+, [79Br ,79Br ,79Br,37Cl]): 424.78171; 
found: 424.78170. 
 
Synthesis of 5-(4-ethylphenyl)-2,3,4-tribromo-1-methylpyrrole (8c):
Starting with 7 (0.199 g, 0.5 mmol) and 4-ethylphenyl boronic acid 
(0.083 g, 1.1 mmol), 8c was isolated (0.158 g, 75%) as a yellow 
solid, mp = 147150 °C. 1H NMR (250 MHz, CDCl3): 	 = 1.22 (t, 3J 
= 7.2 Hz, 3 H, CH3), 2.65 (q, 3J = 7.2 Hz, 2 H, OCH2CH3), 3.58 (3 
H, pyrrole-CH3), 7.20, 7.22 (d, 3J = 8.2 Hz, 2 H, Ar). 13C NMR (75 MHz, CDCl3): 	 = 15.2 
(CH3), 28.7 (CH2), 35.7 (pyrrole-CH3), 98.0, 101.1, 104.2 (CBr), 128.0, 130.3 (2 CH, Ar), 
126.9, 133.8, 144.9 (C). IR (KBr, cm1): ~ = 1700 (w), 1491 (w), 1453 (w), 1373 (w), 1329 
(m), 1183 (w), 1115 (w), 1087 (w), 1016 (w), 974 (w), 819 (s), 7.65 (w), 715 (w), 607 (m). 
MS (EI, 70 eV): m/z (%) = 425 (M+, [81Br,81Br,81Br], 50), 423 (M+, [81Br,81Br,79Br], 100), 421 
(M+, [81Br,79Br,79Br], 41), 419 (M+, [79Br,79Br,79Br], 54). HRMS (EI, 70 eV): calcd for 
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C13H12Br3N (M+, [81Br ,81Br ,79Br]): 422.84789; found: 422.84781; (M+, [81Br ,79Br ,79Br]): 
420.84994; found: 420.84979. 
 
Synthesis of 5-(2-methoxylphenyl)-2,3,4-tribromo-1-methylpyrrole (8d):
Starting with 7 (0.199 g, 0.5 mmol) and 2-methoxylphenyl boronic acid 
(0.084 g, 1.1 mmol), 8d was isolated (0.147 g, 75%) as a yellowish solid, 
mp = 150153 °C. 1H NMR (250 MHz, CDCl3): 	 = 3.39 (s, 3 H, OCH3), 
3.58 (3 H, pyrrole-CH3), 6.67, 7.03 (d, 3J = 8.2 Hz, 1 H, Ar), 7.25, 7.41 
(t, 3J = 8.2 Hz, 1 H, Ar). 13C NMR (75 MHz, CDCl3): 	 = 35.4 (pyrrole-CH3), 55.5 (OCH3), 
98.4, 100.5, 103.9 (CBr), 111.1, 120.7, 130.9, 133.1 (CH, Ar), 119.3, 130.0, 157.7 (C). IR 
(KBr, cm1): ~ = 1733 (w), 1501 (w), 1470 (w), 1393 (w), 1340 (m), 1193 (w), 1129 (w), 
1099 (w), 1019 (w), 979 (w), 831 (s), 761 (w), 727 (w), 600 (m). MS (EI, 70 eV): m/z (%) = 
427 (M+, [81Br,81Br,81Br], 39), 425 (M+, [81Br,81Br,79Br], 100), 423 (M+, [81Br,79Br,79Br], 50), 
421 (M+, [79Br,79Br,79Br], 47). HRMS (EI, 70 eV): calcd for C12H10Br3NO (M+, [81Br ,81Br 
,79Br]): 424.82716; found: 424.82705; (M+, [81Br ,79Br ,79Br]): 422.82921; found: 422.82911. 
 
Synthesis of 5-(3,5-dimethylphenyl)-2,3,4-tribromo-1-methylpyrrole (8f):
Starting with 7  (0.199 g, 0.5 mmol) and 3,5-dimethylphenyl 
boronic acid (0.083 g, 1.1 mmol), 8f was isolated (0.151 g, 72%) as 
a yellowish solid, mp = 160162 °C. 1H NMR (250 MHz, CDCl3): 	 
= 3.37 (s, 6 H, CH3), 3.55 (3 H, pyrrole-CH3), 6.98 (s, 2 CH, Ar), 
7.20 (s, CH, Ar). 13C NMR (75 MHz, CDCl3): 	 = 21.3 (CH3), 35.7 (pyrrole-CH3), 97.9, 
101.0, 104.2 (CBr), 125 (CH, Ar), 128 (2 CH, Ar), 128.7, 134.0, 141.4 (C). IR (KBr, cm1): 
~  = 1709 (w), 1497 (w), 1467 (w), 1361 (w), 1322 (m), 1180 (w), 1111 (w), 1080 (w), 1009 
(w), 972 (w), 817 (s), 7.55 (w), 713 (w), 600 (m). MS (EI, 70 eV): m/z (%) = 425 (M+, 
[81Br,81Br,81Br], 29), 423 (M+, [81Br,81Br,79Br], 100), 421 (M+, [81Br,79Br,79Br], 52), 419 (M+, 
[79Br,79Br,79Br], 31). HRMS (EI, 70 eV): calcd for C13H12Br3N (M+, [81Br ,81Br ,79Br]): 
422.84789; found: 422.84775; (M+, [81Br ,79Br ,79Br]): 420.84994; found: 420.84973. 
 
1.9.2.2 Synthesis of asymmetric 3,4-dibromo-2,5-diaryl-1-methylpyrroles (9a,b) 
 
General procedure for synthesis of asymmetric 3,4-dibromo-2,5-diaryl-1-
methylpyrroles: To a DMF:toluene:EtOH:H2O solution (4:1:1:1 mL) of 8e (0.203 g, 0.5 
mmol) was added Pd(PPh3)4 (0.058 g, 10 mol-%) at 20 °C under argon atmosphere. After 
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stirring for 30 min, the arylboronic acid (1.1 mmol), K3PO4 (4.0 mmol) and water (1.0 mL) 
were added. The mixture was stirred under relux for 48 h. After cooling to 20 °C, the mixture 
was diluted with EtOAc, dried (Na2SO4), and filtered through a short Celite pad. The solution 
was concentrated in vacuo and the residue was purified by flash column chromatography (fine 
flash silica gel, n-heptane).  
 
Synthesis of 3,4-dibromo-2-(4-methoxyphenyl)-5-di(4-tolyl)-1-methylpyrrole (9b):
Starting with 8e (0.199 g, 0.5 mmol) and 4-
methoxyphenyl boronic acid (0.084 g, 1.1 mmol), 9b was 
isolated (0.11 g, 51%) as a yellow solid, mp = 109111 
°C. 1H NMR (250 MHz, CDCl3): 	 = 3.37 (s, 3 H, CH3), 
3.70 (s, 3 H, pyrrole-CH3), 3.81 (s, 3 H, OCH3), 6.42, 6.79, 7.05, 7.19 (d, 3J = 8.2 Hz, 2 H, 
Ar). 13C NMR (75 MHz, CDCl3): 	 =  21.2 (CH3), 33.6 (pyrrole-CH3), 55.2 (OCH3), 113.5, 
113.9 (CBr), 121.0 (C-pyrrole, overlap), 127.8, 129.1, 129.9, 131.3 (4CH, Ar), 135.7, 136.0, 
156.3, 157.7 (C). IR (KBr, cm1): ~ = 2959 (w), 2920 (m), 2848 (w), 1666 (m), 1597 (s), 
1572 (m), 1509 (s), 1420 (m), 1289 (m), 1251 (s), 1165 (s), 1021 (s), 802 (s), 769 (m), 697 
(m). MS (EI, 70 eV): m/z (%) = 437 (M+, [81Br,81Br], 18), 435 (M+, [81Br,79Br], 100), 437 
(M+, [79Br,79Br], 31). HRMS (EI, 70 eV): calcd for C19H17Br2NO (M+, [81Br ,79Br]): 
434.96564, found: 434.96555; (M+, [79Br ,79Br]): 432.96769; found: 432.96759. 
 
1.9.2.3 Synthesis of symmetric 3,4-dibromo-2,5-diaryl-1-methylpyrroles (10a-f) 
 
General procedure for synthesis of 3,4-dibromo-2,5-diaryl-1-methylpyrroles: To a 
solution (4 mL) (see table 5 for each individual compounds) of 7 (0.199 g, 0.5 mmol) was 
added Pd(PPh3)4 (0.058 g, 10 mol-%) at 20 °C under argon atmosphere. After stirring for 30 
min, the arylboronic acid (2.5 mmol), K3PO4 (4.0 mmol) and water (1.0 mL) were added. The 
mixture was stirred under relux for 24 h. After cooling to 20 °C, the mixture was diluted with 
EtOAc, dried (Na2SO4), and filtered through a short Celite pad. The solution was concentrated 
in vacuo and the residue was purified by flash column chromatography (fine flash silica gel, 
n-heptane).  
 
Synthesis of 3,4-dibromo-2,5-di(3-chlorophenyl)-1-methylpyrrole (10a):
Starting with 7 (0.199 g, 0.5 mmol) and 3-chlorophenylboronic 
acid (0.182 g, 2.5 mmol), 10a was isolated (0.130 g, 57%) as a 
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brownish solid, mp = 129131 °C. 1H NMR (250 MHz, CDCl3): 	 = 3.47 (s, 3 H, CH3), 6.91 
(t, 3J = 8.2 Hz, 1 H, Ar), 7.10 (d, 3J = 8.2 Hz, 2 H, Ar), 7.21 (s, 1 H, Ar). 13C NMR (75 MHz, 
CDCl3): 	 = 34.9 (CH3), 99.5 (CBr), 105.5 (C-pyrrole), 126.8, 128.4, 129.2, 130.6 (2 CH, Ar), 
133.7, 135.3 (C). IR (KBr, cm1): ~ = 1928 (w), 1922 (w), 1559 (w), 1520 (w), 1466 (m), 
1439 (w), 1359 (m), 1257 (w), 1120 (w), 1015 (w), 979 (w), 830 (m), 814 (m), 777 (w), 701 
(w). MS (EI, 70 eV): m/z (%) = 465 (M+, [81Br,81Br,37Cl,37Cl], 14), 463 (M+, [81Br, 
79Br,37Cl,37Cl], 22), 461 (M+, [79Br,79Br,37Cl,37Cl], 100), 459 (M+, [79Br,79Br,35Cl,37Cl], 55), 
457 (M+, [79Br,79Br,35Cl,35Cl], 34). HRMS (EI, 70 eV): calcd for C17H11Br2Cl2N (M+, [79Br , 
79Br ,37Cl,37Cl]): 460.85853; found: 460.85839; (M+, [79Br ,79Br,35Cl,37Cl]): 458.86148; found: 
458.86139; (M+, [79Br ,79Br ,35Cl,35Cl]): 456.86353; found: 456.86341. 
 
Synthesis of 3,4-dibromo-2,5-di(4-ethoxyphenyl)-1-methylpyrrole (10b): Starting with 7 
(0.199 g, 0.5 mmol) and 4-ethoxyphenylboronic acid 
(0.187g, 2.5 mmol), 10b was isolated (0.116 g, 52%) as a 
yellowish solid, mp = 124128 °C. 1H NMR (250 MHz, 
CDCl3): 	 = 1.30 (t, 3J = 7.2 Hz, 6 H, 2CH3), 2.72 (q, 3J = 
7.2 Hz, 4 H, 2OCH2CH3), 3.38 (3 H, pyrrole-CH3), 7.32, 7.36 (d, 3J = 8.2 Hz, 2 H, Ar). 13C 
NMR (75 MHz, CDCl3): 	 = 15.2 (CH3), 28.7 (CH2), 34.9 (pyrrole-CH3), 98.7 (CBr), 127.9, 
130.4 (4 CH, Ar), 128.2 (C-pyrrole), 132.7, 144.4 (C). IR (KBr, cm1): ~ = 1929 (w), 1919 
(w), 1551 (w), 1529 (w), 1483 (m), 1441 (w), 1310 (m), 1221 (w), 1110 (w), 1031 (w), 979 
(w), 823 (m), 800 (m), 771 (w), 712 (w). MS (EI, 70 eV): m/z (%) = 449 (M+, [81Br,81Br], 25), 
447 (M+, [81Br, 79Br],100), 445 (M+, [79Br,79Br], 51). HRMS (EI, 70 eV): calcd for 
C21H21Br2N (M+, [81Br , 79Br]): 447.00203; found: 447.00189; (M+, [79Br ,79Br]): 445.00407; 
found: 445.0035. 
 
Synthesis of 3,4-dibromo-2,5-di(4-chlorophenyl)-1-methylpyrrole (10d):
Starting with 7 (0.199 g, 0.5 mmol) and 4-chlorophenyl 
boronic acid (0.170 g, 2.5 mmol), 10d was isolated (0.166 g, 
79%) as a colourless solid, mp = 139142 °C. 1H NMR (250 
MHz, CDCl3): 	 = 3.36 (s, 3 H, CH3), 7.38, 7.43 (d, 3J = 8.2 
Hz, 4 H, Ar). 13C NMR (75 MHz, CDCl3): 	 = 34.5 (CH3), 99.6 (CBr), 128.9, 131.7 (4 CH, 
Ar), 129.1 (C-pyrrole), 131.9, 134.6 (C). IR (KBr, cm1): ~ = 1922 (w), 1920 (w), 1555 (w), 
1529 (w), 1466 (m), 1439 (w), 1359 (m), 1256 (w), 1129 (w), 1012 (w), 988 (w), 834 (m), 
814 (m), 777 (w), 701 (w). MS (EI, 70 eV): m/z (%) = 465 (M+, [81Br,81Br,37Cl,37Cl], 19), 463 
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(M+, [81Br, 79Br,37Cl,37Cl], 27), 461 (M+, [79Br,79Br,37Cl,37Cl], 100), 459 (M+, 
[79Br,79Br,35Cl,37Cl], 47), 457 (M+, [79Br,79Br,35Cl,35Cl], 26). HRMS (EI, 70 eV): calcd for 
C17H11Br2Cl2N (M+, [79Br , 79Br ,37Cl,37Cl]): 460.85853; found: 460.85837; (M+, [79Br 
,79Br,35Cl,37Cl]): 458.86148; found: 458.86138; (M+, [79Br ,79Br ,35Cl,35Cl]): 456.86353; 
found: 456.86344. 
 
Synthesis of 3,4-dibromo-2,5-di(4-methoxyphenyl)-1-methylpyrrole (10e):
Starting with 7 (0.199 g, 0.5 mmol) and 4-
methoxyphenyl boronic acid (0.190 g, 2.5 mmol), 10e 
was isolated (0.178 g, 79%) as a colourless solid, mp = 
159160 °C. 1H NMR (250 MHz, CDCl3): 	 =  3.34 (s, 
3 H, pyrrole-CH3), 3.86 (s, 6 H, 2OCH3), 7.00, 7.36 (d, 3J = 8.2 Hz, 4 H, Ar). 13C NMR (75 
MHz, CDCl3): 	 =  34.7 (pyrrole-CH3), 55.3 (OCH3), 98.5 (CBr), 113.9, 131.8 (4CH, Ar), 
123.3 (C-pyrrole), 132.2, 159.5 (C). IR (KBr, cm1): ~ = 1931 (w), 1925 (w), 1561 (w), 1532 
(w), 1479 (m), 1454 (w), 1370 (m), 1251 (w), 1134 (w), 1029 (w), 977 (w), 829 (m), 807 (m), 
778 (w), 710 (w). MS (EI, 70 eV): m/z (%) = 453 (M+, [81Br,81Br], 29), 451 (M+, [81Br,79Br], 
100), 449 (M+, [79Br,79Br], 38), 244 (24). HRMS (EI, 70 eV): calcd for C19H17Br2NO2 (M+, 
[81Br ,79Br]): 450.96056, found: 450.96042; (M+, [79Br ,79Br]): 448.96260; found: 448.96251. 
 
Synthesis of 3,4-dibromo-2,5-di(2-thienyl)-1-methylpyrrole (10f):
Starting with 7 (0.199 g, 0.5 mmol) and 2-thienyl boronic acid (0.160 
g, 2.5 mmol), 10f was isolated (0.1 g, 50%) as a brownish solid, mp = 
112114 °C. 1H NMR (250 MHz, CDCl3): 	 = 3.65 (s, 3 H, pyrrole-
CH3), 7.01 (t, 3J = 4.01 Hz, 2 H, thiophene), 7.17, 7.21 (d, 3J = 4.01 
Hz , 2 H, thiophene). 13C NMR (75 MHz, CDCl3): 	 = 36.9 (CH3), 100.9 (CBr), 103.5 (C-
pyrrole), 123.7, 124.3, 127.7 (2 CH, thiophene), 137.3 (C). IR (KBr, cm1): ~ = 1934 (w), 
1911 (w), 1538 (w), 1524 (w), 1475 (m), 1456 (w), 1369 (m), 1242 (w), 1127 (w), 1016 (w), 
970 (w), 856 (m), 828 (m). MS (EI, 70 eV): m/z (%) = 405 (M+, [81Br,81Br], 15), 403 (M+, 
[81Br,79Br], 100), 401 (M+, [79Br,79Br], 45). HRMS (EI, 70 eV): calcd for C13H9Br2NS2 (M+, 
[81Br ,79Br]): 402.85227, found: 402.85222; (M+, [79Br ,79Br]): 400.85432; found: 400.85421. 
 
1.9.2.4 Synthesis of tetraaryl-1-methylpyrroles (11a,b,c) 
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General procedure for synthesis of 3,4-dibromo-2,5-diaryl-1-methylpyrroles: To a 
DMF:toluene:EtOH solution (4:1:1 mL) of 7 (0.199 g, 0.5 mmol) was added Pd(PPh3)4 (0.116 
g, 20 mol-%) at 20 °C under argon atmosphere. After stirring for 30 min, the arylboronic acid 
(5 mmol), K3PO4 (5.0 mmol) and water (1.0 mL) were added. The mixture was stirred under 
relux for 48 h. After cooling to 20 °C, the mixture was diluted with EtOAc, dried (Na2SO4), 
and filtered through a short Celite pad. The solution was concentrated in vacuo and the 
residue was purified by flash column chromatography (fine flash silica gel, n-heptane).  
 
Synthesis of tetratolyl-1-methylpyrrole (11c):
Starting with 7 (0.199 g, 0.5 mmol) and tolylboronic acid 
(0.34 g, 5 mmol), 11c was isolated (0.157 g, 71%) as a 
yellow solid, mp = 176180 °C. 1H NMR (250 MHz, 
CDCl3): 	 = 2.13, 2.29 (6 H, CH3), 3.30 (3 H, pyrrole-
CH3), 6.79 (m, 8 H, Ar), 7.02, 7.15 (d, 3J = 8.2 Hz, 4 H, 
Ar). 13C NMR (75 MHz, CDCl3): 	 = 20.9, 21.0 (CH3), 32.7 (pyrrole-CH3), 127.9, 128.6, 
130.5, 131.0 (4 CH, Ar), 121.6, 129.8, 131.3, 132.6, 134.1, 136.6 (C). IR (KBr, cm1): ~ = 
2917 (w), 2862 (w), 1520 (w), 1496 (w), 1360 (w), 1112 (w), 1020 (w), 835 (m), 819 (m), 
804 (m), 746 (m), 721 (m). MS (EI, 70 eV): m/z (%) = 441 (M+, 100), 366 (4), 309 (2), 239 
(1), 91 (12). HRMS (EI, 70 eV): calcd for C33H31N (M+): 441.24510; found: 441.245085. 
 
1.9.2.5 Synthesis of tetraaryl-1-methylpyrroles (12a,b) 
 
General procedure for synthesis of 3,4-dibromo-2,5-diaryl-1-methylpyrroles: To a 
DMF:toluene:EtOH solution (4:1:1 mL) of 10c (0.208 g, 0.5 mmol) was added Pd(PPh3)4 
(0.116 g, 20 mol-%) at 20 °C under argon atmosphere. After stirring for 30 min, the 
arylboronic acid (3 mmol), K3PO4 (4.0 mmol) and water (1.0 mL) were added. The mixture 
was stirred under relux for 96 h. After cooling to 20 °C, the mixture was diluted with EtOAc, 
dried (Na2SO4), and filtered through a short Celite pad. The solution was concentrated in 
vacuo and the residue was purified by flash column chromatography (fine flash silica gel, n-
heptane).  
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Synthesis of 2,5-ditolyl-3,4-di(4-methoxyphenyl)-1-methylpyrrole (12a):
Starting with 10c (0.209 g, 0.5 mmol) and 4-
methoxyphenyl boronic acid (0.228 g, 3 mmol), 12a was 
isolated (0.153 g, 65%) as a yellow solid, mp = 172174 
°C. 1H NMR (250 MHz, CDCl3): 	 = 2.35 (6 H, CH3), 3.4 
(3 H, pyrrole-CH3), 3.71 (6 H, OCH3), 6.63, 6.87, 7.14, 
7.19 (d, 3J = 8.2 Hz, 4 H, Ar). 13C NMR (75 MHz, CDCl3): 	 = 21.25 (CH3), 32.9 (pyrrole-
CH3), 54.9 (OCH3), 112.9, 128.8, 311.2, 131.8 (4 CH, Ar), 121.9, 128.2, 130.1, 131.3, 136.7, 
157.9 (C). IR (KBr, cm1): ~ = 2915 (w), 2849 (w), 1529 (w), 1486 (w), 1359 (w), 1112 (w), 
1020 (w), 835 (m), 820 (m), 802 (m), 755 (m), 722 (m). MS (EI, 70 eV): m/z (%) = 473 (M+, 
100), 444 (5), 353 (3), 211 (1), 112 (12), 97 (11), 69 (5). HRMS (EI, 70 eV): calcd for 
C33H31NO2 (M+): 473.23548; found: 473.23534. 
 
1.9.3 Synthesis of functionalized pyrroles based on alkynylation of tetrabromopyrroles 
 
General procedure for Sonogashira reactions:  
Tetrabromo-N-methylpyrole (7) (750 mg, 1.87 mmol), triphenylphosphane (98 mg, 20 mol%), 
PdCl2(CH3CN)2 (49 mg, 10 mol-%) and CuI (36 mg, 10 mol-%) were added to an oven dry 
Schlenk flask, evacuated for 10 min, and then flushed with argon. To the mixture was added 
thoroughly dried, freshly distilled and oxygen-free diisopropylamine (20 mL). The clear 
yellow solution was stirred for 15 min at 20 °C for the generation of the catalyst. The solution 
was subsequently cooled to 0 °C and the alkyne was dropwise added by syringe. The solution 
was stirred for 1 h at 0 °C and for 3 h at 20 °C. The dark brown mixture was heated at the 
indicated temperature (90°C)  indicated period of time. The solution was allowed to cool to 
ambient temperature, filtered and the filtrate was concentrated in vacuo. To the residue was 
added CH2Cl2 and the solution was extracted with water. The combined organic layers were 
dried (MgSO4), filtered and the filtrate was concentrated in vacuo. The residue was purified 
by column chromatography (neutral silica gel, n-hexane). For the synthesis of products 3, the 
two alkynes were added at the same time. 
 
General procedure for Sonogashira reactions (Procedure C) : a pressure tube was 
evacuated and backfilled argon and then charged under positive pressure of argon with 
PdCl2(CH3CN)2 (5% mol, 6.5 mg) ,L (20%mol, 44.6 mg), Cs2CO3 (5 eq, 0.815 g), followed 
by anhydrous acetonitrile (1 mL), and tetrabromo-N-pyrrole (0.5 mol – 0.191 g). The slightly 
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yellow suspension was stirred for 25 min. The alkyne (2.5 mmole) was injected . The pressure 
tube was seald by Teflon vavle, and the mixture of reaction was stirred at the desired 
temperature (100°C) for the indicated period of time. The organic layer was isolated from 
suspension by funnel, and washed the solid residue several times by ethylacetate. The organic 
layer was concentrated and purified by flash chromatography on fine silicagel to provide the 
desired product. 
 
1.9.3.1  Synthesis of 5-alkynyl-2,3,4-tribromo-1-methylpyrroles 
 
Synthesis of 5-pentylnyl-2,3,4-tribromo-1-methylpyrrole (13a): 
Starting with tetrabromopyrole (500 mg, 1.25 mmol) and 2-pentyne 
(1.3 mmol), 13a was isolated (134 mg, 30%) as a brownish highly 
viscous oil. 1H NMR (300 MHz, CDCl3): 	 = 1.06 (t, 3J = 7.5 3H, Me), 
1.64 (sextet, 3J = 7.2 Hz, 2H, CH2), 2.47 (t, 3J = 7.0 Hz, 2H, CH2), 3.64 
(s, 3H, NCH3). 13C NMR (75 MHz, CDCl3): 	 = 13.5 (CH3), 21.6, 22.0 (CH2), 35.6 (NMe), 
70.1, 98.8 (CC), 100.4, 102.93, 104.19, 118.34 (C, pyrrole). IR (KBr, cm-1): 	 = 3436 (br, s), 
2958 (s), 2932 (m), 2872 (m), 2228 (w), 1717 (m), 1529 (m), 1456 (s), 1431 (m), 1378 (m), 
1330 (s), 1092 (m). MS (EI, 70 eV, 85 °C): m/z (%) = 387 (12) [M+, 81Br, 81Br, 81Br], 385 (13) 
[M+, 79Br, 81Br, 81Br], 383 (48) [M+, 79Br, 79Br, 81Br], 381 (19) [M+, 79Br, 79Br, 79Br], 356 (67), 
354 (58), 275 (14), 224 (54), 194 (60), 115 (100). HRMS (EI, 70 eV): calcd for C10H10Br3N 
([M+, 79Br, 79Br, 79Br]): 380.83579, found 380.83501.  
 
Synthesis of 5-(2-methylbut-2-ol-3-ylnyl)-2,3,4-tribromo-1-methylpyrrole (13b):  
Starting with tetrabromopyrole (500 mg, 1.25 mmol), 2-methyl-3-
pentyne-2-ol (0.15 mL, 1.5 mmol), 13b was isolated (160 mg, 32 
%) as a red brown solid. 1H NMR (300 MHz, CDCl3): 	 = 1.64 (s, 
6H, 2Me), 3.64 (s, 3H, NCH3). 13C NMR (75 MHz, CDCl3): 	 = 
31.32 (2Me), 35.71 (NMe), 65.78 (C, CMe2OH), 71.65 (CC), 100.76 (C, pyrol), 104.09 
(CC), 102.14 (C, pyrrole), 105.49 (C, pyrrole), 116.79 (C, pyrrole). IR (KBr, cm-1): 	 = 3443 
(m), 3014 8 (w), 2983 (s), 2936 (w), 2250 (w), 1723 (s), 1454 (s), 1379 8 (m), 1329 (s), 1216 
(m), 1163 (m), 908 (s), 759 (m), 734 (m). MS (EI, 70 eV, 85 °C): m/z (%) = 401 (51) [M+, 
81Br, 81Br],, 399 (50) [M+, 79Br, 81Br], 397 (19) [M+, 79Br, 79Br] 388 (33) 386 (90), 384 (100) 
[M+-CH3], 382 (42), 320 (23), 193 (18), 145 (22). 
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Synthesis of 5-(pent-1-ol-4-ylnyl)-2,3,4-tribromo-1-methylpyrrole (13d): 
Starting with tetrabromopyrole (500 mg, 1.26 mmol), 4-pentyne-
1-ol (1.32 mmol), 13d was isolated (145 mg, 29 %) as a red 
brown solid. 1H NMR (300 MHz, CDCl3): 	 = 1.88 (pentet, 3J  = 
7.1 2H, CH2), 2.05 (br S, 1H OH), 2.62 (t, 3J = 6.9 Hz, 2H, CH2), 
3.64 (s, 3H, NCH3), 3.82 (br t, 3J = 6.0 Hz, 2H, CH2). 13C NMR (75 MHz, CDCl3): 	 = 16.25 
(CH2), 31.16 (CH2), 35.67 (NMe), 61.4 (CH2OH) 70.40 (CC), 97.95 (C, pyrrole), 100.38 (C, 
pyrrole), 103.11 (C, pyrrole), 104.43 (CC), 118.02 (C, pyrrole). IR (KBr, cm-1): 	 = 3411 
(br, s), 2944 (s), 2873 (m), 1717 (m), 1636 (w), 1479 (m), 1455 (s), 1434 (s), 1377 (m), 1330 
(s), 1186 (m), 1094 (s), 1060 (s), 919 (m), 748 (s), 692 (s), 520 (s), 509 (s). HRMS (EI, 70 
eV): calcd for C10H10NOBr3 [Br79]; 396.83070, found 396.830504. 
 
1.9.3.2 Synthesis of asymmetric 3,4-tribromo-2,5-dialkynyl-1-methylpyrroles
 
Synthesis of 3,4-tribromo- 2-(pent-2-ol-4-ylnyl)-5-tolylacetylyl-1-methylpyrrole (14a): 
Starting with tetrabromopyrole (500 mg, 1.26 mmol), 
4-pentyne-2-ol (1.38 mmol) p-tolyl acetylene (1.38 
mmol), 14a was isolated (216 mg, 40 %) as a red 
solid. The two alkynes were added at the same time. 
1H NMR (300 MHz, CDCl3): 	 = 1.34 (d, 3H, Me), 2.36 (s, 3H, Me-tolyl) 2.68 (d, 3J = 6.9 
Hz,  2H, CH2), 3.71 (s, 3H, NCH3), 4.07 (m, 1H, CH), 7.15 (d, 3J = 7.8 Hz, 2H, tolyl), 7.40 (d, 
3J = 8.1 Hz, 2H, tolyl). 13C NMR (75 MHz, CDCl3): 	 = 21.05 (Me, tolyl), 22.41 (Me), 30.13 
(CH2), 35.66 (NMe), 60.33 (CH), 66.29 (CC), 72.27 (CC), 97.27 (C, pyrrole), 103.57 (C, 
pyrrole), 103.76 (CC), 117.29 (C, pyrrole), 117.65 (C, pyrrole), 119.07 (C, p-tolyl), 129.12 
(CH, p-tolyl), 131.27 (CH, p-tolyl), 139.99 (C, p-tolyl). IR (KBr, cm-1): 	 = 3455 (br, s), 2972 
(s), 2927 (s), 2252 (s), 2212 (w), 1727 (s), 1728 (s), 1656 (s), 1446 (s), 1377 (s), 1341 (m), 
1250(m), 1120 (m), 908 (br, s), 816 (s), 733 (br, s). 
 
Synthesis of 3,4-tribromo- 2-(pent-1-ol-4-ylnyl)-5-tolylacetylyl-1-methylpyrrole (14b): 
Starting with tetrabromopyrole (500 mg, 1.26 
mmol), 4-pentyne-1-ol (1.38 mmol) p-
tolylacetylene (1.38 mmol), 14b was isolated (213 
mg, 39 %) as a red solid. The two alkynes were 
added at the same time. 1H NMR (300 MHz, CDCl3): 	 = 1.88 (m, 2H, CH2), 2.38 (s, 3H, Me-
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olyl) 2.63 (t, 3J = 6.9 Hz, 2H, CH2), 3.72 (s, 3H, NCH3), 3.84 (t, 3J = 6.9 Hz, 2H, CH2), 7.15 
(d, 3J = 8.1 Hz, 2H, tolyl), 7.42 (d, 3J = 7.5 Hz, 2H, tolyl). 13C NMR (75 MHz, CDCl3): 	 = 
16.26 (CH2), 22.60 (Me, tolyl), 31.14 (CH2), 30.13 (CH2), 34.43 (NMe), 61.46 (CH2), 68.52 
(CC), 70.49 (CC), 97.89 (C, pyrrole), 98.00 (C, pyrrole), 103.23 (CC), 103.41 (CC), 
117.10 (C, pyrrole), 117.98 (C, pyrrole), 119.18 (C, p-tolyl), 129.16 (CH, p-tolyl), 131.33 
(CH, p-tolyl), 139.00 (C,  p-tolyl). 
 
Synthesis of 3,4-tribromo- 2-(2-methylbut-2-ol-3-ylnyl)-5-tolylacetylyl-1-methylpyrrole 
(14c):  
Starting with tetrabromopyrole (500 mg, 1.25 mmol), 
2-methyl-3-pentyne-2-ol (1.3 mmol) and p-
tolylacetylene (1.3 mmol), 14c was isolated (238 mg, 
44%) as a red to brown solid. 1H NMR (300 MHz, CDCl3): 	 = 1.65 (s, 6 H, CH3), 2.36 (s, 
3H, Me-tolyl), 3.72 (s, 3H, CH3), 7.16 (d, 3J = 8.1 Hz, 2H, tolyl), 7.43 (d, 3J = 8.1 Hz, 2H, 
tolyl). 13C NMR (75 MHz, CDCl3): 	 = 21.6 (CH3, tolyl), 31.3 (CH3), 34.4 (NCH3), 65.9 (C, 
CMe2OH), 71.7, 71,6 (CC), 97.5, 97.7  (C, pyrrole), 102.2, 103.9 (CC), 116.9, 117.9  (C, 
pyrrole), 119.1, 131.4 (CH, p-tolyl), 139.2 (C, p-tolyl). IR (KBr, cm-1): 	 = 3324 (br, s), 2983 
(s), 2929 (s), 2865 (w), 2249 (m), 1906 (w), 1728 (s), 1534 (m), 1509 (m), 1440 (s), 1232 (s), 
1160 (br, s), 910 (s), 815 (s), 730 (br, s). MS (EI, 70 eV, 110 °C): m/z (%) = 437 [M+, 81Br, 
81Br] (49), 435 [M+, 79Br, 81Br] (100), 433 [M+, 79Br, 79Br] (49), 422 (30), 420 (65), 418  (40), 
417 (11), 405 (17) 377 (18), 356 (15), 354 (14). HRMS (EI, 70 eV): calcd for C17H19NOBr2 
[Br79]: 432.96769, found 432.96751. 
 
Synthesis of 3,4-tribromo- 2-octylyl-5-tolylacetylyl-1-methylpyrrole (14d): 
Starting with tetrabromopyrole (600 mg, 1.51 
mmol), p-tolylacetylene (1.66 mmol), 1-Octyne 
(1.66 mmol), 14d was isolated (285 mg, 41%) as a 
red solid. The two alkynes were added at the same 
time. 1H NMR (300 MHz, CDCl3): 	 = 0.90 (tr, 3J = 6.9 Hz, 3H, Me), 1.32 (br m, 4H, 2CH2), 
1.47 (m, 2H, CH2), 1.63 (m, 2H, CH2), 2.36 (s, 3H, Me-tolyl), 2.49 (tr, 3J = 6.9 Hz, 2H, CH2), 
3.72 (s, 3H, NCH3). 7.15 (d, 3J = 8.0 Hz, 2H, tolyl), 7.42 (d, 3J = 8.1 Hz, 2H, tolyl). 13C NMR 
(75 MHz, CDCl3): 	 = 14.06 (Me), 19.73 (CH2), 21.56 (Me-tolyl), 22.57 (CH2), 28.48 (CH2), 
28.50 (CH2), 31.29 (CH2), 34.41 (NMe), 70.03 (CC), 78.05 (CC), 97.13 (CC), 99.13 (C, 
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pyrrole), 103.14 (C, pyrrole), 103.66 (CC), 116.96 (C, pyrrole), 118.36 (C, pyrrole), 119.30 
(C, p-tolyl), 129.18 (CH, p-tolyl), 131.33 (CH, p-tolyl), 138.96 (C, p-tolyl).  
 
Synthesis of 3,4-tribromo- 2-octylyl-5-(2-methylbut-2-ol-3-ylnyl)-1-methylpyrrole (14e): 
Starting with tetrabromopyrole (700 mg, 1.76 mmol), 2-
methyl-3-pentyne-2-ol (1.94 mmol), 1-Octyne (1.94 
mmol), 14e was isolated (280 mg, 37 %) as a red brown 
solid. The two alkynes were added at the same time. 1H 
NMR (300 MHz, CDCl3): 	 = 0.90 (tr, 3J = 6.9 Hz, 3H, Me), 1.29 (br m, 6H, 3CH2), 1.47 (m, 
2H, CH2), 1.64 (s, 6H, 2Me), 2.49 (tr, 3J = 7.0 Hz, 2H, CH2), 3.63 (s, 3H, NCH3). 13C NMR 
(75 MHz, CDCl3): 	 = 14.02 (Me), 19.65 (CH2), 22.52 (CH2), 28.41 (CH2), 28.44 (CH2), 
31.24 (CH2), 31.34 ((2Me), 34.30 (NMe), 65.80 (C, CMe2OH), 69.83 (CC), 71.80 (CC), 
99.00 (C, pyrrole), 101.61 (C, pyrrole), 101.85 (CC), 103.80 (CC), 115.96 (C, pyrrole), 
118.30 (C, pyrrole). IR (KBr, cm-1): 	 = 3411 (br, s), 2931 (s), 2929 (s), 2859 (s), 2249 (m), 
2223 (m), 1726 (m), 1525 (m), 1378 (s), 1345 (s), 1233 (s), 1159 (s), 908 (br, s), 9734 (br s). 
1.9.3.3 Synthesis of 3-bromo-2,4,5-trialkynyl-1-methylpyrroles
 
Synthesis of 3-bromo-2-(pent-2-ol-4-ylnyl)-4,5-ditolylecetylnyl-1-methylpyrrole (15): 
Starting with tetrabromopyrole (500 mg, 1.26 mmol), 
2-methyl-3-butyne-2-ol (1.38 mmol) phenylacetylene 
(1.38 mmol), 15 was isolated (228 mg, 41%) as a red 
solid. The two alkynes were added at the same time. 
1H NMR (300 MHz, CDCl3): 	 = 1.67 (s, 6 H, 2Me), 
3.77 (s, 3H, NCH3), 7.35 (br, dd, 3J = 6.3, 4J = 3.6 
Hz, 6H, Ph), 7.52 (m, 4H, Ph). 13C NMR (75 MHz, 
CDCl3): 	 = 31.55, (2Me), 34.07 (NMe), 65.78 (C, CMe2OH), 74.29 (CC), 78.52 (CC), 
78.74 (CC), 97.20 (C, pyrrole), 97.73 (C, pyrrole), 98.82 (CC), 104.95 (CC), 111.32 
(CC), 117.56 (C, pyrrole), 120.56 (C, pyrrole), 122.24 (Ph), 122.29 (Ph), 128.44 (Ph), 
128.53 (Ph), 131.34 (Ph), 131.39 (Ph), 131.94 (Ph), 131.99 (Ph). IR (KBr, cm-1): 	 = 3466 (br, 
s), 3294 (br, s), 3056 (m), 2980 (s), 2930 (m), 2201 (s), 2065 (br, s), 1597 (s), 1440 (m), 1363 
(s), 1120 (s), 908 (s), 815 (s), 732 (br, s), 689 (s). HRMS (EI, 70 eV): calcd for C26H20NOBr 
[Br79]: 441.07228, found 441.07232. 
 
N
BrBr
MeMe
HO
Me
N
Br
Me Me
OH
Me
  82
1.9.3.4 Synthesis of symmetric 3,4-tribromo-2,5-dialkynyl-1-methylpyrroles 
 
Synthesis of 3,4-tribromo- 2,5-diphenylacetylnyl-1-methylpyrrole (16a): 
Starting with tetrabromopyrole (750 mg, 1.90 mmol), 
phenylacetylene (1.5 mmol), 16a was isolated (492 mg, 
59%) as a red brown solid. 1H NMR (300 MHz, CDCl3): 
	 = 3.80 (s, 3H, NCH3), 7.36 (m, 6H, Ph), 7.53 (m, 4H, 
Ph). 13C NMR (75 MHz, CDCl3): 	 = 34.62 (NMe), 78.50 (CC), 97.56 (C, pyrrole) 104.46 
(CC), 117.88 (C, pyrrole), 122.21 (C, Ph), 128.45 (Ph), 128.82 (Ph), 131.46 (Ph). (EI, 70 eV, 
RT °C): m/z (%) = 441 (61) [M+ 81Br, 81Br], 439 (100) [M+ 79Br, 81Br], 437 (58) [M+ 79Br, 
79Br], 279 (13), 278 (26), 202 (16), 151 (96), 149 (34), 137 (45), 135 (38), 127 (10). IR (KBr, 
cm-1): 	 = 3430 (br, s), 2980 (m), 2932 (m), 2360 (w), 1723 (s), 1631 (s), 1434 (s), 1380 (s), 
1256 (m), 1160 (m), 994 (m), 881 (m). HRMS (EI, 70 eV): calcd for C21H13Br2N [Br79]: 
436.94093, found 436.940105. 
 
Synthesis of 3,4-tribromo- 2,5-ditolylacetylnyl-1-methylpyrrole (16b): 
Starting with tetrabromopyrole (750 mg, 1.87 
mmol) and p-tolylacetylene (0.6 mL, 4.67 
mmol), 16b (620 mg, 71%) was isolated as a 
white crysaline solid. 1H NMR (300 MHz, 
CDCl3): 	 = 2.36 (s, 6H, CH3, p-tolyl), 3.77 (s, 3H, NCH3), 7.14 (d, 3J = 8.1 Hz, 4H, p-tolyl), 
7.56 (d, 3J = 8.1 Hz, 4H, p-tolyl). 13C NMR (75 MHz, CDCl3): 	 = 21.6 (CH3, p-tolyl), 34.6 
(NCH3), 77.9 (CC), 97.7 (C, pyrrol), 104.1 (CC), 117.9 (C, pyrrol), 119.1 (C, p-tolyl), 
129.2 (CH, p-tolyl), 131.3 (CH, p-tolyl), 139.1 (C, p-tolyl). IR (KBr, cm-1): 	 = 3435 (br, m), 
3023 (m), 2717 (s), 2206 (w), 1537 (s), 1441 (s), 1377 (s), 1345 (s), 817 (s), 809 8s), 535 (s), 
520 (s). MS  (EI, 70 eV, 320 °C): m/z (%) =  469.5 [M+, 81Br, 81Br] (50), 470 (12), 467.6  [M+, 
79Br, 81Br] (100), 466.8 (17), 465.6 [M+, 79Br, 79Br] (51), 403 (16), 306.5 (10), 292.5 (14), 277 
(42). HRMS (EI, 70 eV): calcd for C23H17Br2N [Br79]: 464.97223, found 464.97163. 
 
Synthesis of 3,4-tribromo- 2,5-dipentylnyl-1-methylpyrrole (16d): 
Starting with tetrabromopyrole (600 mg, 1.51 mmol), 1-
pentyne (3.8 mmol), 16d was isolated (252 mg, 45 %) as a 
red brown solid. 1H NMR (300 MHz, CDCl3): 	 = 1.06 (t, 3J 
= 7.5 Hz, 6H, 2Me), 1.63 (hept, 3J =  7.2 Hz 2H, CH2), 2.46 
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(t, 3J = 6.9 Hz, 2H, CH2), 3.63 (s, 3H, NCH3). 13C NMR (75 MHz, CDCl3): 	 = 13.48 (Me), 
21.68, 22.05 (2CH2), 34.27 (NMe), 70.24 (CC), 98.24 (C, pyrrole), 102.61 (CC), 117.38 
(C, pyrrole). (EI, 70 eV, 170 °C): m/z (%) = 374 (55), 372 [M+, 81Br, 81Br] (100), 370[M+, 
81Br, 79Br] (55), 345 (49), 341 (53), 314 (11), 262 (12), 211 (11), 182 (26), 152 (24). IR (KBr, 
cm-1): 	 = 3468 (br, m), 2963, 2934, 2872 (s), 2833 (m), 2228 (w), 1717 (m), 1526 (w), 1456 
(s), 1442 (s), 1379 (s), 1343 (s), 1197 (m), 950 (m), 908 (m), 758 (br, s). HRMS (EI, 70 eV): 
calcd for C15H17Br2N [Br79]: 368.97223, found 368.972072. 
 
Synthesis of 3,4-tribromo- 2,5-di(pent-2-ol-4-ylnyl)-1-methylpyrrole (16i): 
Starting with tetrabromopyrrole (700 mg, 1.76 mmol), 
4-pentyne-2-ol (4.4 mmol), 16i was isolated (496 mg, 
70 %) as a red brown solid. 1H NMR (300 MHz, 
CDCl3): 	 = 1.34 (d, 6H, 2Me), 2.23 (br s, 2OH) 2.68 
(d, 3J = 5.4 Hz, 4H, CH2), 3.66 (s, 3H, NCH3), 4.07 (m, 2H, CH),  13C NMR (75 MHz, 
CDCl3): 	 = 22.42 (Me), 30.15 (CH2), 34.45 (NMe), 66.30 (CH), 72.24 (CC), 94.68 (C, 
pyrrole), 103.34 (CC), 117.12 (C, pyrrole). (EI, 70 eV, 170 °C): m/z (%) = 406 [M+, 81Br, 
81Br] (56), 404 [M+, 81Br, 79Br] (100), 402 [M+, 79Br, 79Br] (54), 461 (32), 357 (29), 314 (30), 
321 (18), 280 (28), 278 (27), 234 (23). IR (KBr, cm-1): 	 = 3366 (br, s), 2947 (s), 2920 (s), 
2898 (2), 2360 (w), 1634 (m), 1442 (s), 1343 (s), 1199 (m), 1107 (s), 1086 (s), 939 (s), 657 
(br, s). HRMS (EI, 70 eV): calcd for C15H17NBr2O2 [Br79]: 400.96206, found 400.96088. 
 
Synthesis of 3,4-tribromo- 2,5-di(pent-1-ol-4-ylnyl)-1-methylpyrrole (16h): 
Starting with tetrabromopyrrole (500 mg, 1.26 
mmol), 4-pentyne-1-ol (3.15 mmol), 16h was 
isolated (309 mg, 61 %) as a red brown solid. 1H 
NMR (300 MHz, CDCl3): 	 = 1.85 (pentet, 3J  = 7.1 
Hz, 4H, 2CH2), 2.27 (br s, 2H, 2OH), 2.58 (m, 4H, 2CH2), 3.46 (s, 3 H, NCH3), 3.81 (br t, 3J 
= 6.8 Hz, 4H, 2CH2). 13C NMR (75 MHz, CDCl3): 	 = 16.28 (CH2), 31.13 (CH2), 50.71 
(CH2), 33.82 (NMe), 70.98 (CC), 97.15 (C, pyrrole), 102.86 (CC), 117.26 (C, pyrrole). 
(EI, 70 eV, 150 °C): m/z (%) = 405 [M+, 81Br, 81Br] (6), 403 [M+ 79Br, 81Br], (8) 401 [M+ 79Br, 
79Br] (5), 279 (10), 278 (48), 277 (100), 276 (4), 202 (5), 201 (28), 199 (37), 196 (8), 185 
(16), 183 (29), 171 (6), 170 (7), 152 (23), 105 (9). IR (KBr, cm-1): 	 = 3391 (br, s), 2947 (s), 
2836 (s), 2228 (w), 1648 (s), 1438 (s), 1378 (m), 1362 (m), 1179 (w), 1120 (m), 1026 (s), 924 
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(w), 724 (br, s). HRMS (EI, 70 eV): calcd for C15H17NO2Br2 [Br79]: 400.96040, found 
400.96126. 
 
Synthesis of 3,4-tribromo- 2,5-dioctylnyl-1-methylpyrrole (16g): 
Starting with tetrabromopyrole (700 mg, 1. 76 mmol), 1-
Octyne (4.4 mmol), 16g was isolated (520 mg, 65%) as a 
red brown solid. 1H NMR (300 MHz, CDCl3): 	 = 0.90 
(tr, 3J = 6.9 Hz, 3H, Me), 1.30 (br m, 8H, 4CH2), 1.49 
(m, 2H, 2CH2), 1.61 (m, 4H, 2CH2), 2.48 (tr, 3J = 6.9 Hz, 2H, CH2), 3.64 (s, 3H, NCH3). 13C 
NMR (75 MHz, CDCl3): 	 = 14.06 (Me), 19.22 (CH2), 22.56 (CH2), 28.51 (CH2), 28.54 
(CH2), 31.32 (CH2), 35.60 (NMe), 77.50 (CC), 98.43 (C, pyrrole), 103.00 (CC), 117.37 (C, 
pyrrole). (EI, 70 eV, 120 °C): m/z (%) = 457 (28) [M+, 81Br, 81Br], 455 (55) [M+, 79Br, 81Br], 
453 (28) [M+, 79Br, 79Br], 427 (35), 418 (45), 425 (39), 384 (46), 356 (56), 354 (45), 307 (40), 
305 (55), 304 (18), 295 (82), 280 (45), 277 (60), 275 (41), 267 (100), 265 (65). HRMS (EI, 70 
eV): calcd for C21H29Br2N  [Br79]: 453.06566, found 453.06613. 
 
Synthesis of 3,4-tribromo- 2,5-di(2-methylbut-2-ol-3-ylnyl)-1-methylpyrrole (16h): 
Starting with tetrabromopyrole (500 mg, 1.25 mmol) and 
2-methyl-3-pentyne-2-ol (0.4 mL, 4.12 mmol), 16h was 
isolated (370 mg, 74%) as a brownish solid. 1H-NMR (250 
MHz, DMSO-d6): 	 = 1.45, 1.48 (2 s, 18H, CH3), 3.60 (s, 
3H, NCH3), 5.42, 5.60, 5.61 (3 s, 3OH). 13C NMR (75 MHz, DMSO-d6): 	 = 31.35, 31.38, 
31.8, (6 CH3), 33.8 (NCH3), 63.8, 63.9, (C, CMe2OH), 69.8, 70.0, 72.4, (CC), 100.1, 102.6, 
103.7 (C, pyrrole), 104.1, 110.0 (CC), 116.8 (C, pyrrole). IR (KBr, cm-1): 	 = 3435 (br, s), 
2980 (s), 2933 (s), 2226 (w), 1634 (m), 1452 (m), 1374 (s), 1374 (s), 1238 (s), 1164 (s), 1137 
(s), 989 (w), 938 (s), 939 (m), 892 (w), 841 (m). MS (EI, 70 eV, 130 °C): m/z (%) = 407 (100) 
[M+, 81Br, 81Br], 405 (99) [M+, 79Br, 81Br], 403 (16) [M+, 79Br, 79Br], 390 (14), 388 (28), 374 
(65), 372 (71), 278 (40), 235 (23). HRMS (EI, 70 eV): calcd for C20H24BrNO3 [Br79]: 
405.09341, found 405.09328.  
 
Synthesis of 3,4-tribromo- 2,5-ditrimethylsilylacetylnyl-1-methylpyrrole (16k): 
Starting with tetrabromopyrole (600 mg, 1.51 mmol),  
trimethylsilaneacetylene (3.8 mmol), 16k was isolated 
(436 mg, 67%) as a red brown solid. 1H NMR (300 MHz, 
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CDCl3): 	 = 0.27 (s, 18H, 2SiMe3), 3.66 (s, 3H, NCH3). 13C NMR (75 MHz, CDCl3): 	 = 0.15 
(SiMe3), 34.60 (NMe), 70.98 (CC), 93.32 (C, pyrrole), 104.05 (CC), 117.88 (C, pyrrole). 
(EI, 70 eV, 60 °C): m/z (%) = 433 (60) [M+, 81Br, 81Br], 431 (100) [M+, 79Br, 81Br], 429 (56) 
[M+, 79Br, 79Br], 419 (11), 418 (45), 417 (22), 416 (74), 414 (40), 359 (63), 357 (33), 346 (34), 
344 (59), 200 (45). HRMS (EI, 70 eV): calcd for C15H21Br2NSi2 [Br79]: 428.957318, found 
428.957075. 
1.9.3.5 Synthesis of tetraalkynyl-1-methylpyrroles 
 
Synthesis of 3,4-diphenylacetylnyl- 2,5-di(2-methyl-2-ol-3-ylnyl)-1-methylpyrrole (17a): 
Compound 16h (500 mg, 1.26 mmol), phenylacetylene 
(5.0 mmol), 17a was isolated (182 mg, 33%) as a red 
brown solid. 1H NMR (300 MHz, CDCl3): 	 = 1.65, (s, 
6H, 2Me), 2.37 (s, 6 H, 2Me), 3.76 (s, 3H, NCH3), 7.17 (br 
d, 3J = 8.1, Hz, 4H, Ph), 7.42 (m, 6H, Ph). 13C NMR (75 
MHz, CDCl3): 	 = 21.6, 31.6 (4Me), 34.08 (NMe), 65.84 
(C, CMe2OH), 74.43 (CC), 77.97 (CC), 78.20 (CC), 97.34 (CC), 98.00, (C, pyrol), 
98.63 (C, pyrol), 104.66 (CC), 111.32 (C, pyrrole), 111.00 (CC), 117.63 (C, pyrrole), 
119.23, 119.28 (C, Ph), 120.92 (CC), 129.20, 129.25 (Ph), 131.35, 131.38 (Ph), 139.03, 
139.06 (Ph). IR (KBr, cm-1): 	 = 3441 (br, s), 2983 (s), 2982 (s), 29.25 (s), 2866 (w),  2249 
(s), 1905 (w), 1729 (s), 1540 (m), 1502 (s), 1453 (s), 1437 (s), 1364 (s), 1256 (m), 1156 (m), 
908 (s), 816 (s), 730 (br, s). 
 
Synthesis of 3,4-tolyl- 2,5-di(2-methyl-2-ol-3-ylnyl)-1-methylpyrrole (17b): 
Starting with compound 16h (500 mg, 1.26 mmol), p-
tolylacetylene (5.0 mmol), 17b was isolated (88 mg, 15 
%) as a red brown solid. 1H NMR (300 MHz, DMSO-d6): 
	 = 1.48 (s, 12H, 2Me), 1.98, 2.32 (2 Me), 3.63 (s, 3H, 
NCH3), 7.23 (d, 3J = 8.1 Hz, 4H, tolyl), 7.34 (d, 3J = 8.1 
Hz, 4H, tolyl). 13C NMR (75 MHz, CDCl3): 	 = 21.05 
(4Me, tolyl), 31.33 (2Me), 33.92 (NMe), 59.73 (C, CMe2OH), 70.03 (CC), 80.98 (CC), 
101.74 (C, pyrrole), 102.63 (C, pyrrole), 103.91 (CC), 104.61 (CC), 109.89 (C, pyrrole), 
120.00 (C, pyrol), 119.42 (C, p-tolyl), 129.39 (CH, p-tolyl), 130.88 (CH, p-tolyl), 138.35 (C, 
p-tolyl). IR (KBr, cm-1): 	 = 3401 (br, s), 2911 (s), 2982 (m), 2833 (s), 2821(w), 2189 (s), 
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1895 (m), 1745 (s), 1580 (m), 1533 (s), 1472 (s), 1410 (s), 1354 (m), 1285 (s), 1160 (m), 903 
(s), 801 (s), 729 (br, s). 
 
1.9.3.6 Synthesis of 3-bromo-2,4,5-trialkynyl-1-methylpyrroles
 
Synthesis of 3-bromo-2,4,5-tritolyl-1-methylpyrrole (18a): 
Starting with tetrabromopyrole (500 mg, 1.26 mmol), 
phenylacetyylene (4.16 mmol), 18a was isolated (208 
mg, 36 %) as a red to brown solid. 1H NMR (300 MHz, 
CDCl3): 	 = 3.81 (s, 3H, NCH3), 7.34 (m, 9H, Ph), 7.55 
(m, 6H, Ph). 13C NMR (75 MHz, CDCl3): 	 = 34.16 
(NMe), 78.6, 78.94, 81.61 (3CC), 94.25, 97.31 (2C, 
pyrrole), 99.00, 105.03 (2CC), 111.97 (CC), 117.83, 120.78 (2C, pyrrole), 122.33, 122.39, 
123.56 (C, Ph), 128.03, 128.25, 128.46, 128.76 (Ph), 131.44, 131.47, 131.53 (Ph). IR (KBr, 
cm-1): 	 = 3435 (br s), 3060 (m), 3031 (m), 2206 (s), 1596 (s), 1479 (s), 1440 (s), 1367 (s), 
1258 (m), 1068 (m), 1025 (m), 911 (m), 753 (s), 687 (s), 521 (m). (EI, 70 eV, 85 °C): m/z (%) 
= 460 [M+, Br79] (100), 462 (97),  480 (100), 378 (12), 351 (5), 338 (6), 238 (16), 237 (12), 
142 (18). HRMS (EI, 70 eV): calcd for C28H18NBr [Br79]: 459.06171, found 459.061708. 
 
Synthesis of 3-bromo-2,4,5-tri(2-methylbut-2-ol-3-ylnyl)-1-methylpyrrole (18c): 
Starting with tetrabromopyrole (500 mg, 1.25 mmol), 2-
methyl-3-pentyne-2-ol (0.4 mL, 4.12 mmol), 18c was 
isolated (198 mg, 39 %) as a brown crystalline solid. 1H-
NMR (250 MHz, DMSO-d6): 	 = 1.45, (s, 12H, 4CH3), 
1.48 (s, 6H, 2CH3), 3.60 (s, 3H, NCH3), 5.42, 5.60, 5.61 
(3 s, 3OH). 13C NMR (75 MHz, DMSO-d6): 	 = 31.35, 
31.38, 31.8, (6 CH3), 33.8 (NCH3), 63.8, 63.9, (C, CMe2OH), 69.8, 70.0, 72.4, (CC), 100.1, 
102.6, 103.7 (C, pyrrole), 104.1, 110.0 (CC), 116.8 (C, pyrrole), 119.9 (C, pyrrole). IR (KBr, 
cm-1): 	 = 3435 (br, s), 2980 (s), 2933 (s), 2226 (w), 1634 (m), 1452 (m), 1374 (s), 1374 (s), 
1238 (s), 1164 (s), 1137 (s), 989 (w), 938 (s), 939 (m), 892 (w), 841 (m). MS (EI, 70 eV, 130 
°C): m/z (%) = 407 (100) [M+, 81Br], 405 (99) [M+, 79Br], 403 (16), 390 (14), 388 (28), 374 
(65), 372 (71), 278 (40), 235 (23). HRMS (EI, 70 eV): calcd for C20H24BrNO3 ([M+, 79Br]): 
405.09341, found 405.09328. 
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1.9.3.7 Synthesis of tetraalkynyl-1-methylpyrroles 
 
Synthesis of tetraphenylacetylnyl-1-methylpyrrole (19a): 
Starting with tetrabromopyrole (500 mg, 1.25 mmol) and 
phenylacetylene (0.82 mL, 7.5 mmol), 19a was isolated 
(150 mg, 25%) as an orange to red oil. 1H NMR (250 
MHz, CDCl3): 	 = 3.81 (s, 3H, NCH3), 7.32 (br s, 4H, 
Ph), 7.35 (m, 8H, Ph), 7.56 (m, 8H, Ph). 13C NMR (75 
MHz, CDCl3): 	 = 33.8 (NCH3), 79.2, 82.3, 94.3 (CC), 
112.7 (C, pyrrole), 120.6 (C, pyrrole), 122.5 (C, Ph), 123.9 (C, Ph), 127.9, 128.3, 128.46, 
128.7, 131.46, 131.52 (CH, Ph). IR (KBr, cm-1): 	 = 3435 (m), 3058 (w), 2959 (s), 2927 (s), 
2871 (m), 2204 (s), 1728 (s), 1597 (s), 1478 (s), 1454 (s), 1376 (m), 1255 (m), 1067 (m), 910 
(m), 754 (s), 688 (s). MS (EI, 70 eV, 85 °C): m/z (%) = 482 (10), 481 (39) [M+], 480 (100), 
476 (6), 401 (4), 338 (6), 239 (22), 230 (2). HRMS (EI, 70 eV): calcd for C37H23N: 
481.18301, found 481.18276. 
 
1.9.4 Synthesis of functionalized selenophene by suzuki-cross coupling reactions of 
tetrabromoselenophenes
 
Synthesis of tetrabromoselenophene, C4Br4Se (20):  
Selenophene (2.50 g, 0.019 mol) was dissloved in CH2Cl2 (10 mL). This 
solution was cooled to 0 °C in an ice bath and subsequently an excess of 
bromine (13.00 g, 0.13 mol) was added dropwise during 2 h. The solution 
was stirred under reflux for 3 days. To the residue was added a saturated aqueous solution of 
NaOH and the solution was heated under reflux for 6 h. The aqueous layer and the organic 
layer were separated. The organic layer was dried (Na2SO4), filtered, and the filtrate was 
concentrated in vacuo. The product was recrystallized from a 1:1-solution of chloroform and 
methanol  at -18 °C. The product (in the form of yellow crystals) was washed with very cold 
ethyl acetate for several times to give the product as slightly yellow crystals (84%), mp. = 97-
98 °C. 13C NMR (75 MHz: CDCl3): 	 = 112.2, 117.9 (CBr). 
 
General procedure A for the synthesis of substituted arylselenophene: To a (1:1, 4 mL) 
toluene/dioxane solution of tetrabromoselenophene (20) (0.134 g, 0.3 mmol) was added 
Pd(PPh3)4 at 20 °C. After stirring for 30 min, the arylboronic acid, K3PO4 and water (1 mL) 
N
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were added. The mixture was stirred and heated under reflux for 8 h. After cooling to ambient 
temperature, the mixture was diluted with EtOAc, dried (Na2SO4), and filtered through a short 
Celite pad. The solution was concentrated in vacuo and the residue was purified by flash 
column chromatography (fine flash silica gel, n-heptane). 
 
Gerneral procedure B for the synthesis of substitutedaryl selenophene: An oven-dried 
Schlenk flask was charged with Pd(OAc)2, ligand L, tetrabromoselenophene (20), boronic 
acid and powdered, anhydrous K3PO4. The Schlenk flask was capped with a rubber septum 
and then evacuated and filled with argon. A (1:1, 4 mL) toluene/dioxane mixture was added 
by syringe through a septum. The septum was replaced by a condenser in an argon stream. 
The reaction mixture was stirred at 100 °C for 6 h under argon. The solution was allowed to 
cool to ambient temperature and water (5 mL) was added. The aqueous and the organic layer 
were separated and the latter was dried (Na2SO4).  The solution was filtered and the filtrate 
was concentrated in vacuo. The residue was purified by flash column chromatography (fine 
flash silica gel, n-heptane). 
 
1.9.4.1 Synthesis of 5-aryl-2,3,4-tribromoselenophenes (21a-d) 
 
Synthesis of 5-(4-ethylphenyl)-2,3,4-tribromoselenophene (21a):
Employed method A. Starting with 20 (0.134 g, 0.3 mmol), 4-
ethylphenylboronic acid (1.0 eq, 0.33 mmol, 0.050 g), and Pd(PPh3)4 
(5 mol-%, 17 mg) and powdered, anhydrous K3PO4 (1.2 mmol, 4.0 
equiv., 0.254 g), water (1 mL), reflux 8h,  21a (50%, 0.07 g) was 
isolated as a slightly yellow solid, mp. = 60-62 °C. 1H NMR (250 MHz, CDCl3): 	 = 1.27 (t, 3 
H, CH3), 2.70 (q, 2 H, CH2), 7.25, 7.44 (d, 3J = 8.2 Hz, 2 H, 2 CH, Ar). 13C NMR (75 MHz, 
CDCl3): 	 = 15.3 (CH3), 28.7 (CH2), 128.2, 129.0 (CH, Ar), 110.2, 111.3, 119.5 (C, CBr), 
131.7, 144.8, 145.5 (C, Ar). IR (KBr, cm1): ~  = 3068 (w), 3037 (w), 3019 (w), 2966 (w), 
2925 (w), 2847 (w), 1905 (w), 1885 (w), 1660 (w), 1607 (w), 828 (w). MS (EI, 70 eV): m/z 
(%) = 475 (M+, [81Br, 81Br, 81Br], 11), 473 (M+, [81Br,  81Br, 79Br], 16), 472 (100), 471 (M+, 
[81Br, 79Br, 79Br], 19), 469 (M+, [79Br, 79Br, 79Br], 13).  HRMS (EI, 70 eV): calcd for 
C12H9Br3Se (M+, [81Br, 81Br, 79Br]): 473.73732; found: 473.73826, (M+, [81Br, 79Br, 79Br]): 
471.73936, found : 471.73943, (M+, [79Br, 79Br, 79Br]): 469.74141, found: 469.74065. 
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Synthesis of 5-(3,5-dimethylphenyl)-2,3,4-tribromoselenophene (21b).  
Employed method B. Starting with 20 (0.134 g, 0.3 mmol) and 3,5-
dimethylphenylboronic acid (1.1 eq, 0.33 mmol, 0.050 g), Pd(OAc)2 
(3.4 mg, 5 mol-%), L (12.3 mg, 10 mol-%), reflux 8h, 21b (85%, 
0.12 g) was isolated as a white solid, mp. = 130-132 °C. 1H NMR 
(250 MHz, CDCl3): 	 = 2.36 (s, 6 H, 2CH3), 7.04 (s, 1 H, CH, Ar), 7.12 (s, 2 H, 2 CH, Ar). 
13C NMR (75 MHz, CDCl3): 	 = 21.3 (CH3), 126.8, 130.8 (CH, Ar), 110.2, 111.4, 119.4 (C, 
CBr), 134.1, 138.4, 145.1 (C, Ar). IR (KBr, cm1): ~  = 2909 (w), 2851 (w), 2721 (w), 1796 
(w), 1769 (w), 1746 (w), 1722 (w), 1592 (w), 1453 (w), 1229 (w), 848 (w), 722 (w), 690 (m). 
MS (EI, 70 eV): m/z (%) = 475 (M+, [81Br, 81Br, 81Br], 10), 473 (M+, [81Br,  81Br, 79Br], 17), 
472 (100), 471 (M+, [81Br, 79Br, 79Br], 19), 469 (M+, [79Br, 79Br, 79Br], 13). HRMS (EI, 70 
eV): calcd for C12H9Br3Se (M+, [81Br, 81Br, 79Br]): 473.73732; found: 473.73824, (M+, [81Br, 
79Br, 79Br]): 471.73936, found: 471.73962, (M+, [79Br, 79Br, 79Br]): 469.74141, found: 
469.74110. 
 
Synthesis of 5-(4-methoxyphenyl)-2,3,4-tribromoselenophene (21c):  
Employed method A. Starting with 20 (0.134 g, 0.3 mmol) and 4-
methoxyphenylboronic acid (1.1 eq, 0.33 mmol, 0.051 g), and 
Pd(PPh3)4 (5 mol-%, 17 mg) and powdered, anhydrous K3PO4 (1.2 
mmol, 4.0 equiv., 0.254 g), water (1 mL), reflux 8h, 2c (68%, 0.96 
g) was isolated as a yellow solid, mp. = 125-127 °C. 1H NMR (250 MHz, CDCl3): 	 = 3.84 (s, 
3 H, CH3), 6.94, 7.44 (d, 2 H, CH, Ar). 13C NMR (75 MHz, CDCl3): 	 = 55.4 (CH3), 114.1, 
130.4 (d, 3J = 8.2 Hz, CH, Ar), 110.0, 110.9, 119.4 (C, CBr), 126.7, 144.6, 160.2 (C, Ar). IR 
(KBr, cm1): ~  = 3026 (w), 2953 (w), 2895 (w), 2830 (w), 2546 (w), 2090 (w), 1884 (w), 
1601 (w), 1492 (w), 1245 (w), 1029 (w), 826 (w), 690 (m). MS (EI, 70 eV): m/z (%) = 477 
(M+, [81Br, 81Br, 81Br], 7), 475 (M+, [81Br,  81Br, 79Br], 14), 474 (100), 473 (M+, [81Br, 79Br, 
79Br], 18), 471 (M+, [79Br, 79Br, 79Br], 12). HRMS (EI, 70 eV): calcd for C11H7Br3OSe (M+, 
[81Br, 79Br, 79Br]): 473.71863, found: 473.72001, (M+, [79Br, 79Br, 79Br]): 471.72068, found: 
471.72235. 
 
Synthesis of 5-(3-biphenyl)-2,3,4-tribromoselenophene (21d):
Employed method A. Starting with 20 (0.134 g, 0.3 mmol) and 4-
methoxyphenylboronic acid (1.1 eq, 0.33 mmol, 0.065 g), and 
Pd(PPh3)4 (5 mol-%, 17 mg) and powdered, anhydrous K3PO4 (1.2 
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mmol, 4.0 equiv., 0.254 g), water (1 mL), reflux 8h, 21d (47%, 0.73 g) was isolated as a 
yellow solid, mp. = 90-93 °C. 1H NMR (250 MHz, CDCl3): 	 =  7.38-7.74 (m, 9 H, CH, Ar). 
13C NMR (75 MHz, CDCl3): 	 = 127.21, 127.91, 128.93 (CH, 2CH, Ar), 127.79, 127.85, 
129.2 (CH, 1 CH, Ar), 110.9, 111.9, 119.7 (C, CBr), 134.8, 140.2, 141.8, 144.5 (C, Ar). IR 
(KBr, cm1): ~  = 3057 (w), 3024 (w), 1926 (w), 1874 (w), 1798 (w), 1693 (w), 1568 (w), 
1468 (w), 1233 (w), 745 (w), 689 (w), 619 (w), 588 (m). MS (EI, 70 eV): m/z (%) = 523 (M+, 
[81Br, 81Br, 81Br], 6), 521 (M+, [81Br,  81Br, 79Br], 10), 519 (M+, [81Br, 79Br, 79Br], 9), 517 (M+, 
[79Br, 79Br, 79Br], 7). HRMS (EI, 70 eV): calcd for C16H9Br3Se (M+, [81Br, 81Br, 79Br]): 
521.73732; found: 521.73765, (M+, [81Br, 79Br, 79Br]): 519.73936, found: 519.73924, (M+, 
[79Br, 79Br, 79Br]): 517.74141, found: 517.74031. 
 
1.9.4.2 Synthesis of unsymmetrical-2,5-diaryl-3,4-dibromoselenophenes 
 
General procedure B for synthesis of unsymmetrical 2,5-diaryl-3,4-
dibromoselenophenes (22a,b): An oven-dried Schenk flask was charged with Pd(OAc)2 (3.4 
mg, 5 mol-%), L (12,3 mg, 10 mol-%), 22a, b (0.3 mmol), the boronic acid (1.1 equiv., 0.33 
mmol) and powdered, anhydrous K3PO4 (1.2 mmol, 4.0 equiv., 0.254 g). The Schlenk flask 
was evacuated and subsequently flushed with argon. A mixture of toluene and dioxane (1:1, 4 
mL) was added by syringe. The reaction mixture was heated under reflux for 6 h. The mixture 
was allowed to cool to ambient temperature and water (5mL) was added. The aqueous and the 
organic layer were separated. The latter was dried (Na2SO4), filtered, and the filtrate was 
concentrated in vacuo. The residue was purified by flash column chromatography (fine silica 
gel, heptanes). 
 
Synthesis of 2-ethylphenyl-5-(p-tolyl)-3,4-dibromoselenophene (22a):  
Employed method B. Starting with 21b (0.141 g, 0.3 
mmol), Pd(OAc)2 (3.4 mg, 5 mol-%), L (12,3 mg, 10 mol-
%) and powdered, anhydrous K3PO4 (1.2 mmol, 4.0 equiv., 
0.254 g) and 4-methylphenylboronic acid (1.0 eq, 0.33 
mmol, 0.041 g, reflux 8h, 22a (76%, 0.11 g) was isolated as an orange highly viscous oil. 1H 
NMR (250 MHz, CDCl3): 	 = 1.25 (t, 3 H, CH3), 2.35 (s, 3 H, CH3), 2.67 (q, 2 H, CH2), 7.19, 
7.25, 7.42, 7.47 (d, 3J = 8.2 Hz, 2 H, 2 CH, Ar). 13C NMR (75 MHz, CDCl3): 	 = 15.6, 21.1 
(CH3), 28.5 (CH2), 126.79, 126.90, 128.2, 129.4 (CH, Ar), 132.06, 132.28, 136.7, 138.6, 
143.0, 145.0 (C, Ar), 112.0 (overlap of two CBr, Ar). IR (KBr, cm1): ~  = 3020 (w), 2961 
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(w), 2927 (w), 2968 (w), 1901 (w), 1605 (w), 1490 (m), 940 (w), 817 (m), 799 (m), 718 (w). 
MS (EI, 70 eV): m/z (%) = 485 (M+, [81Br, 81Br], 11), 484 (100), 483 (M+, [81Br, 79Br], 19), 
481 (M+, [79Br, 79Br], 22). HRMS (EI, 70 eV): calcd for C19H16Br2Se (M+, [81Br, 81Br]): 
485.87425; found: 485.87411, (M+, [81Br, 79Br]): 483.87635, found: 483.87642, (M+, [79Br, 
79Br]): 481.87840, found: 481.87849.  
 
Synthesis of 3,5-dimethylphenyl-5-(p-tolyl)-3,4-dibromoselenophene (22b):
Employed method B. Starting with 21b (0.141 g, 0.3 mmol), 
Pd(OAc)2 (3.4 mg, 5 mol-%), L (12,3 mg, 10 mol-%) and 
powdered, anhydrous K3PO4 (1.2 mmol, 4.0 equiv., 0.254 g) 
and 4-methylphenylboronic acid (1.1 eq, 0.33 mmol, 0.041 
g), reflux 8h, 22b (80%, 0.116 g) was isolated as an orange highly viscous oil. 1H NMR (250 
MHz, CDCl3): 	 = 1.25 (s, 6 H, 2CH3), 1.30 (s, 3 H, CH3), 7.19, 7.28 (d, 3J = 8.2 Hz, 2 H, 2 
CH, Ar), 7.51 (s, 1 H, CH, Ar), 7.59 (s, 2 H, 2 CH, Ar). 13C NMR (75 MHz, CDCl3): 	 = 21.1, 
21.4 (CH3), 125.1 (C, 1 CH, Ar), 126.8, 129.1, 129.4 (C, 2 CH, Ar), 132.1, 136.7, 138.1, 
138.8, 141.4, 142.9 (C, Ar), 112.1 (overlap of two CBr, Ar). IR (KBr, cm1): ~  = 3019 (w), 
2914 (w), 2857 (w), 2729 (w), 1666 (w), 1597 (m), 1490 (m), 1239 (m), 840 (m), 799 (m), 
693 (w). MS (EI, 70 eV): m/z (%) = 485 (M+, [81Br, 81Br], 12), 484 (100), 483 (M+, [81Br, 
79Br], 21), 481 (M+, [79Br, 79Br], 22).  HRMS (EI, 70 eV): calcd for C19H16Br2Se (M+, [81Br, 
81Br]) : 485.87425; found : 485.87431, (M+, [81Br, 79Br]) : 483.87635, found : 483.87649, 
(M+, [79Br, 79Br]) : 481.87840, found : 481.87836. 
 
1.9.4.3 Synthesis of symmetrical 2,5-diaryl-3,4-dibromoselenophenes (23a-h) 
 
Synthesis of 2,5-ditolyl-3,4-dibromoselenophene (23a): 
Employed method A. Starting with 20 (0.134 g, 0.3 mmol) 
and p-tolylboronic acid (2.2 eq, 0.66 mmol, 0.09 g), 
Pd(PPh3)4 (5 mol-%, 17 mg) and powdered, anhydrous 
K3PO4 (1.2 mmol, 4.0 equiv., 0.254 g), water (1 mL), 
reflux 8h, 23a (83%, 0.117 g) was isolated as a yellow solid, mp. = 98-102 °C. 1H NMR (250 
MHz, CDCl3): 	 = 2.25 (s, 6 H, 2CH3), 7.22, 7.39 (d, 3J = 8.2 Hz, 4 H, 4 CH, Ar). 13C NMR 
(75 MHz, CDCl3): 	 = 21.3 (CH3), 129.5, 129.8 (CH, Ar), 132.1, 138.8, 142.9 (C, Ar), 112.1 
(CBr, Ar). IR (KBr, cm1): ~  = 3019 (w), 2914 (w), 2725 (w), 1894 (w), 1565 (w), 1488 (m), 
1246 (w), 1178 (w), 1021 (w), 957 (w), 809 (m), 719 (m), 637 (m). MS (EI, 70 eV): m/z (%) 
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= 471 (M+, [81Br, 81Br], 20), 469 (M+, [81Br, 79Br], 23), 470 (100), 467 (M+, [79Br, 79Br], 19).  
HRMS (EI, 70 eV): calcd for C18H14Br2Se (M+, [81Br, 81Br]): 471.85811; found: 471.85951, 
(M+, [81Br, 79Br]): 469.86015, found: 469.86074, (M+, [79Br, 79Br]): 467.86220, found: 
467.86196. 
 
Synthesis of 2,5-diethylphenyl-3,4-dibromoselenophene (23b):
Employed method A. Starting with 20 (0.134 g, 0.3 mmol) 
and p-ethylphenylboronic acid (2.2 eq, 0.66 mmol, 0.099 g), 
Pd(PPh3)4 (5 mol-%, 17 mg) and powdered, anhydrous 
K3PO4 (1.2 mmol, 4.0 equiv., 0.254 g), water (1 mL), reflux 
8h. Employed method B. Starting with 20 (0.134 g, 0.3 mmol) and p-ethylphenylboronic acid 
(2.2 eq, 0.66 mmol, 0.099 g), Pd(OAc)2 (3.4 mg, 5 mol-%), L (12,3 mg, 10 mol-%) and 
powdered, anhydrous K3PO4 (1.2 mmol, 4.0 equiv., 0.254 g), reflux 8h, 23b (method A : 69%, 
0.103 g ; method B : 0.124 g) was isolated as a yellow solid, mp. = 68-72 °C. 1H NMR (250 
MHz, CDCl3): 	 = 1.19 (t, 6 H, 2CH3), 2.56 (q, 4 H, 2CH2), 7.12, 7.41 (d, 3J = 8.2 Hz, 4 H, 4 
CH, Ar). 13C NMR (75 MHz, CDCl3): 	 = 15.3 (CH3), 28.6 (CH2), 128.2, 129.1 (CH, Ar), 
132.2, 143.0, 145.0 (C, Ar), 112.1 (CBr, Ar). IR (KBr, cm1): ~  = 2959 (w), 2926 (w), 2867 
(w), 1906 (w), 1668 (w), 1607 (w), 1522 (w), 1490 (m), 1453 (w), 834 (m), 796 (m), 769 (m), 
688 (m). MS (EI, 70 eV): m/z (%) = 499 (M+, [81Br, 81Br], 21), 498 (100), 497 (M+, [81Br, 
79Br], 23), 495 (M+, [79Br, 79Br], 19).  HRMS (EI, 70 eV): calcd for C20H18Br2Se (M+, [81Br, 
81Br]): 499.88941; found: 499.88998, (M+, [81Br, 79Br]): 497.89145, found: 497.89169, (M+, 
[79Br, 79Br]): 495.89350, found: 495.89277.  
 
Synthesis of 2,5-(3,5-dimethylphenyl)-3,4-dibromoselenophene (23c):  
Employed method A. Starting with 20 (0.134 g, 0.3 mmol) 
and 3,5-dimethylboronic acid (2.2 eq, 0.66 mmol, 0.099 g), 
Pd(PPh3)4 (5 mol-%, 17 mg) and powdered, anhydrous K3PO4 
(1.2 mmol, 4.0 equiv., 0.254 g), water (1 mL), reflux 8h. 
Employed method B. Starting with 20 (0.134 g, 0.3 mmol) and 3,5-dimethylboronic acid (2.2 
eq, 0.66 mmol, 0.099 g), Pd(OAc)2 (3.4 mg, 5 mol-%), L (12,3 mg, 10 mol-%) and powdered, 
anhydrous K3PO4 (1.2 mmol, 4.0 equiv., 0.254 g), reflux 8h, 23c (method A : 65%, 0.097 g ; 
method B : 79%, 0.118 g) was isolated as a yellow solid, mp. = 162-164 °C. 1H NMR (250 
MHz, CDCl3): 	 = 2.29 (s, 12 H, 4CH3), 6.97 (s, 2 H, 2 CH, Ar), 7.12 (s, 4 H, 4 CH, Ar). 13C 
NMR (75 MHz, CDCl3): 	 = 31.3 (CH3), 126.9, 130.4 (CH, Ar), 134.8, 138.2, 143.1 (C, Ar), 
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112.0 (CBr, Ar). IR (KBr, cm1): ~  = 2995 (w), 2911 (w), 2857 (w), 2725 (w), 1737 (w), 
1595 (w), 1444 (w), 1228 (m), 888 (w), 843 (m), 784 (m), 691 (m). MS (EI, 70 eV): m/z (%) 
= 499 (M+, [81Br, 81Br], 21), 498 (100), 497 (M+, [81Br, 79Br], 25), 495 (M+, [79Br, 79Br], 20).  
HRMS (EI, 70 eV): calcd for C20H18Br2Se (M+, [81Br, 81Br]): 499.88941; found: 499.89033 
(M+, [81Br, 79Br]): 497.89145, found: 497.89246, (M+, [79Br, 79Br]): 495.89350, found: 
495.89365.  
 
Synthesis of 2,5-(p-methoxyphenyl)-3,4-dibromoselenophene (23d):  
Employed method A. Starting with 20 (0.134 g, 0.3 
mmol) and p-methoxyphenylboronic acid (2.2 eq, 0.66 
mmol, 0.09 g), Pd(OAc)2 (3.4 mg, 5 mol-%), L (12,3 
mg, 10 mol-%) and powdered, anhydrous K3PO4 (1.2 
mmol, 4.0 equiv., 0.254 g), reflux 8h, 23d (82%, 0.123 g) was isolated as a yellow solid, mp. 
= 157-161 °C. 1H NMR (250 MHz, CDCl3): 	 = 3.75 (s, 6 H, 2OCH3), 6.84, 7.45 (d, 3J = 8.2 
Hz, 4 H, 4 CH, Ar). 13C NMR (75 MHz, CDCl3): 	 = 55.3 (OCH3), 114.0, 130.4 (CH, Ar), 
127.3, 142.3, 159.9 (C, Ar), 111.7 (CBr, Ar). IR (KBr, cm1): ~  = 2983 (w), 2965 (w), 2832 
(w), 1605 (m), 1491 (m), 1242 (m), 1174 (m), 1028 (m), 827 (m), 783 (w), 728 (w), 685 (w), 
656 (w), 631 (m). MS (EI, 70 eV): m/z (%) = 503 (M+, [81Br, 81Br], 11), 502 (100), 501 (M+, 
[81Br, 79Br], 21), 500 (100), 499 (M+, [79Br, 79Br], 17). HRMS (EI, 70 eV): calcd for 
C18H14Br2O2Se (M+, [81Br, 81Br]): 503.84794; found: 503.84884, (M+, [81Br, 79Br]): 
501.84998, found: 501.84986, (M+, [79Br, 79Br]): 499.85203, found: 499.85235.  
 
Synthesis of 2,5-(o-methoxyphenyl)-3,4-dibromoselenophene (23e):  
Employed method A. Starting with 20 (0.134 g, 0.3 mmol) and o-
methoxyphenylboronic acid (2.2 eq, 0.66 mmol, 0.09 g), Pd(PPh3)4 
(5 mol-%, 17 mg) and powdered, anhydrous K3PO4 (1.2 mmol, 4.0 
equiv., 0.254 g), water (1 mL), reflux 8h. Employed method B. 
Starting with 20 (0.134 g, 0.3 mmol) and o-methoxyphenylboronic acid (2.2 eq, 0.66 mmol, 
0.09 g), Pd(OAc)2 (3.4 mg, 5 mol-%), L (12,3 mg, 10 mol-%) and powdered, anhydrous 
K3PO4 (1.2 mmol, 4.0 equiv., 0.254 g), reflux 8h, 23e (method A : 42%, 0.063 g; method B : 
68%, 0.102 g) was isolated as a yellow solid, mp. = 85-87 °C. 1H NMR (250 MHz, CDCl3): 	 
= 3.76 (s, 6 H, 2OCH3), 6.89, 6.98 (t, 3J = 8.2 Hz, 2 H, 2 CH, Ar), 7.29, 7.35 (d, 3J = 8.2 Hz, 2 
H, 2 CH, Ar). 13C NMR (75 MHz, CDCl3): 	 = 55.6 (OCH3), 111.2, 120.3, 130.3, 131.8 (CH, 
Ar), 123.8, 139.2, 156.5 (C, Ar), 113.6 (CBr, Ar). IR (KBr, cm1): ~  = 3011 (w), 2936 (w), 
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2833 (w), 1472 (m), 1428 (m), 1256 (m), 1237 (m), 1113 (m), 1017 (m), 805 (w), 747 (w), 
681 (w), 565 (w), 537 (m). MS (EI, 70 eV): m/z (%) = 503 (M+, [81Br, 81Br], 14), 502 (100), 
501 (M+, [81Br, 79Br], 23), 500 (100), 499 (M+, [79Br, 79Br], 19).  HRMS (EI, 70 eV): calcd for 
C18H14Br2O2Se (M+, [81Br, 81Br]): 503.84794; found: 503.84889, (M+, [81Br, 79Br]): 
501.84998, found: 501.84990, (M+, [79Br, 79Br]): 499.85203, found: 499.85213.  
 
Synthesis of 2,5-(m-chlorophenyl)-3,4-dibromoselenophene (23f):
Employed method A. Starting with 20 (0.134 g, 0.3 mmol) and m-
chlorophenylboronic acid (2.2 eq, 0.66 mmol, 0.103 g), Pd(PPh3)4 (5 
mol-%, 17 mg) and powdered, anhydrous K3PO4 (1.2 mmol, 4.0 
equiv., 0.254 g), water (1 mL), reflux 8h. Employed method B. 
Starting with 20 (0.134 g, 0.3 mmol) and m-chlorophenylboronic 
acid (2.2 eq, 0.66 mmol, 0.103 g), Pd(OAc)2 (3.4 mg, 5 mol-%), L (12,3 mg, 10 mol-%) and 
powdered, anhydrous K3PO4 (1.2 mmol, 4.0 equiv., 0.254 g), reflux 8h, 23f (method A : 45%, 
0.069 g; method B : 15%, 0.023 g) was isolated as a white solid, mp. = 170-171 °C. 1H NMR 
(250 MHz, CDCl3): 	 = 7.37, 7.39 (d, 3J = 8.2 Hz, 4 H, 4 CH, Ar), 7.46 (t, 3J = 8.2 Hz, 2 H, 2 
CH, Ar), 7.58 (s, 2H, 2CH, Ar). 13C NMR (75 MHz, CDCl3): 	 =  127.4, 129.0, 129.2, 129.9 
(CH, Ar), 134.6, 136.3, 141.8 (C, Ar), 113.4 (CBr, Ar). IR (KBr, cm1): ~  = 3154 (w), 3097 
(w), 3045 (w), 1942 (w), 1874 (w), 1802 (w), 1757 (w), 1693 (w), 1590 (m), 1557 (m), 1545 
(m), 878 (m), 767 (m), 688 (m). MS (EI, 70 eV): m/z (%) = 515 (M+, [81Br, 81Br, 37Cl, 37Cl], 
6), 513 (M+, [81Br, 79Br, 37Cl, 37Cl], 32), 511 (M+, [79Br, 79Br, 37Cl, 37Cl], 77), 509 (M+, [79Br, 
79Br, 35Cl, 37Cl], 100), 507 (M+, [79Br, 79Br, 35Cl, 35Cl], 65). HRMS (EI, 70 eV): calcd for 
C16H8Br2Cl2Se (M+, [81Br, 81Br, 35Cl, 35Cl]): 511.74886; found: 511.74944, (M+, [81Br, 79Br, 
37Cl, 37Cl]): 509.75091, found: 509.75133, (M+, [79Br, 79Br, 35Cl, 35Cl]): 507.75295, found: 
507.75284.  
 
Synthesis of 2,5-(p-bromophenyl)-3,4-dibromoselenophene (23g):
Employed method A. Starting with 20 (0.134 g, 0.3 mmol) 
and p-bromophenylboronic acid (2.2 eq, 0.66 mmol, 0.185 
g), Pd(PPh3)4 (5 mol-%, 17 mg) and powdered, anhydrous 
K3PO4 (1.2 mmol, 4.0 equiv., 0.254 g), water (1 mL), reflux 
8h, 23g (55%, 0.099 g)  was isolated as a white solid, mp. = 207-209 °C. 1H NMR (250 MHz, 
CDCl3): 	 = 7.47, 7.56 (d, 3J = 8.2 Hz, 4 H, 4 CH, Ar). 13C NMR (75 MHz, CDCl3): 	 = 
130.71, 131.89, (CH, Ar), 123.2, 133.6, 142.0 (C, Ar), 113.2 (CBr, Ar). IR (KBr, cm1): ~  = 
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3083 (w), 3044 (w), 3017 (w), 2923 (w), 2295 (w), 1895 (w), 1584 (w), 1472 (m), 1391 (m), 
1071 (m), 1008 (m), 820 (m), 733 (m). MS (EI, 70 eV): m/z (%) = 603 (M+, [81Br, 81Br, 81Br, 
81Br], 10), 601 (M+, [79Br, 81Br, 81Br, 81Br], 17), 599 (M+, [79Br, 79Br, 81Br, 81Br], 19), 597 (M+, 
[79Br, 79Br, 79Br, 81Br], 16), 595 (M+, [79Br, 79Br, 79Br, 79Br], 9).  HRMS (EI, 70 eV): calcd for 
C16H8Br4Se (M+, [79Br, 81Br, 81Br, 81Br]): 601.64578; found: 601.64663, (M+, [79Br, 79Br, 81Br, 
81Br]): 599.64783, found: 599.64887, (M+, [79Br, 79Br, 79Br, 79Br]): 595.65192, found: 
595.65151. 
 
Synthesis of 2,5-(3-biphenyl)-3,4-dibromoselenophene (23h):  
Employed method A. Starting with 20 (0.134 g, 0.3 
mmol) and 3-biphenylboronic acid (2.2 eq, 0.66 mmol, 
0.131 g), Pd(PPh3)4 (5 mol-%, 17 mg) and powdered, 
anhydrous K3PO4 (1.2 mmol, 4.0 equiv., 0.254 g), water 
(1 mL), reflux 8h, 23h (48%, 0.085 g) was isolated as a yellow solid, mp. = 90-93 °C. 1H 
NMR (250 MHz, CDCl3): 	 = 7.35-7.87 (m, 18 H, 18 CH, Ar). 13C NMR (75 MHz, CDCl3): 	 
= 125.2, 125.5, 125.7, 125.0, 126.9, 127.1 (CH, Ar), 133.3, 138.4, 139.7, 141.1 (C, Ar), 110.7 
(CBr, Ar). IR (KBr, cm1): ~  = 3054 (w), 3027 (w), 2961 (w), 1945 (w), 1878 (w), 1799 (w), 
1594 (m), 1467 (m), 1261 (m), 1238 (m), 904 (m), 749 (m), 692 (m). MS (EI, 70 eV): m/z (%) 
= 595 (M+, [81Br, 81Br], 24), 593 (M+, [81Br, 79Br], 24), 591 (M+, [79Br, 79Br], 19).  HRMS (EI, 
70 eV): calcd for C28H18Br2Se (M+, [81Br, 81Br]): 595.88941; found: 595.89002, (M+, [81Br, 
79Br]): 593.8914, found: 593.89108, (M+, [79Br, 79Br]): 591.89350, found : 591.89212. 
Synthesis of tetraarylselenophenes 
 
1.9.4.4 Synthesis of tetraarylselenophenes 
 
General procedure for synthesis of tetraarylselenophenes (24a-e): An oven-dried Schenk 
flask was charged with Pd(OAc)2 (6.8 mg, 10 mol-%), L (24.6 mg, 20 mol-%), 20 (0.3 
mmol), the boronic acid (5 equiv., 1. 5 mmol) and powdered, anhydrous K3PO4 (2.4 mmol, 
8.0 equiv., 0.508 g). The Schlenk flask was evacuated and subsequently flushed with argon. A 
1:1-mixture (4 mL) of toluene and dioxane was added by syringe. The reaction mixture was 
heated under reflux for 8 h. The mixture was allowed to cool to ambient temperature and 
water (5 mL) was added. The aqueous and the organic layer were separated. The latter was 
dried (Na2SO4), filtered, and the filtrate was concentrated in vacuo. The residue was purified 
by flash column chromatography (fine silica gel, heptanes). 
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Synthesis of tetraphenylselenophene (24a):
Employed method A. Starting with 20 (0.134 g, 0.3 mmol) and 
phenylboronic acid (5.0 eq, 1.5 mmol, 0.183 g), Pd(PPh3)4 (10 mol-
%, 34 mg) and powdered, anhydrous K3PO4 (1.2 mmol, 4.0 equiv., 
0.254 g), water (1 mL), reflux 14h. Method B. Starting with 20 
(0.134 g, 0.3 mmol) and phenylboronic acid (5.0 eq, 1.5 mmol, 
0.183 g), Pd(OAc)2 (6.8 mg, 10 mol-%), L (24.6 mg, 20 mol-%) and powdered, anhydrous 
K3PO4 (2.4 mmol, 8.0 equiv., 0.508 g), reflux 8h, 24a ( method A : 55%, 0.072 g; method B : 
79%, 0.103 g) was isolated as a yellow solid, mp. = 158-162 °C. 1H NMR (250 MHz, CDCl3): 
	 = 6.94-7.21 (m, 20 H, 12 CH, Ar). 13C NMR (75 MHz, CDCl3): 	 = 124.4, 125.0, 125.7, 
126.2, 127.4, 128.9 (CH, Ar), 124.2, 135.9, 139.7, 142.6 (C, Ar). IR (KBr, cm1): ~  = 3056 
(w), 3020 (w), 2962 (w), 1948 (w), 1876 (w), 1806 (w), 1596 (m), 1440 (m), 1068 (m), 1025 
(m), 789 (m), 758 (m), 690 (m). MS (EI, 70 eV): m/z (%) = 435 (M+, 11), 434 (52), 434 (19), 
433 (15), 150 (12).  HRMS (EI, 70 eV): calcd for C28H20Se (M+): 436.07302; found : 
436.07311. 
 
Synthesis of tetratolylselenophene (24b):
Employed B. Starting with 20 (0.134 g, 0.3 mmol) and 
tolylboronic acid (5.0 eq, 1.5 mmol, 0.205 g), Pd(OAc)2 
(6.8 mg, 10 mol-%), L (24.6 mg, 20 mol-%) and 
powdered, anhydrous K3PO4 (2.4 mmol, 8.0 equiv., 0.508 
g), reflux 8h, 24b (89%, 0.131 g) was isolated as a yellow 
solid, mp. = 240-244 °C. 1H NMR (250 MHz, CDCl3): 	 = 
2.26, 2.31 (s, 6 H, 2CH3), 6.86, 6.90, 7.03, 7.10 (d, 3J = 8.2 Hz, 4 H, 4 CH, Ar). 13C NMR (75 
MHz, CDCl3): 	 = 21.13, 21.22 (CH3), 128.4, 128.9, 129.3, 130.7 (CH, Ar), 133.6, 135.2, 
135.7, 136.6, 141.4, 144.0 (C, Ar). IR (KBr, cm1): ~  = 3021 (w), 2917 (w), 2860 (w), 1907 
(w), 1738 (w), 1511 (m), 1495 (m), 1181 (m), 1110 (m), 857 (m), 831 (m), 813 (m), 731 (m). 
MS (EI, 70 eV): m/z (%) = 491 (M+, 15), 490 (47), 489 (17), 488 (15), 206 (9).  HRMS (EI, 
70 eV): calcd for C32H28Se (M+): 492.13507; found: 492.13510. 
 
Synthesis of tetra(p-ethylphenyl)selenophene (24c):
Employed B. Starting with 20 (0.134 g, 0.3 mmol) and p-ethylphenylboronic acid (5.0 eq, 1.5 
mmol, 0.225 g), Pd(OAc)2 (6.8 mg, 10 mol-%), L (24.6 mg, 20 mol-%) and powdered, 
Se
Se
Me Me
MeMe
  97  
anhydrous K3PO4 (2.4 mmol, 8.0 equiv., 0.508 g), reflux 8h, 
24c (0.98%, 0.161 g) was isolated as a yellow solid, mp. = 
101-103 °C. 1H NMR (250 MHz, CDCl3): 	 = 1.20, 1.25 (t, 
6 H, 2CH3), 2.57, 2.64 (q, 4 H, 2CH2), 6.90, 6.93, 7.06, 7.14 
(d, 3J = 8.2 Hz, 4 H, 4 CH, Ar), 13C NMR (75 MHz, CDCl3) 
	 = 15.16, 15.27 (CH3), 28.43 (overlap of two carbons) 
(CH2), 127.0, 127.6, 129.3, 130.8 (CH, Ar), 133.9, 135.5, 141.6, 142.0, 142.8, 144.0 (C, Ar). 
IR (KBr, cm1): ~  = 2961 (m), 2930 (w), 2871 (w), 1903 (w), 1789 (w), 1510 (m), 1494 (m), 
1453 (m), 1019 (m), 830 (m), 800 (m), 680 (m), 546 (m). MS (EI, 70 eV): m/z (%) = 547 (M+, 
13), 546 (50), 547 (14), 546 (19), 262 (13).  HRMS (EI, 70 eV): calcd for C36H36Se (M+): 
548.49767; found: 548.19767.  
 
Synthesis of tetra-(3,5-dimethylphenyl)selenophene (24d):
Employed A. Starting with 20 (0.134 g, 0.3 mmol) and 3,5-
dimethylphenylboronic acid (5.0 eq, 1.5 mmol, 0.225 g), 
Pd(PPh3)4 (10 mol-%, 34 mg) and powdered, anhydrous 
K3PO4 (1.2 mmol, 4.0 equiv., 0.254 g), water (1 mL), reflux 
14h, 24d (74%, 0.122 g) was isolated as a yellow solid, mp. = 
158-160 °C. 1H NMR (250 MHz, CDCl3): 	 = 2.11, 2.19 (s, 
12 H, 4CH3), 6.72, 6.81 (s, 2 H, 2 CH, Ar), 6.61, 6.86 (s, 4 H, 4 CH, Ar). 13C NMR (75 MHz, 
CDCl3): 	 = 21.1, 21.2 (CH3), 127.2, 128.7, 136.6, 137.3 (CH, Ar), 127.7 (overlap of two 
quatery carbon), 128.5, 138.1, 142.1, 143.7 (C, Ar). IR (KBr, cm1): ~  = 2997 (w), 2947 (w), 
2915 (w), 2858 (w), 1593 (m), 1463 (m), 1375 (m), 847 (m), 810 (m), 693 (m). MS (EI, 70 
eV): m/z (%) = 547 (M+, 13), 546 (51), 547 (13), 546 (20), 262 (12). HRMS (EI, 70 eV): 
calcd for C36H36Se (M+): 548.49767; found: 548.19747. 
 
Synthesis of tetra(p-methoxyphenyl)selenophene (24e):
Employed B. Starting with 20 (0.134 g, 0.3 mmol) and 
p-ethylphenylboronic acid (5.0 eq, 1.5 mmol, 0.228 g), 
Pd(OAc)2 (6.8 mg, 10 mol-%), L (24.6 mg, 20 mol-%) 
and powdered, anhydrous K3PO4 (2.4 mmol, 8.0 equiv., 
0.508 g), reflux 8h, 24e (89%, 0.148 g) was isolated as 
a yellow solid, mp. = 188-193 °C. 1H NMR (250 MHz, CDCl3): 	 = 3.72, 3.76 (s, 6 H, 
OCH3), 6.66, 6.75, 6.83, 7.10 (d, 3J = 8.2 Hz, 4 H, 4 CH, Ar). 13C NMR (75 MHz, CDCl3) 	 = 
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54.9, 55.1 (CH3), 113.1, 113.6, 130.5, 132.0 (CH, Ar), 129.0, 130.6, 140.7, 143.1, 157.9, 
158.4 (C, Ar). IR (KBr, cm1): ~  = 3002 (w), 2955 (w), 2838 (w), 1891 (w), 1601 (m), 1494 
(m), 1281 (m), 1236 (m), 1110 (m), 1027 (m), 830 (m), 779 (m), 547 (m). MS (EI, 70 eV): 
m/z (%) = 555 (M+, 18), 554 (51), 553 (21), 542 (16), 539 (10), 223 (15), 195 (15), 152 (11), 
44 (20).  HRMS (EI, 70 eV): calcd for C32H28O4Se (M+): 556.11339; found: 556.11393. 
 
General procedure for synthesis of tetraarylselenophenes (25a,b): An oven-dried Schlenk 
flask was charged with Pd(OAc)2 (6.8 mg, 10 mol-%), L (24.6 mg, 20 mol-%), 23b,c (0.3 
mmol), the boronic acid (3 equiv., 0.9 mmol) and powdered, anhydrous K3PO4 (2.4 mmol, 8.0 
equiv., 0.508 g). The Schlenk flask was evacuated and subsequently flushed with argon. A 
mixture (1:1, 4 mL) of toluene and dioxane was added by syringe. The reaction mixture was 
heated under reflux for 8 h. The mixture was allowed to cool to ambient temperature and 
water (5 mL) was added. The aqueous and the organic layer were separated. The latter was 
dried (Na2SO4), filtered, and the filtrate was concentrated in vacuo. The residue was purified 
by flash column chromatography (fine silica gel, heptanes). 
 
Synthesis of 2,5-di(p-ethylphenyl-3,4-di(p-methoxyphenyl)selenophene (25a):
Employed method B. Starting with 23b (0.149 g, 0.3 mmol) 
and p-methoxyboronic acid (3 eq, 0.9 mmol, 0.137 g), 
Pd(OAc)2 (6.8 mg, 10 mol-%), L (24.6 mg, 20 mol-%) and 
powdered, anhydrous K3PO4 (2.4 mmol, 8.0 equiv., 0.508 
g), reflux 8h, 25a (79%, 0.13 g) was isolated as a yellow 
solid, mp. = 182-185 °C. 1H NMR (250 MHz, CDCl3): 	 = 
1.22 (t, 6 H, 2CH3), 2.60 (q, 4 H, 2CH2), 3.73 (s, 6 H, OCH3), 6.66, 6.84, 7.04, 7.10 (d, 3J = 
8.2 Hz, 4 H, 4 CH, Ar), 13C NMR (75 MHz, CDCl3), 	 = 15.2, 55.0 (CH3), 28.4 (CH2), 113.1, 
127.7, 129.3, 132.0 (CH, Ar), 130.7, 133.9, 141.1, 142.7, 143.9, 157.9 (C, Ar). IR (KBr, 
cm1): ~  = 2962 (w), 2930 (w), 2834 (w), 2058 (w), 1894 (w), 1604 (m), 1506 (m), 1493 (m), 
1241 (m), 1029 (m), 807 (m), 779 (m), 554 (m). MS (EI, 70 eV): m/z (%) = 551 (M+, 16), 550 
(47), 549 (11), 549 (16), 266 (17). HRMS (EI, 70 eV): calcd for C34H32O2Se (M+): 
552.15620; found: 552.15502. 
 
Synthesis of 2,5-di(3,5-dimethylphenyl)-3,4-di(p-methoxyphenyl)selenophene (25b):
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Employed B. Starting with 23c (0.149 g, 0.3 mmol) and p-
methoxyboronic acid (3.0 eq, 0.9 mmol, 0.137 g), Pd(OAc)2 
(6.8 mg, 10 mol-%), L (24.6 mg, 20 mol-%) and powdered, 
anhydrous K3PO4 (2.4 mmol, 8.0 equiv., 0.508 g), reflux 8h, 
25b (82%, 0.135 g) was isolated as a yellow solid, mp. = 238-
240 °C. 1H NMR (250 MHz, CDCl3): 	 = 2.19 (s, 12 H, 
4CH3), 3.73 (s, 6 H, 2OCH3), 6.66, 6.81 (d, 3J = 8.2 Hz, 4 H, 4 CH, Ar), 6.83 (s, 4 H, 4CH, 
Ar), 6.87 (s, 2 H, 2 CH, Ar), 13C NMR (75 MHz, CDCl3), 	 = 21.2 (CH3), 55.1(OCH3), 130.1, 
127.7, 128.7, 131.9 (CH, Ar), 130.8, 136.4, 141.2, 144.1, 157.8, 158.0 (C, Ar). IR (KBr, 
cm1): ~  = 2959 (w), 2913 (w), 2836 (w), 2532 (w), 1727 (w), 1599 (m), 1495 (m), 1462 (m), 
1242 (m), 1105 (m), 1032 (m), 1011 (m), 800 (m). MS (EI, 70 eV): m/z (%) = 551 (M+, 15), 
550 (49), 549 (10), 549 (18), 266 (12). HRMS (EI, 70 eV): calcd for C34H32O2Se (M+): 
552.15620; found: 552.15655. 
 
1.9.4.5 Synthesis of tetraalylnylselenophenes 
 
General procedure for the synthesis of tetra(phenylethynyl)selenophene (26): An oven-
dried Schenk flask was charged with Pd(Ph3)4 (35 mg, 10 mol-%), 20 (0.3 mmol), 
phenyacetylene (5.0 equiv., 1.5 mmol, 153 mg) and CuI (1.2 mmol, 4.0 equiv., 229 mg). The 
Schlenk flask was evacuated and subsequently flushed with argon. To the mixture 12 mL of 
iPr2NH was added by syringe. After cooling to 0 °C for 4 h, the reaction was heated under 
reflux for 8 h. The mixture was allowed to cool to ambient temperature and the solvent was 
removed in vacuo. The residue was purified by flash column chromatography (fine silica gel, 
heptanes). Product 26 (77%, 0.123 g) was isolated as a yellow solid, mp. = 80-81 °C. 1H 
NMR (250 MHz, CDCl3): 	 = 7.33, 7.36 (t, 3J = 8.2 Hz, 4 
H, 4 CH, Ar), 7.38, 7.39 (t, 3J = 8.2 Hz, 2 H, 2 CH, Ar), 
7.52, 7.55 (d, 3J = 8.2 Hz, 4 H, 4 CH, Ar). 13C NMR (75 
MHz, CDCl3): 	 = 128.4, 128.5, 129.2, 1231.6, 132.5 
(overlap of two CH) (CH, Ar), 73.9, 81.6, 83.3, 100.8 (C, 
acetylene), 119.6, 122.1, 132.9 (C, Ar). IR (KBr, cm1): 
~  = 2959 (w), 2913 (w), 2836 (w), 2532 (w), 1727 (w), 1599 (m), 1495 (m), 1462 (m), 1242 
(m), 1105 (m), 1032 (m), 1011 (m), 800 (m). MS (EI, 70 eV): m/z (%) = 531 (M+, 15), 530 
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(100), 529 (37), 528 (22), 452 (17), 389 (15). HRMS (EI, 70 eV): calcd for C36H20Se (M+): 
532.07302; found: 532.070312. 
 
1.9.5  Synthesis of functionalized thioephenes based on suzuki-cross coupling and 
metal-halide exchange reactions of tetrabromothiophene
 
Synthesis of tetrabromothiophene (30):
To a chloroform solution (10 mL) of thiophene  (25 mL) a chloroform 
solution (20 mL) of bromine (60 mL) was dropwise added within 45 minutes 
at 0 °C. The reaction mixture was warmed to room temperature and an 
additional amount of bromine (10 mL) was added and the reaction mixture was subsequently 
stirred under reflux for three hours. A saturated aqueous solution of NaOH was added and the 
mixture was stirred under reflux for 6 h to remove the bromine. The solvent and the excess of 
bromine was removed in vacuo. The product was recrystallized from a 1:1 solution of 
chloroform and methanol. The crude product (red to brownish crystals) was washed with cold 
ethyl acetate for several times to give pure 3 as colourless crystals (87%). 13C NMR (75 MHz, 
CDCl3): 	 = 110.3, 116.9; MS (EI, 70 eV): m/z (%) = 400 (M+, 100), 321 (65), 240 (34), 161 
(41). 
1.9.5.1 Synthesis of tetraarylthiophenes 
 
General procedure A for the synthesis of 31a-h:  
To a solution (for the solvents, see the individual procedures given below) of 30 was added 
Pd(PPh3)4 (10 mol-%) at 20 °C. After stirring for 30 min, the arylboronic acid, K3PO4 (8.0 
mmol) and water (1.0 mL) were added. The mixture was stirred for the indicated period of 
time at the indicated temperature. After cooling to ambient temperature, the mixture was 
diluted with EtOAc, dried (Na2SO4), and filtered through a short Celite pad. The solution was 
concentrated in vacuo and the residue was purified by flash column chromatography (fine 
flash silica gel, n-heptane). The solvents and the amounts are given in the individual 
procedures (see below). 
 
General procedure B for the synthesis of 31a-h:  
An oven-dried Schlenk flask was charged with Pd(OAc)2 (5 mol-%), ligand L (10 mol-%), the 
starting material 30, the boronic acid (6.0 eq) and powered, anhydrous K3PO4 (8.0 eq). The 
Schlenk flask was filled with argon. The solvent was added by syringe through a septum. The 
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septum was replaced by a condenser in an argon stream. The reaction mixture was stirred and 
refluxed for the indicated period of time at the indicated temperature. The solution was 
allowed to cool to ambient temperature and water (5 mL) was added. The aqueous and the 
organic layer were separated and the latter was dried Na2SO4. The solution was filtered and 
the filtrate was concentrated under reduced pressure. The residue was purified by flash 
column chromatography (fine flash silica gel, heptanes). The solvents and the amounts are 
given in the individual procedures (see below). 
 
General procedure A for the synthesis of 2,3,4,5-tetraarylthiophenes (33a-f):  
To a solution of 3,4-dibromothiophene 32 (1.0 mmol) was added Pd(PPh3)4 (0.116 g, 10 mol-
%) at 20 °C. After stirring for 30 min, the arylboronic acid (3.0 mmol), K3PO4 (4.0 mmol) and 
water (2.0 mL) were added. The mixture was stirred at 90 °C for 24 h. After cooling to 
ambient temperature, the mixture was diluted with EtOAc, dried (Na2SO4), and filtered 
through a short Celite pad. The solution was concentrated in vacuo and the residue was 
purified by flash column chromatography (fine flash silica gel, n-heptane). 
 
Synthesis of tetra(4-methoxyphenyl)thiophene (31b):
Procedure A: dioxane:H2O = 4:1 (5 mL), reflux 24 h, 
100 °C. Starting with 30 (0.400 g, 1.0 mmol) and (4-
methoxyphenyl)boronic acid (0.759 g, 5.0 mmol), 
Pd(PPh3)4 (0.115 g, 10 mol-%), K3PO4 (1.7 g, 8.0 
mmol), 31b was isolated (0.477 g, 94%) as a colourless 
solid; mp 183185 °C. 1H NMR (300 MHz, CDCl3): 	 = 3.65, 3.72 (s, 12 H, 2×2OCH3), 6.59, 
6.69, 6.82, 7.09 (d, 4×4H, CH, Ar). 13C NMR (75 MHz, CDCl3): 	 = 55.00, 56.06 (C, OCH3), 
114.8, 116.0, 130.2, 131.9  (CH, Ar), 127. 0, 129.0, 137.1, 138.3, 158.0, 158.6 (C, ArC). IR 
(KBr, cm1): ~  = 3431 (w), 3031 (m), 3003 (m), 2957 (m), 2924 (m), 2840 (m), 1607 (m), 
1511 (s), 1495 (s), 1286 (s), 1175 (s), 1031 (s), 834 (s), 799 (m). MS (EI, 70 eV): m/z (%) = 
508 (M+, 100), 255 (31), 178 (15), 172 (29), 160 (26), 96 (10). HRMS (EI, 70 eV): calcd for 
C32H28O4S (M+): 508.6273; found: 508.6277.  
 
Synthesis of tetra(4-chlorophenyl)thiophene (31f):  
Procedure A: toluene:H2O = 4:1 (5 mL), reflux 24 h, 100 
°C. Starting with 30 (0.400 g, 1.0 mmol) and 4-
chlorophenylboronic acid (0.782 g, 5.0 mmol), Pd(PPh3)4 
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(0.115 g, 10 mol-%), K3PO4 (1.7 g, 8.0 mmol), 31f was isolated (0.468 g, 89%) as a 
colourless solid; mp 139140 °C. 1H NMR (300 MHz, CDCl3): 	 = 6.75, 7.05, 7.08, 7.09 (d, 
8×2H, Ar). 13C NMR (75 MHz, CDCl3): 	 = 128.5, 128.7, 130.3, 131.9 (CH, Ar), 130.3, 
131.8, 131.9, 132.4, 137.3, 147.3 (C, Ar). IR (KBr, cm1): ~  = 3432 (m), 3066 (w), 1492 (s), 
1480 (s), 1093 (s), 1086 (s), 834 (s), 806 (s), 769 (m), 526 (m), 520 (w), 501 (w), 487 (w). MS 
(EI, 70 eV): m/z (%) = 530 (M+, [37Cl,37Cl,37Cl,35Cl], 13), 528 (M+, [37Cl,37Cl,35Cl,35Cl], 51), 
526 (M+, [37Cl,35Cl,35Cl,35Cl], 100), 524 (M+, [35Cl,35Cl,35Cl,35Cl], 71). HRMS (EI, 70 eV): 
calcd for C28H16Cl4S ((M+, [37Cl,35Cl,35Cl,35Cl]): 526.3026; found: 526.3022.  
 
Synthesis of tetra(thien-2-yl)thiophene (31h):
Procedure B: 5 mL of toluene, reflux 8 h, 100 °C. Starting with 30 
(0.200 g, 0.5 mmol) and (thien-2-yl)boronic acid (6.0 equiv., 0.383 g, 
0.6 mmol), Pd(OAc)2 (11 mg, 5 mol-%), L (41 mg, 10 mol-%), K3PO4 
(1.7 g, 8.0 mmol), 31h was isolated (0.166g, 81%) as a yellow solid. 
mp. = 110-112 °C. 1H NMR (250 MHz, CDCl3): 	 = 6.90, 7.10, 7.19, 7.30 (d, 2 H, 4 CH, 
thienyl), 6.94, 6.96 (t, 2 H, CH, thienyl). 13C NMR (75 MHz, CDCl3): 	 = 125.4, 126.3, 126.4, 
126.8, 127.1, 128.4 (2 CH, thienyl), 132.4, 133.3, 135.3, 135.6 (C). IR (KBr, cm1): ~  = 3096 
(w), 2959 (w), 2922 (w), 2851 (w), 1259 (w), 1216 (w), 1060 (w), 1036 (w), 1024 (w), 816 
(w), 695 (m). MS (EI, 70 eV): m/z (%) = 412 (M+, 100), 378 (M+, 8), 367 (M+,9), 346 (M+,6), 
285 (M+,4), 283 (M+,4). HRMS (EI, 70 eV): calcd for C20H12S5 (M+): 411.95371, found: 
411.95369.  
 
Synthesis of 3,4-di(4-methoxyphenyl)-2,5-di(4-tolyl)thiophene (33c):
Procedure A: Toluene:dioxane:H2O = 2:2:1 (5 mL), reflux 
24 h, 100 °C. Starting with 32b (0.42 g, 1.0 mmol) and (4-
methoxyphenyl)boronic acid (0.455 g, 3.0 mmol), 
Pd(PPh3)4 (0.115 g, 10 mol-%), K3PO4 (0.848 g, 4.0 
mmol), 33c was isolated (0.361 g, 76%) as a colourless 
solid; 230231 °C. 1H NMR (300 MHz, CDCl3): 	 = 2.20 (s, 3 H, CH3), 3.62 (s, 3 H, OCH3), 
6.53, 6.75, 6.97, 7.06 (m, 16 H, 4×4CH, Ar). 13C NMR (75 MHz, CDCl3): 	 = 21.25 (C, CH3), 
55.10 (C, OCH3), 113.37, 129.07, 129.09, 132.00 (CH, Ar), 129.00, 131.88, 136.84, 138.44, 
139.86, 158.18 (C, ArC). IR (KBr, cm1): ~  = 3446 (m), 2999 (m), 2962 (m), 2835 (m), 1608 
(s), 1513 (s), 1290 (s), 1245 (s), 1034 (s), 841 (s), 809 (s), 563 (w). MS (EI, 70 eV): m/z (%) = 
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476 (M+, 100), 83 (10), 71 (10), 69 (13), 57 (17), 43 (22), 40 (13).  HRMS (EI, 70 eV): calcd 
for C32H28O2S (M+): 476.6258; found: 476.6255.  
 
Synthesis of 3,4-bis(4-hydroxyphenyl)-2,5-di(4-tolyl)thiophene (33e):  
Procedure A: Toluene:dioxane:H2O = 2:2:1 (5 mL), reflux 
24 h, 90 °C. Starting with 32b (0.42 g, 1.0 mmol) and (4-
hydroxyphenyl)boronic acid (0.433 g, 3.0 mmol), 
Pd(PPh3)4 (0.115 g, 10 mol-%), K3PO4 (0.848 g, 4.0 
mmol), 33e was isolated (0.367 g, 82%) as a colourless 
solid; mp 186187 °C. 1H NMR (300 MHz, CDCl3): 	 = 2.18 (s, 3 H, CH3 ), 6.49, 6.67, 6.92, 
7.06 (d, 16 H, 4×4CH, Ar). 13C NMR (75 MHz, CDCl3): 	 = 20.2 (C, CH3), 128.7, 128.9, 
131.7, 131.8 (CH, Ar), 127.3, 127.9, 136.8, 137.2, 139.6, 156.2 (C, Ar). IR (KBr, cm1): ~  = 
3383 (m), 3062 (w), 2921 (m), 1609 (m), 1513 (s), 1263 (s), 1210 (s), 815 (s), 559 (w). MS 
(EI, 70 eV): m/z (%) = 449 (M+, 57), 448 (100), 364 (23), 362 (20), 283 (15), 69 (13), 57 (14), 
43 (12), 40 (11).  HRMS (EI, 70 eV): calcd for C30H24O2S (M+): 448.5754; found: 448.5752.  
1.9.5.2 Synthesis of 2,3,4-tetrabromo-5-arylthiophenes 
 
General procedure B for the synthesis of 34a-e: An oven-dried Schlenk flash was charged 
with Pd(OAc)2 (5 mol-%), ligand L (10 mol-%), the starting material, the boronic acid (1.0 
equiv.) and powered, anhydrous K3PO4 (4 equiv.). The Schlenk flask was filled with argon. 
The solvent was added by syringe through a septum. The septum was replaced by a condenser 
in an argon stream. The reaction mixture was stirred and refluxed for the indicated period of 
time at the indicated temperature. The solution was allowed to cool to ambient temperature 
and water (5 mL) was added. The aqueous and the organic layer were separated and the latter 
was dried Na2SO4. The solution was filtered and the filtrate was concentrated under reduced 
pressure. The residue was purified by flash column chromatography (fine flash silica gel, 
heptanes). The solvents and the amounts are given in the individual procedures (see below). 
 
Synthesis of 2,3,4-tribromo-5-(2-methoxyphenyl)thiophene (34a):
Procedure B: toluene:dioxane = 1:1 (4 mL), reflux 8 h, 100 °C. Starting 
with 30 (0.200 g, 0.5 mmol) and (2-methoxyphenyl)boronic acid (0.091 
g, 0.6 mmol), Pd(OAc)2 (5,6 mg, 5 mol-%), L (20.5 mg, 10 mol-%), 
K3PO4 (0.424 g, 4.0 mmol), 34a was isolated (0.158 g, 75%) as a white 
solid. mp. =  72-78 °C. 1H NMR (250 MHz, CDCl3): 	 = 3.83 (s, 3 H, OMe), 6.98, 7.03 (d, 1 
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H, CH, Ar), 7.34, 7.44 (t, 1 H, CH, Ar). 13C NMR (75 MHz, CDCl3): 	 = 55.6 (OMe), 110.5, 
112.6, 117.3 (CBr), 111.3, 120.5, 131.0, 131.9 (CH, Ar), 120.9, 136.3, 157.0 (C). IR (KBr, 
cm1): ~  = 3077 (w), 3008 (w), 2933 (m), 2831 (m), 2487 (w), 2042 (w), 1903 (w), 1579 (s), 
1246 (s), 1022 (s), 744 (s), 723 (s). MS (EI, 70 eV): m/z (%) = 430 (M+, [81Br,81Br,81Br], 35), 
428 (M+, [81Br,81Br,79Br], 99), 426 (M+, [81Br,79Br,79Br], 100), 424 (M+, [79Br,79Br,79Br], 33). 
HRMS (EI, 70 eV): calcd for C11H7Br3S (M+, [81Br,81Br,81Br]): 429.77009, found: 429.77005; 
(M+, [81Br,81Br,79Br]): 427.77213, found: 427.77182; (M+, [81Br,79Br,79Br]): 425.77418, 
found: 425.77375; (M+, [79Br,79Br,79Br]): 423.77622, found: 423.77569. 
 
Synthesis of 2,3,4-tribromo-5-(4-methoxyphenyl)thiophene (34b):
Procedure B: toluene:dioxane = 1:1 (4 mL), reflux 8 h, 100 °C. 
Starting with 30 (0.200 g, 0.5 mmol) and (4-
methoxyphenyl)boronic acid (0.091 g, 0.6 mmol), Pd(OAc)2 (5,6 
mg, 5 mol-%), L (20.5 mg, 10 mol-%), K3PO4 (0.424 g, 4.0 
mmol), 34b was isolated (0.17 g, 80%) as a white solid. mp. = 124-125 °C. 1H NMR (250 
MHz, CDCl3): 	 = 3.84 (s, 3 H, OMe), 6.96, 7.49 (d, 2 H, CH, Ar). 13C NMR (75 MHz, 
CDCl3): 	 = 55.4 (OMe), 109.3, 109.9, 118.3 (CBr), 114.2, 130.3 (2 CH, Ar), 124.6, 140.0, 
160.3 (C). IR (KBr, cm1): ~  = 3028 (w), 3005 (w), 2954 (w), 2895 (w), 2830 (w), 1879 (w), 
1603 (w), 1489 (m), 1248 (m), 1177 (m), 1031 (m), 832 (m). MS (EI, 70 eV): m/z (%) = 430 
(M+, [81Br,81Br,81Br], 35), 428 (M+, [81Br,81Br,79Br], 97), 426 (M+, [81Br,79Br,79Br], 100), 424 
(M+, [79Br,79Br,79Br], 33). HRMS (EI, 70 eV): calcd for C11H7Br3S (M+, [81Br,81Br,81Br]): 
429.77009, found: 429.76984; (M+, [81Br,81Br,79Br]): 427.77213, found: 427.77152; (M+, 
[81Br,79Br,79Br]): 425.77418, found: 425.77363; (M+, [79Br,79Br,79Br]): 423.77622, found: 
423.77564. 
 
Synthesis of 2,3,4-tribromo-5-(3-biphenyl)thiophene  (34c). Procedure B: 5 mL of toluene, 
reflux 8 h, 100 °C. Starting with 30 (0.200 g, 0.5 mmol) and 3-
biphenylboronic acid (0.119 g, 0.6 mmol), Pd(OAc)2 (5,6 mg, 5 
mol-%), L (20.5 mg, 10 mol-%), K3PO4 (0.424 g, 4.0 mmol), 34c 
was isolated (0.181 g, 77%) as a yellow solid. mp. = 116-117 °C. 
1H NMR (250 MHz, CDCl3): 	 = 7.38-7.79 (m, 9 H, CH, Ar). 13C NMR (75 MHz, CDCl3): 	 
= 110.3, 110.6, 118.6 (CBr), 127.2, 129.9 (2CH, Ar), 127.7, 127.8, 127.9, 129.2 (CH, Ar), 
132.7, 139.9, 140.2, 141.9 (C). IR (KBr, cm1): ~  = 3077 (w), 3056 (w), 3024 (w), 1595 (w), 
1567 (w), 1468 (w), 1273 (w), 786 (m), 748 (m), 691 (m). MS (EI, 70 eV): m/z (%) = 476 
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(M+, [81Br,81Br,81Br], 36), 474 (M+, [81Br,81Br,79Br], 97), 472 (M+, [81Br,79Br,79Br], 100), 470 
(M+, [79Br,79Br,79Br], 33). HRMS (EI, 70 eV): calcd for C16H9Br3S (M+, [81Br,81Br,81Br]): 
475.79082, found: 475.79034; (M+, [81Br,81Br,79Br]): 473.79287, found: 473.79226; (M+, 
[81Br,79Br,79Br]): 471.79491, found: 471.79506; (M+, [79Br,79Br,79Br]): 469.79696, found: 
469.79689. 
 
Synthesis of 2,3,4-tribromo-5-(naphth-2-yl)thiophene (34d): 
Procedure B: 5 mL of toluene, reflux 8 h, 100 °C. Starting with 30 
(0.200 g, 0.5 mmol) and (naphtha-2-yl)boronic acid (0.103 g, 0.7 
mmol), Pd(OAc)2 (5,6 mg, 5 mol-%), L (20.5 mg, 10 mol-%), 
K3PO4 (0.424 g, 4.0 mmol), 34d was isolated (0.153 g, 69%) as an 
orange viscous oil. 1H NMR (250 MHz, CDCl3): 	 = 7.47-7.97 (m, 7 H, CH, Ar). 13C NMR 
(75 MHz, CDCl3): 	 = 110.9, 113.7, 117.6 (CBr), 125.0, 125.5, 126.4, 127.0, 128.5, 129.4, 
130.2 (CH, Ar), 129.5, 131.5, 133.5, 138.2 (C). IR (KBr, cm1): ~  = 3050 (w), 2962 (w), 
2848 (w), 1926 (w), 1875 (w), 1814 (w), 1501 (w), 1434 (m), 1386 (m), 1261 (m), 793 (s), 
796 (s) 729 (m). MS (EI, 70 eV): m/z (%) = 450 (M+, [81Br,81Br,81Br], 17), 448 (M+, 
[81Br,81Br,79Br], 48), 446 (M+, [81Br,79Br,79Br], 48), 444 (M+, [79Br,79Br,79Br], 16). HRMS 
(EI, 70 eV): calcd for C14H7Br3S (M+, [81Br,81Br,79Br]): 447.77777, found: 447.77769; (M+, 
[81Br,79Br,79Br]): 445.77981, found: 445.77989. 
 
Synthesis of 2,3,4-tribromo-5-(4-ethylphenyl)thiophene (34e):
Procedure B: 5 mL of toluene, reflux 8 h, 100 °C. Starting with 30 
(0.200 g, 0.5 mmol) and (4-ethylphenyl)boronic acid (0.090 g, 0.6 
mmol), Pd(OAc)2 (5,6 mg, 5 mol-%), L (20.5 mg, 10 mol-%), K3PO4 
(0.424 g, 4.0 mmol), 34e was isolated (0.183 g, 87%) as a light 
yellow solid; mp 58-63 °C. 1H NMR (250 MHz, CDCl3): 	 = 1.20 (t, 3 H, CH3), 2.62 (q, 2 H, 
CH2), 7.20, 7.40 (d, 2 H, CH, Ar). 13C NMR (75 MHz, CDCl3): 	 = 15.3 (CH3), 28.7 (2 H, 
CH2), 109.7, 110.0, 118.4 (CBr), 128.3, 128.8 (2 CH, Ar), 129.6, 140.2, 145.6 (C). IR (KBr, 
cm1): ~  = 2965 (m), 2923 (w), 2874 (w), 2836 (w), 1901 (w), 1888 (w), 1608 (w), 1484 (w), 
1433 (w), 1409 (w), 1268 (m), 824 (m). MS (EI, 70 eV): m/z (%) = 428 (M+, [81Br,81Br,81Br], 
34), 426 (M+, [81Br,81Br,79Br], 96), 424 (M+, [81Br,79Br,79Br], 97), 422 (M+, [79Br,79Br,79Br], 
33). HRMS (EI, 70 eV): calcd for C12H9Br3S (M+, [81Br,81Br,81Br]): 427.79082, found: 
427.79059; (M+, [81Br,81Br,79Br]): 425.79287, found: 425.79277; (M+, [81Br,79Br,79Br]): 
423.79491, found: 423.79458; (M+, [79Br,79Br,79Br]): 421.79696, found: 421.79606. 
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1.9.5.3 Synthesis of unsymmetrical 3,4-dibromo-2,5-diarylthiophenes
 
Synthesis of 3,4-dibromo-2-(4-methoxyphenyl)-5-(4-ethylphenyl)thiophene (35a):
Procedure B: toluene:dioxane = 1:1 (4 mL), reflux 8 h, 
100 °C. Starting with 34b (0.212 g, 0.5 mmol) and (4-
ethylphenyl)boronic acid (0.090 g, 0.6 mmol), Pd(OAc)2 
(5,6 mg, 5 mol-%), L (20.5 mg, 10 mol-%), K3PO4 (0.424 
g, 4.0 mmol), 35b was isolated (0.163 g, 72%) as an orange solid; mp 61-76 °C. 1H NMR 
(250 MHz, CDCl3): 	 = 1.33 (t, 3 H, CH3), 2.76 (q, 2 H, CH2), 3.89 (s, 3 H, OMe), 7.02, 7.34, 
7.62, 7.65 (d, 2 H, CH, Ar). 13C NMR (75 MHz, CDCl3): 	 = 15.3 (CH3), 28.6 (CH2), 55.3 
(OMe), 111.57, 111.63  (CBr), 114.0, 128.1, 128.9, 130.3 (CH, Ar), 125.9, 127.6, 137.6, 
137.7, 145.0, 159.0 (C). IR (KBr, cm1): ~  = 2997 (w), 2960 (w), 2929 (w), 2871 (w), 2047 
(w), 1905 (w), 1603 (w), 1486 (m), 1248 (m), 1028 (m), 827 (m), 800 (m). MS (EI, 70 eV): 
m/z (%) = 454 (M+, [81Br,81Br], 53), 452 (M+, [81Br,79Br], 100), 450 (M+, [79Br,79Br], 50), 439 
(M+, 22), 437 (M+, 40), 435(M+, 21). HRMS (EI, 70 eV): calcd for C19H16Br2SO (M+, 
[81Br,81Br]): 453.92422, found: 453.92399, (M+, [81Br,79Br]): 451.92627, found: 451.92589; 
(M+, [79Br,79Br]): 449.92831, found: 449.92798. 
 
Synthesis of 3,4-dibromo-2-(4-methoxyphenyl)-5-(3,5-dimethylphenyl)thiophene (35b).
Procedure B: tolulene:dioxane = 1:1 (4 mL), reflux 8 h, 
100 °C. Starting with 34b (0.212 g, 0.5 mmol) and (3,5-
dimethylphenyl)boronic acid (0.090 g, 0.6 mmol), 
Pd(OAc)2 (5,6 mg, 5 mol-%), L (20.5 mg, 10 mol-%), 
K3PO4 (0.424 g, 4.0 mmol), 35b was isolated (0.150 g, 67%) as an orange solid; mp 85-89 °C. 
1H NMR (250 MHz, CDCl3): 	 = 2.30 (s, 6 H, CH3), 3.77 (s, 3 H, OCH3), 6.89, 7.51 (d, 2 H, 
CH, Ar), 6.96 (d, H, CH, Ar), 7.18 (s, 2 H, CH, Ar). 13C NMR (75 MHz, CDCl3): 	 = 21.3 
(CH3), 55.3 (O CH3), 111.5, 111.7  (CBr), 114.2, 126.8, 131.4 (2 CH, Ar), 131.2 (CH, Ar), 
114.3, 125.3, 132.7, 137.7, 138.2, 160.0 (C). IR (KBr, cm1): ~  = 2994 (w), 2931 (w), 2912 
(w), 2832 (w), 2545 (w), 2077 (w), 1880 (w), 1599 (m), 1530 (m), 1469 (m), 1248 (m), 1033 
(m), 824 (m), 796 (m), 739 (m), 689 (m). MS (EI, 70 eV): m/z (%) = 454 (M+, [81Br,81Br], 
53), 452 (M+, [81Br,79Br], 100), 450 (M+, [79Br,79Br], 49), 439 (M+, 17), 437 (M+, 32), 
435(M+, 16). HRMS (EI, 70 eV): calcd for C19H16Br2SO (M+, [81Br,81Br]): 453.92422, found: 
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453.92398, (M+, [81Br,79Br]): 451.92627, found: 451.92577; (M+, [79Br,79Br]): 449.92831, 
found: 449.92776. 
 
Synthesis of 3,4-dibromo-2-(4-methoxyphenyl)-5-(3-biphenyl)thiophene (35c):
Procedure B: toluene:dioxane = 1:1 (4 mL), reflux 8 h, 
100 °C. Starting with 34b (0.212 g, 0.5 mmol) and 3-
biphenylboronic acid (0.119 g, 0.6 mmol), Pd(OAc)2 
(5,6 mg, 5 mol-%), L (20.5 mg, 10 mol-%), K3PO4 
(0.424 g, 4.0 mmol), 35c was isolated (0.171 g, 69%) as an orange solid; mp 60-62 °C. 1H 
NMR (250 MHz, CDCl3): 	 = 3.86 (s, 3 H, OCH3), 6.99 (d, 2 H, CH, Ar), 7.33-7.65 (m, 11 H, 
CH, Ar). 13C NMR (75 MHz, CDCl3): 	 = 55.4 (O CH3), 111.8, 112.2 (CBr), 114.1, 127.2, 
128.9, 130.3 (2 CH, Ar), 127.2, 127.6, 127.7, 127.8, 129.1 (CH, Ar), 125.2, 133.4, 137.3, 
138.2, 140.5, 141.7, 160.1 (C). IR (KBr, cm1): ~  = 3057 (w), 3029 (w), 3003 (w), 2929 (w), 
2833 (w), 1873 (w), 1604 (w), 1474 (m), 1450 (m), 1253 (m), 1179 (m), 1033 (m), 821 (m), 
747 (m), 961 (m). MS (EI, 70 eV): m/z (%) = 502 (M+, [81Br,81Br], 14), 500 (M+, [81Br,79Br], 
30), 498 (M+, [79Br,79Br], 13), 497 (M+, 66), 486 (M+, 12), 484 (M+, 24). HRMS (EI, 70 eV): 
calcd for C23H16Br2SO (M+, [81Br,81Br]): 501.92422, found: 501.92450, (M+, [81Br,79Br]): 
499.92627, found: 499.92610; (M+, [79Br,79Br]): 497.92831, found: 497.92959. 
 
1.9.5.4 Synthesis of dimethyl 3,4-diarylthiophene-2,5-dicarboxylate
 
General procedure A for the synthesis of 38a-d:  
To a solution (for the solvents, see the individual procedures given below) of starting material 
was added Pd(PPh3)4 (10 mol-%) at 20 °C. After stirring for 30 min, the arylboronic acid, 
K3PO4 (8.0 mmol) and water (1.0 mL) were added. The mixture was stirred for the indicated 
period of time at the indicated temperature. After cooling to ambient temperature, the mixture 
was diluted with EtOAc, dried (Na2SO4), and filtered through a short Celite pad. The solution 
was concentrated in vacuo and the residue was purified by flash column chromatography (fine 
flash silica gel, n-heptane). The solvents and the amounts are given in the individual 
procedures (see below). 
 
General procedure B for the synthesis of 38a-d:  
An oven-dried Schlenk flash was charged with Pd(OAc)2 (10 mol-%), ligand L (20 mol-%), 
the starting material, the boronic acid and powered, anhydrous K3PO4 (8 equiv.). The Schlenk 
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flask was filled with argon. The solvent was added by syringe through a septum. The septum 
was replaced by a condenser in an argon stream. The reaction mixture was stirred and 
refluxed for the indicated period of time at the indicated temperature. The solution was 
allowed to cool to ambient temperature and water (5 mL) was added. The aqueous and the 
organic layer were separated and the latter was dried Na2SO4. The solution was filtered and 
the filtrate was concentrated under reduced pressure. The residue was purified by flash 
column chromatography (fine flash silica gel, heptanes). The solvents and the amounts are 
given in the individual procedures (see below). 
 
Synthesis of dimethyl 3,4-di(4-chlorophenyl)thiophene-2,5-dicarboxylate (38a):  
Procedure A: toluene:H2O = 4:1 (5 mL), reflux 24 h, 100 °C. 
Starting with 36g (0.358 g, 1.0 mmol) and (4-chlorophenyl)boronic 
acid (0.469 g, 3 mmol), Pd(PPh3)4 (0.060 g, 5 mol-%), K3PO4 
(0.848 g, 4.0 mmol), 38a was isolated (0.176 g, 42%) as a white 
solid; mp 149151 °C 1H NMR (300 MHz, CDCl3): 	 = 3.64 (s, 
6H, 2OCH3), 7.14, 7.51 (d, 3J = 8.2 Hz, 2H, CH, Ar), 7.31 (d, 3J = 8.2 Hz, 4H, CH, Ar). 13C 
NMR (75 MHz, CDCl3): 	 = 51.56 (C, OCH3), 127.56, 129.07, 129.85, 132.42 (CH, Ar), 
141.30, 159.19 113.73, 141.85 (C, Ar), 160.09 (C, CO). IR (KBr, cm1): ~  = 3429 (m), 2950 
(m), 1899 (w), 1721 (s), 1593 (w), 1522 (w), 1437 (s),  1095 (m), 1016 (m), 829 (m), 807 (s), 
761 (m). MS (EI, 70 eV): m/z (%) = 421 (M+, 35), 350 (100), 240 (16), 210 (10), 191 (11), 
149 (9), 112 (7), 97 (9), 83 (12), 81 (19), 44 (7). HRMS (EI, 70 eV): calcd for C30H22O4Cl2S 
(M+): 421.2938; found: 421.2936.  
 
Synthesis of dimethyl 3,4-di(2-methoxyphenyl)thiophene-2,5-dicarboxylate (38b):   
 Procedure B: 5 mL of dioxane, reflux 8 h, 100 °C. Starting with 36g 
(0.358 g, 1.0 mmol) and (2-methoxyphenyl)boronic acid (0.299 g, 
2.2 mmol), Pd(OAc)2 (11.2 mg, 5 mol-%), L (41 mg, 10 mol-%), 
K3PO4 (0.848 g, 4.0 mmol), 38b was isolated (0.185 g, 45%) as a 
colourless solid; mp 205207 °C. A doubling of some signals in the 1H and 13C NMR spectra 
is observed, due to the presence of two atropisomers. 1H NMR (300 MHz, CDCl3): 	 = 3.43, 
3.51 (2 x s, 6 H, OCH3), 3.67, 3.68 (2 x s, 6 H, CO2CH3), 6.61, 6.72 (d, 3J = 8.2 Hz, 2 H, CH, 
Ar), 6.83, 7.18 (t, 3J = 8.2 Hz, 2 H, CH, Ar); 13C NMR (75 MHz, CDCl3): 	 = 52.0 (C, OCH3), 
55.0, 55.1 (CH3, OCOCH3), 110.0, 110.1, 119.4, 119.5, 129.0, 129.1, 130.5, 130.8 (CH, Ar), 
132.0, 132.1, 145.3, 146.0 (C, Ar), 123.8, 124.1, 156.6 (C, thiophene), 161.8, 161.9 (C=O). IR 
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(KBr, cm1): ~  = 3433 (br, w), 3065 (w), 3029 (w), 3001 (w), 2953 (s), 2833 (s), 1724 (s), 
1601 (m), 1583 (s), 1508 (s), 1468 (s), 1289 (s), 1158 (m), 1079 (m), 1048 (m), 762 (s), 750 
(s). MS (EI, 70 eV): m/z (%) = 412 (M+, 98), 382 (25), 381 (100), 322 (10), 321 (46), 307 
(16), 305 (9), 287 (19). HRMS (EI, 70 eV): calcd for C22H20O6S (M+): 412.0975; found: 
412.0971. 
 
Synthesis of dimethyl 3,4-di(2-hydroxyphenyl)thiophene-2,5-dicarboxylate (38c):   
Procedure A: toluene:dioxane:H2O = 2:2:1 (5 mL). Starting with
36g (0.358 g, 1.0 mmol) and (2-hydroxyphenyl)boronic acid (0.443 
g, 3 mmol), Pd(PPh3)4 (0.060 g, 5 mol-%), K3PO4 (0.848 g, 4.0 
mmol), 38c was isolated (0.188 g, 49%) as a colourless solid; mp 
159160 °C. 1H NMR (300 MHz, CDCl3): 	 = 3.79 (s, 6 H, 2OCH3), 7.31, 9.00 (d, 3J = 8.2 
Hz, 2 H, CH, Ar), 7.39, 7.51 (t, 3J = 8.2 Hz, 2 H, CH, Ar). 13C NMR (75 MHz, CDCl3): 	 = 
116.7, 118.0, 123.1, 124.4 (CH, Ar), 112.7, 130.7, 140.6, 155.9 (C, Ar), 160.2 (C, CO). IR 
(KBr, cm1): ~  = 3333 (br, s), 3062 (m), 3023 (m), 2921 (m), 2900 (m), 1688 (m), 1670 (s), 
1596 (s), 1523 (s), 1494 (s), 1236 (s), 1142 (m), 1100 (m), 1010 (m), 833 (s), 816 (s). MS (EI, 
70 eV): m/z (%) = 384 (M+, 26), 364 (35), 322 (10), 321 (46), 307 (16), 305 (9), 287 (19), 283 
(100). HRMS (EI, 70 eV): calcd for C20H16O6S (M+): 384.4024; found: 384.4028. 
 
1.9.5.5 Synthesis of 3,4-dibromothiophenes 
 
General procedure for the synthesis of 3,4-dibromothiophenes 36a-h: To a THF solution 
of tetrabromothiophene (30) (0.400 g, 1.0 mmol) was added 1 mL of n-butyllithium (2.5 M in 
heptane) at –78 °C. After stirring for 60 min at –78 °C, the electrophile (3.0 mmol) was added 
at –78 °C. After warming of the mixture to 20 °C within 16 h, a saturated aqueous solution of 
NH4Cl (30 mL) was added. The organic and the aqueous layer were separated and the latter 
was extracted with ethyl acetate (2 x 30 mL). The combined organic layers were dried 
(Na2SO4), filtered and the solvent of the filtrate was removed in vacuo. The residue was 
purified by chromatography (fine silica gel, n-heptane). 
 
Synthesis of 3,4-dibromo-2,5-dimethylthiophene (36a):
Starting with tetrabromothiophene  (30) (0.400 g, 1.0 mmol) and 
iodomethane (0.426 g, 3.0 mmol), 36a was isolated (0.151 g, 56%) as a 
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colourless oil. 1H NMR (300 MHz, CDCl3): 	 = 2.85 (s,  6 H, 2CH3). 13C NMR (75 MHz, 
CDCl3): 	 = 15.4 (C, CH3), 112.2, 131.7 (C, ArC). IR (KBr, cm1): ~  = 2965 (m), 2928 (m), 
2879 (w), 1515 (w), 1448 (m), 1445 (w), 1315 (w). MS (EI, 70 eV): m/z (%) = 272 (M+, 
[81Br,81Br], 52), 270 (M+, [81Br,79Br], 100), 268 (M+, [79Br,79Br], 51), 191 (93), 189 (93), 95 
(12), 51 (16). Anal. Calcd for C6H6Br2S: C 26.69, H 2.24, S 11.88; found: C 26.65, H 2.26, S 
11.88.  
Synthesis of 3,4-dibromo-2,5-dibutylthiophene (36b): 
Starting with tetrabromothiophene  (30) (0.400 g, 1.0 mmol) and 1-
iodobutane (0.546 g, 3.0 mmol), 36b was isolated (0.333 g, 94%) as a 
colourless oil. 1H NMR (300 MHz, CDCl3): 	 = 0.82 (t, 3J = 7.2 Hz, 6H, 
2CH3), 1.22-1.32 (m, 4H, 2CH2, CH2CH3), 1.40-1.55 (m, 4H, 2CH2, CH2CH2CH3), 2.69 (t, 3J 
= 7.2 Hz, 4H, 2CH2, CH2CH2CH2CH3). 13C NMR (75 MHz, CDCl3): 	 = 13.9 (C, CH3), 22.4, 
29.7, 32.3 (C, CH2), 118.8, 137.3 (C, ArC). IR (KBr, cm1): ~  = 2956 (s), 2926 (m), 2869 
(m), 1466 (m), 1384 (w), 1366 (w), 1360 (w). MS (EI, 70 eV): m/z (%) = 356 (M+, 
[81Br,81Br], 14), 354 (M+, [81Br,79Br], 26), 352 (M+, [79Br,79Br], 13), 313 (52), 311 (100), 309 
(51), 269 (13), 255 (17), 231 (14), 194 (12). Anal. Calcd for C12H18Br2S: C, 40.70, H, 5.12, S, 
9.05; found: C, 40.74, H, 5.12, S, 9.05. 
Synthesis of 3,4-dibromo-2,5-di(isopentyl)thiophene (36c): 
Starting with tetrabromothiophene (30) (0.400 g, 1.0 mmol) and 1-
bromo-3-methylbutane (0.453 g, 3.0 mmol), 36c was isolated 
(0.294 g, 77%) as a colourless oil. 1H NMR (300 MHz, CDCl3): 	 
= 1.08 (d, 3J = 7.2 Hz, 12H, 2×2CH3), 1.64 (m, 4H, 2CH2, CH2(CH3)2), 1.73 (m, 2H, 2CH), 
2.90 (m, 4H, 2CH2, CH2CH2(CH3)2). 13C NMR (75 MHz, CDCl3): 	 = 23.2 (C, CH3), 27.6, 
30.0 (C, CH2), 39.4 (C, CH), 119.8 , 137.2 (C, ArC). IR (KBr, cm1): ~  = 2956 (s), 2926 (m), 
2869 (m), 1466 (m), 1384 (w), 1366 (w), 1360 (w). MS (EI, 70 eV): m/z (%) = 384 (M+, 
[81Br,81Br], 11), 382 (M+, [81Br,79Br], 21), 380 (M+, [79Br,79Br], 10), 327 (17), 323 (17), 271 
(20), 269 (38), 267 (19), 255 (17), 248 (12), 247 (99), 245 (100), 57 (13). Anal. Calcd for 
C14H22Br2S: C, 44.00, H, 5.80, S, 8.39; found: C, 44.05, H, 5.72, S, 8.33. 
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Synthesis of 2,5-dibenzoyl-3,4-dibromothiophene (36h):
Starting with tetrabromothiophene  (30) (0.400 g, 1.0 mmol) and 
benzoyl chloride (2.2 mmol), 36h was isolated (0.306 g, 68%) as a 
colourless oil. 1H NMR (300 MHz, CDCl3): 	 = 7.49 (m, 4H, 2CH, Ar), 
7.61 (m, 2H, 2CH, Ar), 7.79 (m, 4H, 2CH, Ar). 13C NMR (75 MHz, 
CDCl3): 	 = 129.5, 131.4, 135.4 (CH, Ar), 120.5, 140.6, 141.5 (C, ArC), 187.9 (C, CO). IR 
(KBr, cm1): ~  = 3067 (w), 2940 (m), 2917 (m), 2862 (w), 1755 (s), 1644 (s),  1600 (m), 
1444 (m), 1440 (m), 1298 (s), 1266 (s), 1076 (m), 772 (s), 689 (m). MS (EI, 70 eV): m/z (%) 
= 452 (M+, [81Br,81Br], 18), 450 (M+, [81Br,79Br], 42), 448 (M+, [79Br,79Br], 70), 354 (100), 
310 (16), 267 (18), 178 (15), 165 (6), 121 (9), 77 (8). HRMS (EI, 70 eV): calcd for 
C18H10Br2O2S (M+, [81Br,79Br]): 450.1438; found: 450.1441. 
 
1.9.5.6 Synthesis of 3,4-dibromo-5-alkyl-2-trimethylsiylthiophenes
 
General procedure for the synthesis of 3,4-dibromothiophenes 37a-f:  
To a THF solution (15 mL) of  nBuLi (2.5 M in n-hexane, 1.05 mL, 2.5 mmol) and TMEDA 
(0.775 mL, 2.5 mmol) was added tetrabromothiophene (30) (0.200 g, 0.5 mmol) at -78 °C 
under Argon atmosphere and the mixture was stirred for 30 min. To the stirred solution was 
dropwise added a THF solution (5 mL) of TMSCl (0.063 mL, 0.5 mmol) over a period of 3 h. 
The reaction mixture was stirred for further 30 min and, subsequently, the 1-bromoalkane 
(0.75 mmol) was added. After stirring for 4 h, to the solution was added a saturated aqueous 
solution of Na2SO4 (10 mL). The aqueous and the organic layer were separated. The organic 
layer was dried (Na2SO4), filtered and concentrated in vacuo. The residue was purified by 
flash column chromatography (fine flash silica gel, n-heptane).  
 
Synthesis of 3,4-dibromo-5-ethyl-2-trimethylsilylthiophene (37a):
Starting with 30 (0.200 g, 0.5 mmol) and 1-bromoethane (0.6 mmol, 0.09 
mL), 37a was isolated (0.112 g, 65%) as a colourless oil. 1H NMR (250 
MHz, CDCl3): 	 = 0.44 (s, 9 H, Si(CH3)3), 1.33 (t, 3 H, CH3), 2.89 (q, 2 
H, CH2). 13C NMR (75 MHz, CDCl3): 	 = 0.7 (CH3, Si(CH3)3) , 15.0 (CH3), 23.4 (CH2), 
110.5, 113.7  (CBr), 131.7, 146.7 (C). IR (KBr, cm1): ~  = 2955 (w), 2931 (w), 2896 (w), 
2872 (w), 1248 (s), 1004 (s), 996 (s), 832 (s), 756 (s), 696 (s), 632 (m). MS (EI, 70 eV): m/z 
(%) = 344 (M+, [81Br,81Br], 17), 342 (M+, [81Br,79Br], 30), 340 (M+, [79Br,79Br], 15), 329 (M+, 
55), 327 (M+, 100), 325 (M+, 50). HRMS (EI, 70 eV): calcd for C9H14Br2SSi (M+, 
S
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[81Br,81Br]): 343.89058, found: 343.89041, (M+, [81Br,79Br]): 341.89263, found: 341.89283; 
(M+, [79Br,79Br]): 339.89467, found: 339.89459. 
 
Synthesis of 5-butyl-3,4-dibromo-2-trimethylsilylthiophene (37b):
Starting with 30 (0.200 g, 0.5 mmol) and 1-bromobutane (0.6 mmol, 
0.06 mL), 37b was isolated (0.113 g, 61%) as a colourless oil. 1H 
NMR (250 MHz, CDCl3): 	 = 0.45 (s, 9 H, Si(CH3)3), 0.98 (t, 3 H, 
CH3), 1.37-1.54 (m, 4 H, CH2), 2.67 (q, 2 H, CH2). 13C NMR (75 MHz, CDCl3): 	 = 0.4 (CH3, 
Si(CH3)3), 13.8 (CH3), 22.4, 30.6, 32.7 (CH2), 110.8, 114.0  (CBr), 138.7, 149.9 (C). IR (KBr, 
cm1): ~  = 2954 (w), 2897 (w), 2859 (w), 1248 (s), 1052 (s), 1005 (s), 913 (w), 831 (s), 756 
(s), 695 (m), 638 (m), 538 (m). MS (EI, 70 eV): m/z (%) = 372 (M+, [81Br,81Br], 32), 370 (M+, 
[81Br,79Br], 32), 368 (M+, [79Br,79Br], 16), 357 (M+, 57), 355 (M+, 100), 353 (M+, 49), 327 
(M+, 18). HRMS (EI, 70 eV): calcd for C11H18Br2SSi (M+, [81Br,79Br]): 369.92448, found: 
369.92439; (M+, [79Br,79Br]): 367.92652, found: 367.92648. 
 
Synthesis of 3,4-dibromo-5-isopentyl-2-trimethylsilylthiophene (37c):
Starting with 30  (0.200 g, 0.5 mmol) and 1-bromo-3-methylbutane 
(0.6 mmol, 0.08 mL), 37c was isolated (0.115 g, 60%) as a 
colourless oil. 1H NMR (250 MHz, CDCl3): 	 = 0.37 (s, 9 H, 
Si(CH3) 3), 0.93, 0.96 (t, 3 H, CH3), 1.66 (m, H, CH), 1.51 (q, 2 H, 
CH2), 2.81 (t, 2 H, CH2). 13C NMR (75 MHz, CDCl3): 	 = 0.3 (CH3, Si(CH3)3), 23.2 (CH3), 
28.6 (CH), 29.9, 40.3 (CH2), 115.1, 120.6 (CBr), 132.9, 146.4 (C). IR (KBr, cm1): ~  = 2954 
(m), 2925 (m), 2869 (w), 1248 (s), 993 (s), 835 (s), 756 (s), 696 (m), 620 (m), 555 (m). MS 
(EI, 70 eV): m/z (%) = 386 (M+, [81Br,81Br], 22), 384 (M+, [81Br,79Br], 40), 382 (M+, 
[79Br,79Br], 19), 371 (M+, 54), 370 (M+, 18), 369 (M+, 98), 367 (M+, 48), 327 (M+, 29), 249 
(M+, 100). HRMS (EI, 70 eV): calcd for C12H20Br2SSi (M+, [81Br,81Br]): 385.93753, found: 
385.93628; (M+, [81Br,79Br]): 383.93958, found: 383.93849; (M+, [79Br,79Br]): 381.94162, 
found: 381.94032. 
 
Synthesis of 3,4-dibromo-5-hexyl-2-trimethylsilylthiophene (37d):
Starting with 30 (0.200 g, 0.5 mmol) and 1-bromohexane (0.6 mmol, 
0.09 mL), 37d was isolated (0.119 g, 60%) as a colourless oil. 1H 
NMR (250 MHz, CDCl3): 	 = 0.38 (s, 9 H, Si(CH3) 3), 0.89 (t, 3 H, 
CH3), 1.33-1.42 (m, 6 H, CH2), 1.62 (q, 2 H, CH2), 2.80 (q, 2 H, 
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CH2). 13C NMR (75 MHz, CDCl3): 	 = 0.3 (CH3, Si(CH3)3), 14.4 (CH3), 23.2, 30.4, 30.5, 
30.9, 32.0 (CH2), 115.1, 120.6 (CBr), 132.8, 146.5 (C). IR (KBr, cm1): ~  = 2954 (m), 2925 
(m), 2855 (w), 1248 (s), 994 (s), 834 (s), 756 (s), 696 (m), 637 (m), 557 (m). MS (EI, 70 eV): 
m/z (%) = 400 (M+, [81Br,81Br], 19), 398 (M+, [81Br,79Br], 34), 396 (M+, [79Br,79Br], 16), 385 
(M+, 56), 384 (M+, 18), 383 (M+, 100), 381 (M+, 49), 327 (M+, 26), 327 (M+, 26). HRMS (EI, 
70 eV): calcd for C13H22Br2SSi (M+, [81Br,81Br]): 399.95318, found: 399.95288, (M+, 
[81Br,79Br]): 397.95523, found: 397.95562; (M+, [79Br,79Br]): 395.95727, found: 395.95728. 
 
Synthesis of 3,4-dibromo-5-heptyl-2-trimethylsilylthiophene (37e):
Starting with 30 (0.200 g, 0.5 mmol) and 1-bromoheptane (0.6 
mmol, 0.09 mL), 37e was isolated (0.113 g, 55%) as a colourless oil. 
1H NMR (250 MHz, CDCl3): 	 = 0.39 (s, 9 H, Si(CH3) 3), 0.78 (t, 3 
H, CH3), 1.18-1.39 (m, 8 H, CH2), 1.73 (q, 2 H, CH2), 3.25 (q, 2 H, 
CH2). 13C NMR (75 MHz, CDCl3): 	 = 0.4 (CH3, Si(CH3)3), 14.6 (CH3), 22.6, 28.5, 28.6, 
31.3, 31.6, 33.0, 33.8 (CH2), 115.0, 120.3 (CBr), 136.5, 140.5 (C). IR (KBr, cm1): ~  = 2954 
(m), 2925 (m), 2855 (w), 1248 (s), 994 (s), 834 (s), 756 (s), 696 (m), 637 (m), 557 (m). MS 
(EI, 70 eV): m/z (%) = 414 (M+, [81Br,81Br], 16), 412 (M+, [81Br,79Br], 35), 410 (M+, 
[79Br,79Br], 22), 385 (M+, 54), 384 (M+, 19), 383 (M+, 100), 381 (M+, 51), 327 (M+, 31), 327 
(M+, 21). HRMS (EI, 70 eV): calcd for C14H24Br2SSi (M+, [81Br,79Br]): 412.29886, found: 
412.29874; (M+, [79Br,79Br]): 409.97347, found: 409.97339. 
 
Synthesis of 3,4-dibromo-2-trimethylsilyl-5-undecylthiophene (37f):
Starting with 30 (0.200 g, 0.5 mmol) and 1-bromoundecane (0.6 
mmol, 0.27 mL), 37f was isolated (0.119 g, 51%) as a colourless 
oil. 1H NMR (250 MHz, CDCl3): 	 = 0.39 (s, 9 H, Si(CH3) 3), 
0.78 (t, 3 H, CH3), 1.18-1.39 (m, 16 H, CH2), 1.73 (q, 2 H, 
CH2), 3.25 (q, 2 H, CH2). 13C NMR (75 MHz, CDCl3): 	 = 0.4 (CH3, Si(CH3)3), 14.6 (CH3), 
22.9, 28.7, 28.9, 29.41, 29.46, 29.49, 25.32, 25.39, 32.1, 32.7 (CH2), 115.0, 120.3 (CBr), 
136.5, 140.5 (C). IR (KBr, cm1): ~  = 2954 (m), 2925 (m), 2855 (w), 1248 (s), 994 (s), 834 
(s), 756 (s), 696 (m), 637 (m), 557 (m). MS (EI, 70 eV): m/z (%) = 470 (M+, [81Br,81Br], 21), 
468 (M+, [81Br,79Br], 28), 466 (M+, [79Br,79Br], 21), 383 (M+, 100), 381 (M+, 39), 327 (M+, 
32), 327 (M+, 19). HRMS (EI, 70 eV): calcd for C18H32Br2SSi (M+, [81Br,79Br]): 468.40518, 
found: 468.40510; (M+, [79Br,79Br]): 466.03607, found: 466.03600.
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1.9.5.7 Synthesis of natural analog products 
 
Synthesis of 3,4-di(4-hydroxyphenyl)thiophene-dicarboxylic acid (39):
Compound 38d  (0.115 g, 0.3 mmol) was dissolved in a mixture of 
EtOH (5 mL) and of an aqueous solution of KOH (10 mL, 30%) 
and the solution was refluxed for 2.5 h. The mixture was extracted 
several times with CH2Cl2. The combined organic layers were 
dried (Na2SO4), filtered and the filtrate was concentrated in vacuo. 
The crude product was washed to give 39 as a brownish solid (0.111 g, 96%). 1H NMR (250 
MHz, CDCl3): 	 = 6.5, 7.4 (d, 2 H, 2 CH, Ar), 7.25 (s, 2 H, OH), 8.14 (b, 2 H, COOH, Ar). 
13C NMR (75 MHz, CDCl3): 	 = 115.0, 132.3 (CH, Ar), 128.2, 132.8, 150.0, 157.5, 162.8 (C). 
IR (KBr, cm1): ~  = 3417 (w), 3071 (w), 2920 (m), 2850 (m), 2721 (w), 1722 (s), 1601 (s), 
1401 (s), 1342 (s), 1187 (s), 1055 (s), 744 (s). MS (EI, 70 eV): m/z (%) = 356 (M+, 55), 312 
(M+, 100), 293 (M+, 15), 268 (M+, 26), 64 (M+, 74), 247 (M+, 13), 220 (M+, 50), 203 (M+, 14), 
128 (M+, 23), 44 (M+, 43). HRMS (EI, 70 eV): calcd for C18H12O6S (M+): 356.03546, found: 
356.03539. 
 
Synthesis of the sulphur analogue 40 of ningaline A:  
To a CH2Cl2 solution (2.5 mL) of 38b (75 mg, 0.2 mmol) was added BBr3 
(1.6 mmol, 0.881 g) at 0 °C. The solution was allowed to warm to 20 °C 
during 4 days. To the solution was added an aqueous solution of KOtBu 
(10 mL, 0.1 M), and the solution was stirred for 30 min. The organic layer 
was separated, dried (Na2SO4) and filtered, and the filtrate was 
concentrated in vacuo. The product was purified by chromatography (silica gel) and isolated 
as a yellow solid (49 mg, 65%). 1H NMR (250 MHz, CDCl3): 	 = 7.58, 8.40 (d, 2 H, CH, Ar), 
7.41, 7.62 (t, 2 H, CH, Ar). 13C NMR (75 MHz, CDCl3): 	 = 118.4, 124.4, 125.2, 131.2 (CH, 
Ar), 117.1, 133.26, 140.3, 152.7, 156,8 (C). IR (KBr, cm1): ~  = 3417 (w), 3071 (w), 2920 
(m), 2850 (m), 2721 (w), 1722 (s), 1601 (s), 1401 (s), 1342 (s), 1187 (s), 1055 (s), 744 (s). 
MS (EI, 70 eV): m/z (%) = 321 (M+, 19), 320 (M+, 100), 319 (M+, 17), 263 (M+, 4), 208 (M+, 
13), 163 (M+, 13). HRMS (EI, 70 eV): calcd for C18H8O4S (M+): 320.01378, found: 
320.01316. 
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1.9.6  Synthesis of pyrazole-3-carboxylates and pyrazole-1,5-dicarboxylates by one-pot 
cyclization of hydrazone dianions with diethyl oxalate 
1.9.6.1 Synthesis of pyrazole-3-carboxylates 
 
Typical procedure for the synthesis of pyrazole-3-carboxylates 3a-q:  
To a THF solution of hydrazone 41a-q (2.0 mmol) was added n-butyllithium (2 mL, 2.5 M 
solution in hexane) at –78 °C. After stirring for 45 min at –78 °C, the mixture was stirred for 
15 min at 20 °C and, subsequently, diethyl oxalate (2.2 mmol) was added at –78 °C. After 
warming of the reaction mixture to 20 °C within 16 h, the solvent (THF) was removed in 
vacuo. To the residue were added p-TsOH (8.0 mmol, 1.52 g) and 30 mL of toluene. The 
mixture was stirred under reflux for 8 h. After cooling to 20 °C, a saturated aqueous solution 
(20 mL) of NaHCO3 was added and the mixture was stirred for 15 min at 20 °C. The organic 
layer was separated, dried (Na2SO4), and filtered. The solvent of the filtrate was removed in 
vacuo. The residue was purified by chromatography (silica gel, n-hexane/EtOAc = 10:1-2:1). 
 
Ethyl 5-(naphth-1-yl)-1H-pyrazole-3-carboxylate (43f): 
Starting with a THF solution (20 mL) of hydrazone 41f (2.0 mmol, 
0.568 g), n-butyllithium (2.0 mL, 2.0 M solution in hexane, 2.5 
mmol), diethyl oxalate (0.3 mL, 2.2 mmol), p-TsOH (8.0 mmol, 1.52 
g) and 30 mL of toluene, 43f (45%, 239 mg) was isolated as a yellow 
solid, mp. 172-174°C. 1H-NMR (300 MHz, CDCl3): 	 = 1.20 (t, 3J = 
7.2 Hz, 3H, OCH2CH3), 4.39 (q, 3J = 7.2 Hz, 2H, OCH2CH3), 7.17 (s, 1H, CH), 7.57 (m, 3H, 
NaphH), 7.72 (d, 1H, NaphH), 7.96 (d, 2H, NaphH), 8.02 (s, 1H, NaphH). 13C-NMR (75 
MHz, CDCl3): 	 = 18.9 (OCH2CH3), 65.6 (OCH2CH3), 114.0 (CH), 130.5, 130.6, 131.2, 
131.8, 132.4, 133.5, 134.1 (CH), 135.0, 148.6, 149.1 (3C), 150.3, 159.0 (C, pyrazole), 160.8 
(CO). IR (KBr, cm1): ~  = 3138 (m), 3058 (m), 2979 (m), 1732 (s), 1560 (m), 1382 (s), 1262 
(s), 1244 (s), 1144 (s), 1100 (s), 1024 (s), 802 (s), 777 (s), 659 (m), 570 (m). MS (EI, 70 eV): 
m/z (%) = 266 (M+, 19), 221 (100), 193 (26), 139 (25), 127 (56), 73 (35), 45 (16). HRMS (EI, 
70 eV): calcd for C16H14O2N2 (M+): 266.1055, found: 266.1048. 
 
Ethyl 5-(4-fluorophenyl)-1H-pyrazole-3-carboxylate (43i): 
Starting with a THF solution (20 mL) of hydrazone 41i (2.0 mmol, 0.448 
g), n-butyllithium (2.0 mL, 2.0 M solution in hexane, 2.5 mmol) and 
diethyl oxalate (0.3 mL, 2.2 mmol), p-TsOH (8.0 mmol, 1.52 g) and 30 
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mL of toluene, 43i (47%, 228 mg) was isolated as a yellow solid, mp. 188-189 °C. 1H-NMR
(300 MHz, CDCl3): 	 = 1.19 (t, 3J = 7.2 Hz, 3H, OCH2CH3), 4.18 (q, 3J = 7.2 Hz, 2H, 
OCH2CH3), 6.86 (s, 1H, CH), 7.00 (t, 3J = 8.4 Hz, 2H, ArH), 7.60 (t, 3J = 8.4 Hz, 2H, ArH), 
9.50 (s, br, 1H, NH). 13C-NMR (75 MHz, CDCl3): 	 = 14.1 (OCH2CH3), 61.3 (OCH2CH3), 
105.1 (CH), 115.7, 116.1 (d, 3JCF= 95, CH, Ar), 127.5, 127.6 (d, 2JCF = 109 Hz, CH, Ar), 126.6 
(C, Ar), 160.7, 160. (d, 1JCF = 240 Hz, CF, Ar), 140.0, 137.6 (C, pyrazole), 164.8 (CO). IR 
(KBr, cm1): ~  = 3437 (w), 3193 (m), 3133 (m), 3058 (m), 2985 (w), 1727 (s), 1612 (w), 
1508 (s), 1449 (w), 1411 (m), 1275 (s), 1246 (s), 1197 (s), 994 (s), 840 (s), 824 (s), 779 (s), 
615 (m). MS (EI, 70 eV): m/z (%) = 234 [M+, (73)], 189 (15), 188 (18), 134 (9), 133 (16), 
132(100). HRMS (EI, 70 eV): calcd for C12H11O2N2F (M+): 234.0799, found: 234.0797. 
 
Ethyl 5-isopropyl-1H-pyrazole-3-carboxylate (43j): 
Starting with a THF solution (20 mL) of hydrazone 41j (2.0 mmol, 0.334 
g), n-butyllithium (2.0 mL, 2.0 M solution in hexane, 2.5 mmol), diethyl 
oxalate (0.3 mL, 2.2 mmol), p-TsOH (8.0 mmol, 1.52 g) and 30 mL of 
toluene, 43j (72%, 262 mg) was isolated as a yellow solid, mp. 61-63 °C. 
1H-NMR (300 MHz, CDCl3): 	 = 1.40 (m, 3J =7.2 Hz, 9H, 3CH3), 3.27 (m, 3J = 7.2 Hz, 1H, 
(CH3)2CH), 4.48 (q, 3J = 7.2 Hz, 2H, OCH2CH3), 6.70 (s, 1H, CH). 13C-NMR (75 MHz, 
CDCl3): 	 = 13.5, 22.3 ((CH3)2CH), 32.2 (OCH2CH3), 61.0 (OCH2CH3), 104.6, 105.9 (CH), 
142.0, 153.4 (C, Pyrazole), 162.5 (CO). IR (KBr, cm1): ~  = 2997 (m), 2968 (m), 2835 (m), 
1809 (s), 1759 (s), 1534 (w), 1468 (s), 1386 (s), 1231 (s), 1219(s), 1011 (s), 1000 (m), 969 
(m), 778 (m). MS (EI, 70 eV): m/z (%) = 182 (M+, 27), 121 (100), 107 (23), 79 (24), 67 (17), 
29 (21). HRMS (EI, 70 eV): calcd for C9H14O2N2 (M+): 182.1055, found: 182.1052. 
 
Ethyl 5-n-propyl-1H-pyrazole-3-carboxylate (43k): 
Starting with a THF solution (20 mL) of hydrazone 41k (2.0 mmol, 0.334 
g), n-butyllithium (2.0 mL, 2.0 M solution in hexane, 2.5 mmol) and 
diethyl oxalate (0.3 mL, 2.2 mmol), p-TsOH (8.0 mmol, 1.52 g) and 30 
mL of toluene, 43k (63%, 228 mg) was isolated as a yellow solid, mp. 
67-69 °C. 1H-NMR (300 MHz, CDCl3): 	 = 0.79 (t, 3J =7.2 Hz, 3H, CH2CH2CH3), 	 = 1.19 
(t, 3J =7.2 Hz, 3H, OCH2CH3), 1.52 (m, 3J =7.2 Hz, 2H, CH2CH2CH3), 2.54 (t, 3J =7.2 Hz, 
2H, CH2CH2CH3), 4.20 (q, 3J = 7.2 Hz, 2H, OCH2CH3), 6.45 (s, 1H, CH). 13C-NMR (75 
MHz, CDCl3): 	 = 13.9 (CH2CH2CH3), 14.5 (OCH2CH3), 22.7, 29.4 (2CH2), 62.4 
(OCH2CH3), 106.4 (CH), 142.4, 147.3 (C, pyrazole), 162.5 (CO). IR (KBr, cm1): ~  = 2999 
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(m), 2964 (m), 2831 (m), 1803 (s), 1765 (s), 1523 (w), 1478 (s), 1389 (s), 1236 (s), 1212(s), 
1019 (s), 1003 (m), 969 (m), 778 (m). MS (EI, 70 eV): m/z (%) = 182 (M+, 18), 121 (100), 
108 (51), 107 (23), 79 (14), 43 (15), 29 (11). HRMS (EI, 70 eV): calcd for C9H14O2N2 (M+): 
182.1055, found: 182.1051. 
 
Ethyl 4-methyl-5-phenyl-1H-pyrazole-3-carboxylate (43l): 
Starting with a THF solution (20 mL) of hydrazone 41l (2.0 mmol, 0.438 
g), n-butyllithium (2.0 mL, 2.0 M solution in hexane, 2.5 mmol) and 
diethyl oxalate (0.3 mL, 2.2 mmol), p-TsOH (8.0 mmol, 1.52 g) and 30 
mL of toluene, 43l (62%, 251 mg) was isolated as a colourless oil. 1H-
NMR (300 MHz, CDCl3): 	 = 1.22 (t, 3J =7.2 Hz, 3H, OCH2CH3), 2.54 
(s, 3H, CH3) 4.25 (q, 3J = 7.2 Hz, 2H, OCH2CH3), 7.48 (m, 3H, ArH), 7.63 (d, 3J = 8.2 Hz, 
2H, ArH). 13C-NMR (75 MHz, CDCl3): 	 = 10.1 (CH2CH3), 14.5 (CH3), 60.8 (OCH2CH3), 
128.0, 128.4, 129.0, 130.2, 130.8 (CH, ArH), 133.7 (C, Ar), 117.4, 138.3, 145.0 (C, pyrazole), 
161.21 (CO). IR (KBr, cm1): ~  = 3221 (w), 3123 (m), 3099 (m), 3025 (m), 2956 (w), 1861 
(s), 1821 (s), 1399 (s), 1365 (s), 1332 (s), 1299 (s), 1251 (s), 1989 (s), 1005 (s), 986 (s), 865 
(m), 779 (m), 763 (m), 699 (m). MS (EI, 70 eV): m/z (%) = 231 (M+, 13), 230 (90), 185 (18), 
184 (26), 183 (29), 129 (13), 128 (100), 77 (18). HRMS (EI, 70 eV): calcd for C13H14O2N2 
(M+): 203.1055, found: 203.1057. 
 
Ethyl 4,5,6,7,8,9-hexahydro-1H-cycloocta[c]pyrazole-3-carboxylate (43p):  
Starting with a THF solution (20 mL) of hydrazone 41p (2.0 mmol, 0.426 
g), n-butyllithium (2.0 mL, 2.0 M solution in hexane, 2.5 mmol), diethyl 
oxalate (0.3 mL, 2.2 mmol), p-TsOH (8.0 mmol, 1.52 g), 30 mL of toluene,
43p (38%, 168 mg) was isolated as a yellow solid, mp. 121-123 °C. 1H-
NMR (300 MHz, CDCl3): 	 = 1.20 (t, 3J = 7.2 Hz, 3H, OCH2CH3), 1.25-
1.40 (m, 4H, 2CH2), 1.50-1.60 (m, 4H, CH2 ), 2.68, 2.75 (mm, 4H, 2CH2), 4.19, 4.30 (q, 3J = 
7.2 Hz, 2H, OCH2CH3), 13C-NMR (75 MHz, CDCl3): 	 = 12.9 (OCH2CH3), 20.4, 23.7, 24.5, 
24.6, 27.4, 28.9 (6CH2), 59.6 (OCH2CH3), 121.9, 134.6, 146.9 (3C), 160.9 (CO). IR (KBr, 
cm1): ~  = 3183 (m), 3125 (m), 2928 (m), 2853 (m), 1717 (s), 1456 (s), 1445 (s), 1270 (s), 
1245 (s), 1151 (s), 1095 (s), 1043 (s), 948(m), 865 (m), 779 (m), 732 (m).  MS (EI, 70 eV): 
m/z (%) = 222 (M+, 46), 194 (14), 193 (86), 177 (12), 176 (25), 175 (100), 149 (13), 147 (12), 
121 (12), 120 (12). HRMS (EI, 70 eV): calcd for C12H18O2N2 (M+): 222.1362, found: 
222.1358. 
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1.9.6.2 Synthesis of pyrazole-1,5-dicarboxylates 
 
Typical procedure for the synthesis of pyrazole-1,5-carboxylates 44a-q:  
To a THF solution of hydrazone 41a-q (2.0 mmol) was added n-butyllithium (2 mL, 2.5 M 
solution in hexane) at –78 °C. After stirring for 45 min at –78 °C, the mixture was stirred for 
15 min at 20 °C and, subsequently, diethyl oxalate (2.2 mmol) was added at –78 °C. After 
warming of the reaction mixture to 20 °C within 16 h, the solvent (THF) was removed in 
vacuo. To the residue were added TFA (1 mL) and 30 mL of CH2Cl2. The mixture was stirred 
under reflux for 8 h. After cooling to 20 °C, a saturated solution (20 mL) of NaHCO3 was 
added and the mixture was stirred for 15 min at 20 °C. The combined organic layers were 
dried (Na2SO4), filtered and the solvent of the filtrate was removed in vacuo. The residue was 
purified by chromatography (silica gel, n-hexane/EtOAc = 10:1-2:1). 
 
Diethyl phenylpyrazole-1,5-dicarboxylate (44a): 
Starting with a THF solution (20 mL) of  hydrazone 41a (2.0 mmol, 
0.412 g), n-butyllithium (2.0 mL, 2.0 M solution in hexane, 2.5 mmol), 
diethyl oxalate (0.3 mL, 2.2 mmol), TFA (1 mL) and 30 mL of CH2Cl2,
44a (59%, 339 mg) was isolated as a yellow oil. 1H-NMR (300 MHz, 
CDCl3): 	 = 1.28-1.39 (tt, 3J =7.2 Hz, 6H, 2OCH2CH3), 4.29-4.59 (qq, 
3J = 7.2 Hz, 4H, 2OCH2CH3), 7.06 (s, 1H, CH), 7.39 (m, 3H, ArH), 7.87 (d, 3J = 8.2 Hz, 2H, 
ArH). 13C-NMR (75 MHz, CDCl3): 	 = 14.4, 14.7 (2CH2CH3), 62.0, 65.6 (2OCH2CH3), 110.4 
(CH, pyrazole), 126.8, 127.1, 128.4, 129.1, 129.8 (CH, ArH), 130.9 (C, Ar), 138.8, 149.4 (C, 
pyrazole), 154.4, 160.6 (2CO). IR (KBr, cm1): ~  = 3201 (m), 3012 (s), 2956 (m), 2931 (w), 
1798 (s), 1731 (s), 1615 (m), 1565 (m), 1538 (m), 1465 (s), 1321 (s), 1254 (s), 935 (s), 865 
(m), 732 (m). MS (EI, 70 eV): m/z (%) = 288 (M+, 56), 171 (100), 170 (15), 142 (23), 114 
(29), 104 (8), 89 (29), 77 (18). HRMS (EI, 70 eV): calcd for C15H16O4N2 (M+): 288.1110, 
found: 288.1115. 
 
Diethyl 3-(4-fluorophenyl)pyrazole-1,5-dicarboxylate (44i):  
Starting with a THF solution  (20 mL) of hydrazone 41i (2.0 mmol, 
0.448 g), n-butyllithium (2.0 mL, 2.0 M solution in hexane, 2.5 mmol), 
diethyl oxalate (0.3 mL, 2.2 mmol), TFA (1 mL) and 30 mL of 
CH2Cl2, 44i (41%, 250 mg) was isolated as a colourless oil. 1H-NMR
(300 MHz, CDCl3): 	 = 1.22-1.38 (tt, 3J = 7.2 Hz, 6H, 2OCH2CH3), 
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4.26-4.49 (qq, 3J = 7.2 Hz, 4H, 2OCH2CH3), 6.89 (s, 1H, CH), 7.00 (t, 3J = 8.3 Hz, 2H, ArH), 
7.70 (t, 3J = 8.3 Hz, 2H, ArH). 13C-NMR (75 MHz, CDCl3): 	 = 14.4, 14.4 (2CH3), 62.7, 65.4 
(2CH2), 110.1 (CH), 116.1, 116.3(d, 3JCF = 95, CH, Ar), 127.5, 127. 8 (d, 2JCF = 109 Hz, CH, 
Ar), 127.5 (C, Ar), 153.4, 160.4 (d, 1J = 240 Hz, CF, Ar), 138.9, 149.3 (C, pyrazole), 162.2, 
165.5 (CO). IR (KBr, cm1): ~  = 3139 (w), 3067 (w), 2985 (s), 2940 (m), 2908 (w), 1763 (s), 
1739 (s), 1608 (s), 1455 (s), 1433 (s), 1371 (s), 1244 (s), 1159 (s), 949 (s), 831 (s), 770 (s). 
MS (EI, 70 eV): m/z (%) = 306 [M+, (45)], 235 (10), 234 (75), 233 (26), 189 (47), 188 (39), 
162 (23), 134 (16), 133 (25), 132 (100). HRMS (EI, 70 eV): calcd for C15H15O4N2F (M+): 
306.1016, found: 306.1011. 
 
Diethyl isopropylpyrazole-1,5-dicarboxylate (44j): 
Starting with a THF solution (20 mL) of hydrazone 41j (2.0 mmol, 0.344 
g), n-butyllithium  (2.0 mL, 2.0 M solution in hexane, 2.5 mmol), diethyl 
oxalate (0.3 mL, 2.2 mmol), TFA (1 mL) and 30 mL of CH2Cl2, 44j 
(72%, 365 mg) was isolated as a yellow oil. 1H-NMR (300 MHz, CDCl3): 
	 = 1.15 (d, 3J =7.2 Hz, 6H, (CH3)2CH), 	 = 1.22-1.34 (tt, 3J =7.2 Hz, 6H, 2OCH2CH3), 2.95 
(m, 3J =7.2 Hz, 1H, (CH3)2CH), 4.19-4.43 (qq, 3J = 7.2 Hz, 4H, 2OCH2CH3), 6.49 (s, 1H, 
CH). 13C-NMR (75 MHz, CDCl3): 	 = 14.2, 28.0 (2OCH2CH3), 22.2 ((CH3)2CH), 62.4, 65.7 
(2CH2), 110.1, 110.2 (2CH), 149.3, 160.8 (C, pyrazole), 138.2, 162.1 (2CO). IR (KBr, cm1): 
~  = 2973 (m), 2938 (w), 2876 (w), 1776 (s), 1739 (s), 1657 (s), 1479 (s), 1373 (s), 1292 (s), 
1235(s), 1064 (s), 1017 (m), 981 (m), 771 (m). MS (EI, 70 eV): m/z (%) = 254 (M+, 38), 209 
(12), 182 (16), 181 (62), 167 (30), 137 (38), 136 (26), 135 (70), 121 (100), 67 (12), 29 (31). 
HRMS (EI, 70 eV): calcd for C12H18O4N2 (M+): 254.1261, found: 254.1258. 
 
Diethyl n-propylpyrazole-1,5-dicarboxylate (44k): 
Starting with a THF solution (20 mL) of hydrazone 41k (2.0 mmol, 
0.344 g), n-butyllithium (2.0 mL, 2.0 M solution in hexane, 2.5 mmol), 
diethyl oxalate (0.3 mL, 2.2 mmol), TFA (1 mL) and 30 mL of CH2Cl2, 
44k (70%, 365 mg) was isolated as a yellow oil. 1H-NMR (300 MHz, 
CDCl3): 	 = 0.85 (t, 3J = 7.2 Hz, 3H, CH2CH2CH3): 	 = 1.24-1.40 (tt, 3J =7.2 Hz, 6H, 
2OCH2CH3), 1.61 (m, 3J =7.2 Hz, 2H, CH2CH2CH3), 2.55 (t, 3J =7.2 Hz, 2H, CH2CH2CH3), 
4.24-4.48 (qq, 3J = 7.2 Hz, 4H, 2OCH2CH3), 6.49 (s, 1H, CH). 13C-NMR (75 MHz, CDCl3): 	 
= 14.5 (CH2CH2CH3), 22.6, 30.7 (2OCH2CH3), 62.5, 65.3 (2CH2), 111.7 (CH), 149.2, 160.8 
(C, pyrazole), 132.9, 158.3 (2CO). IR (KBr, cm1): ~  = 2964 (m), 2936 (m), 2874 (m), 1775 
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(s), 1739 (s), 1558 (w), 1471 (s), 1374 (s), 1297 (s), 1237(s), 1064 (s), 1018 (m), 986 (m), 770 
(m). MS (EI, 70 eV): m/z (%) = 254 (M+, 4), 226 (27), 209 (10), 182 (21), 154 (83), 137 (42), 
136 (17), 121 (24), 108 (100), 107 (14), 79 (21). HRMS (EI, 70 eV): calcd for C12H18O4N2 
(M+): 254.1261, found: 254.1264. 
 
Diethyl 4-methyl-5-phenylpyrazole-1,5-dicarboxylate (44l): 
Starting with a THF solution  (20 mL) of hydrazone 41l (2.0 mmol, 
0.412 g), n-butyllithium (2.0 mL, 2.0 M solution in hexane, 2.5 mmol), 
diethyl oxalate (0.3 mL, 2.2 mmol), TFA (1 mL) and 30 mL of CH2Cl2, 
44l (69%, 416 mg) was isolated as a yellow oil. 1H-NMR (300 MHz, 
CDCl3): 	 = 1.30-1.40 (tt, 3J =7.2 Hz, 6H, 2OCH2CH3), 2.20 (s, 3H, 
CH3), 4.30-4.59 (qq, 3J = 7.2 Hz, 4H, 2OCH2CH3), 7.30 (m, 3H, ArH), 7.59 (d, 3J = 8.2 Hz, 
2H, ArH). 13C-NMR (75 MHz, CDCl3): 	 = 9.8, 14.5 (2CH2CH3), 15.6 (CH3), 62.9, 65.4 
(2OCH2CH3), 128.7, 128.9, 129.3 (CH, ArH), 131.9 (C, Ar), 120.8, 136.1, 149.5 (C, 
pyrazole), 155.0, 161.6 (2CO). IR (KBr, cm1): ~  = 3063 (w), 2982 (m), 2964 (m), 2953 (m), 
2873 (w), 1771 (s), 1758 (s), 1444 (s), 1371 (s), 1345 (s), 1302 (s), 1244 (s), 1216 (s), 1083 
(s), 1047 (s), 860 (m), 774 (m), 763 (m), 700 (m). MS (EI, 70 eV): m/z (%) = 302 (M+, 60), 
230 (47), 229 (23), 207 (13), 185 (47), 184 (45), 128 (100), 104 (22), 77 (22), 29 (26). HRMS 
(EI, 70 eV): calcd for C16H18O4N2 (M+): 302.1261, found: 302.1263. 
 
Diethyl 4,5-dihydrobenzo[g]indazole-1,5-carboxylate (44m): 
Starting with a THF solution (20 mL) of hydrazone 41m (2.0 mmol, 
0.464 g), n-butyllithium (2.0 mL, 2.0 M solution in hexane, 2.5 mmol), 
diethyl oxalate (0.3 mL, 2.2 mmol), TFA (1 mL) and 30 mL of CH2Cl2,
44m (49%, 339 mg) was isolated as a yellow solid, mp. 131-133 .1H-
NMR (300 MHz, CDCl3): 	 = 1.36-1.51 (tt, 3J = 7.2 Hz, 6H, 
2OCH2CH3), 2.94 (m, 4H, CH2), 4.20-4.58 (qq, 3J = 7.2 Hz, 4H, 2OCH2CH3), 7.29 (m, 3H, 
ArH), 8.03 (m, 1H, ArH), 13C-NMR (75 MHz, CDCl3): 	 = 14.2, 19.152 (2OCH2CH3), 29.4, 
31.9 (2CH2), 62.0, 64.9 (2OCH2CH3), 124.0, 127.1, 128.5, 129.5 (CH), 127.4, 137.6 (2C), 
127.4, 129.5, 151.4 (3C, pyrazole), 149.5, 160.5 (CO). IR (KBr, cm1): ~  = 3434 (w), 3412 
(m), 3142 (m), 2956 (m), 1856 (s), 1567 (w), 1354 (s), 1198(s), 1101 (w), 899 (w), 856 (s), 
785 (m). MS (EI, 70 eV): m/z (%) = 314 (M+, 100), 242 (36), 241 (20), 213 (37), 196 (49), 
195 (65), 169 (80), 168 (59), 140 (88), 139 (63), 115 (35). HRMS (EI, 70 eV): calcd for 
C17H18O4N2 (M+): 314.1261, found: 314.1262. 
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Diethyl 4,5,6,7,8,9,10,11,12,13-decahydrocyclododeca[c]pyrazole-1,5-dicarboxylate (4q): 
Starting with a THF solution (20 mL) of hydrazone 31q (2.0 mmol, 0.536 
g), n-butyllithium  (2.0 mL, 2.0 M solution in hexane, 2.5 mmol), diethyl 
oxalate (0.3 mL, 2.2 mmol), TFA (1 mL) and 30 mL of CH2Cl2, 4q (65%, 
227,5 mg) was isolated as a colourless oil. 1H-NMR (300 MHz, CDCl3): 	 
= 1.36, 1.37 (t, 3J = 7.2 Hz, 6H, 2OCH2CH3), 1.32-1.54 (m, 12H, 6CH2), 
1.63, 1.79 (m, 4H, CH2 ), 2.51, 2.68 (t, 4H, 2CH2), 4.39, 4.49 (q, 3J = 7.2 
Hz, 4H, 2OCH2CH3), 13C-NMR (75 MHz, CDCl3): 	 = 13.7, 13.9 (2OCH2CH3), 20.1, 22.7, 
22.8, 23.0, 24.7, 24.9, 25.5, 25.6, 27.4, 27.9 (10CH2), 61.68, 64.39 (2OCH2CH3), 125.9, 
134.61, 149.0 (3C), 156.8, 161.7 (CO). IR (KBr, cm1): ~  = 3485 (w), 2989 (m), 2927 (s), 
2855 (m), 1749 (s), 1736 (s), 1485 (s), 1459 (s), 1381 (s), 1374 (s), 1235 (s), 1157 (s), 1049 
(s), 969(w), 862 (m), 831 (m), 765 (m).  MS (EI, 70 eV): m/z (%) = 350 (M+, 22), 278 (19), 
277 (100), 240 (17), 231 (21), 205 (11), 121 (10). HRMS (EI, 70 eV): calcd for C15H22O4N2 
(M+): 350.2200 found: 350.2195. 
1.9.7  Synthesis of  6-halomethyl-5,6-dihydro-4H-1,2-oxazines  
 
General procedure for the preparation of oximes 47:
To a THF solution (20 mL) of oxime 45 (2.0 mmol) was added n-butyllithium (5.0 mmol, 2.5 
M) at 78 °C. After stirring for 1 h at 78 °C, the mixture was warmed to 20 °C and stirred 
for 10 min. Subsequently, allylbromide (0.484 g, 4.0 mmol) was added at 78 °C. After 
warming of the mixture to 20 °C for 16 h, a saturated aqueous solution of NH4Cl (30 mL) was 
added. The organic and the aqueous layer were separated and the latter was extracted with 
ethyl acetate (3 x 50 mL). The combined organic layers were dried (Na2SO4), filtered and the 
solvent of the filtrate was removed in vacuo. The residue was purified by column 
chromatography (silica gel, n-heptane/EtOAc = 5:1). 
 
General procedure for the synthesis of 1,2-oxazines 48a-k and 48p: To a CH2Cl2 solution 
(15 mL) of 47a-k,l (0.81 mmol) and of I2 (0.406 g, 1.6 mmol) was added a saturated aqueous 
solution of NaHCO3 (16 mL) and the solution was stirred for 12 h at 20 °C. The excess of 
iodine was removed by addition of a saturated aqueous solution of Na2SO3 (40 mL). The 
organic and the aqueous layer were separated and the latter was extracted with ethyl acetate (3 
x 50 mL). The combined organic layers were dried (Na2SO4), filtered and the solvent of the 
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filtrate was removed in vacuo. The residue was purified by column chromatography (silica 
gel, n-heptane  n-heptane/EtOAc = 4:1). 
 
General procedure for the synthesis of 1,2-oxazines 48l-o: To a CH2Cl2 solution (10 mL) 
of 47e,f,j,k (2.0 mmol) was portionwise added NBS (0.356 g, 2.0 mmol) over 15 min at 0 °C. 
The resultant solution was stirred for 2 h at room temperature. The residue was purified by 
column chromatography (silica gel, n-heptane  n-heptane/EtOAc = 4:1). 
6-Iodomethyl-3-p-tolyl-5,6-dihydro-4H-[1,2]oxazine (48b): 
Starting with 1-(3-tolyl)pent-4-en-1-one oxime 47b (0.342 g, 1.80 
mmol), I2 (0.914 g, 3.60 mmol), and a saturated aqueous solution of 
NaHCO3 (18 mL) in CH2Cl2 (30 mL), 48b was isolated as a 
colourless solid  (0.471 g, 83%); mp 120-122 °C. 1H NMR (250 
MHz, CDCl3): 	 = 1.85 (m, 1H, CH2), 2.32 (m, 1H, CHCH2), 2.36 (s, 3H, CArCH3), 2.68 (m, 
2H, CCH2), 3.25 (dd, 2J = 10.5 Hz, 3J = 7.3 Hz, 1H, CHCH2I), 3.41 (dd, 2J = 10.5 Hz, 3J = 5.0 
Hz, 1H, CHCH2I), 3.84 (m, 1H, OCHCH2), 7.18 (d, 3J = 8.1 Hz, 2H, CHAr), 7.57 (d, 3J = 8.1 
Hz, 2H, CHAr). 13C NMR (75.5 MHz, CDCl3): 	 = 5.5 (CH2I), 21.3 (CArCH3), 21.6, 24.3 
(CHCH2CH2C), 74.0 (CHO), 125.3 (CHAr), 129.2 (CHAr), 132.3 (C), 139.8 (C), 154.8 (C). IR 
(KBr, cm1): ~  = 3431 (br, w), 3034 (m), 2935 (br, w), 2910 (w), 1611 (w), 1592 (w), 1510 
(w), 1418 (w), 1407 (m), 1380 (m), 1335 (s), 1297 (m), 1233 (m), 1198 (s), 1163 (w), 1111 
(w), 1088 (w), 1062 (w), 1013 (s), 936 (w), 915 (s), 812 (s), 760 (w), 710 (w). MS (GC/MS, 
70 eV): m/z (%) = 315 (M+, 100), 188 (9), 174 (20), 143 (14), 132 (32), 117 (33), 105 (9), 91 
(40), 77 (7), 65 (17). HRMS (EI): calculated for C12H14NOI (M+): 315.01146, found 
315.01158. 
 
6-Iodomethyl-3-(3-methoxyphenyl)-5,6-dihydro-4H-[1,2]oxazine (48c): 
Starting with 1-(4-methoxyphenyl)pent-4-en-1-one oxime 47c 
(0.205 g, 1 mmol), I2 (0.508 g, 2 mmol), and a saturated aqueous 
solution of NaHCO3 (5  mL) in CH2Cl2 (10 mL), 48c was isolated 
as a brown oil (0.219 g, 66%). 1H NMR (300 MHz, CDCl3): 	 = 
1.76, 2.22 (m, 2 H, CH2), 2.55  (m, 2 H, CH2), 3.19, 3.35 (t, 2 H, CH2), 3.75 (m, 1 H, CH), 
7.85, 7.25 (s, 1 H, Ar), 7.12, 7.15 (d, 3J = 8.2 Hz, 2 H, Ar). 13C NMR (75 MHz, CDCl3): 	 = 
6.7, 22.0, 24.5 (3C, CH2), 55.4 (C, CH3), 74.1 (C, CH), 110.4, 116.3, 119.5, 129.6 (4C, 
ArCH), 136.6, 154.6 (2C, ArC), 159.6 (C, CN); IR (KBr, cm1); ~  = 3067 (w), 2994 (w), 2954 
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(w), 2932 (w), 2832 (w), 1597 (m), 1568 (m), 1425 (m), 1287 (m), 1234 (m), 1175 (m), 1038 
(s), 924 (m), 823 (m), 779 (m), 688 (m). MS (EI, 70 eV): m/z (%) = 332 (M+, 14), 331 (100), 
204 (14), 190 (21), 187 (16), 186 (18), 178 (20), 133 (23). HRMS (EI, 70 eV): calcd for 
C12H14NO2I (M+): 331.00637; found: 331.00608. 
 
3-(4-Chlorophenyl)-6-iodomethyl-5,6-dihydro-4H-[1,2]oxazine (48h): 
Starting with 1-(4-chlorophenyl)pent-4-en-1-one oxime 47h (0.209 
g, 1.0 mmol), I2 (0.508 g, 2.0 mmol), and a saturated aqueous 
solution of NaHCO3 (5  mL) in CH2Cl2 (10 mL), 48h was isolated 
as a brownish oil (0.172 g, 52%). 1H NMR (300 MHz, CDCl3): 	 = 
1.82, 2.22 (m, 2 H, CH2), 2.65 (q, 2 H, CH2), 3.19, 3.31 (t, 2 H, CH2), 3.75 (m, 1 H, CH), 
7.25, 7.46 (d, 3J = 8.2 Hz, 2 H, Ar). 13C NMR (75 MHz, CDCl3): 	 = 5.4, 23.0, 26.0 (3C, 
CH2), 74.4 (C, CH), 127.7, 129.3 (4C, ArCH), 134.0, 136.0 (2C, ArC), 153.7 (C, CN); IR 
(KBr, cm1); ~  = 3049 (w), 3005 (w), 2928 (w), 1548 (m), 1456 (m), 1349(m), 1075 (m), 924 
(s), 819 (s), 752 (m). MS (EI, 70 eV): m/z (%) = 336 (M+, [37Cl], 7), 334 (M+, [35Cl], 19), 192 
(55), 180 (100), 177 (38), 143 (61), 137 (29), 112 (35), 101 (19). HRMS (EI, 70 eV): calcd 
for C11H11INOCl (M+, [35Cl]): 334.95738; found: 334.95742. 
 
6-Iodomethyl-4-(naphthalen-1-yl)-5,6-dihydro-4H-[1,2]oxazine (48i): 
Starting with 1-(1-naphthyl)pent-4-en-1-one oxime 47i (0.225 g, 1.0 
mmol), I2 (0.508 g, 2.0 mmol), and a saturated aqueous solution of 
NaHCO3 (5 mL) in CH2Cl2 (10 mL), 48i was isolated as a brownish 
oil (0.232 g, 66%). 1H NMR (300 MHz, CDCl3): 	 = 1.92, 2.31 (m, 2 
H, CH2), 2.61 (t, 2 H, CH2), 2.35, 2.41 (t, 2 H, CH2), 3.94 (m, 1 H, CH), 7.31 (t, 3J = 8.2 Hz, 2 
H, Ar), 7.38 (d, 3J = 8.2 Hz, 2 H, Ar), 7.73, 7.79 (d, 3J = 8.2 Hz, 2 H, Ar), 7.87 (t, 3J = 8.2 Hz, 
1 H, Ar). 13C NMR (75 MHz, CDCl3): 	 = 5.6, 24.6, 26.3 (3C, CH2), 125.0, 125.1, 125.7, 
126.1, 126.8, 128.5, 129.6  (7C, ArCH),  131.3, 133.8, 133.9 (3C, ArC), 158.0 (C, CN); IR 
(KBr, cm1); ~  = 3044 (w), 2953 (w), 2932 (m), 2852 (m), 1673 (m), 1506 (m), 1368 (m), 
1280 (m), 1127 (m), 999 (m), 895 (s), 772 (s). MS (EI, 70 eV): m/z (%) = 351 (M+, 100), 350 
(11), 224 (15), 206 (15), 165 (15), 153 (46), 152 (33), 127 (38). HRMS (EI, 70 eV): calcd for 
C15H14NO2I (M+): 351.01146; found: 351.01165. 
N
O
I
Cl
N
O
I
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Appendix
1.10 Crystallographic Data  
Ethyl 5-(4-fluorophenyl)-1H-pyrazole-3-carboxylate
 
Table 1.  Crystal data and structure refinement for 43i. 
 
Identification code  tung36 
Empirical formula  C12H11FN2O2 
Formula weight  234.23 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group (H.-M.)  P21/n   
Space group (Hall)  -P 2yn 
Unit cell dimensions a = 14.176(3) Å  = 90°. 
 b = 5.0195(8) Å  = 106.664(4)°. 
 c = 16.533(3) Å  = 90°. 
Volume 1127.0(4) Å3 
Z 4 
Density (calculated) 1.380 Mg/m3 
Absorption coefficient 0.107 mm-1 
F(000) 488 
Crystal size 0.74 x 0.22 x 0.05 mm3 
	 range for data collection 3.00 to 28.30°. 
Index ranges -18h18, -6k3, -22l22 
Reflections collected 11338 
Independent reflections 2689 [R(int) = 0.0415] 
Completeness to 	 = 28.30° 95.7 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9947 and 0.9252 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2689 / 0 / 158 
Goodness-of-fit on F2 1.022 
Final R indices [I>2
(I)] R1 = 0.0428, wR2 = 0.0958 
R indices (all data) R1 = 0.0755, wR2 = 0.1114 
Largest diff. peak and hole 0.169 and -0.205 e.Å-3 
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Abbreviations
 
Ac  Acetyl  
Anal.  Elemental Analysis  
APT  Attached Proton Test  
bp.  Boiling point  
calcd  Calculated  
CI  Chemical Ionization  
COSY  Correlated Spectroscopy  
DABCO 1,4-Diazabicyclo[2.2.2]octane  
DEPT  Distortionless Enhancement by Polarization Transfer  
dr  Diastereomeric ratio  
ee  Enantiomeric excess  
EI  Electron Impact   
Et2O  Diethyl ether  
EtOH  Ethanol  
GC  Gas Chromatography  
GP  General Procedure  
HMBC Heteronuclear Multiple Bond Correlation  
HPLC  High Performance Liquid Chromatography  
HRMS  High Resolution Mass Spectrometry  
IR  Infrared Spectroscopy  
LDA  Lithium diisopropylamide  
Me3SiCl Chlorotrimethylsilane  
Me3SiOTf Trimethylsilyl trifluoromethanesulfonate  
MS  Mass Spectrometry  
mp  Melting point  
NaOEt  Sodium ethanolate  
nBuLi  n-Butyllithium  
NEt3  Triethylamine  
NMR  Nuclear Magnetic Resonance  
NOESY Nuclear Overhauser and Exchange Spectroscopy 
ORTEP Oak Ridge Thermal Ellipsoid Plot   
OTf  Triflate  
Ph  Phenyl  
ppm  Parts per million  
Rf  Retention factor  
SET  Single electron transfer  
Tf2O  Trifluoromethanesulfonic anhydride (triflic anhydride) 
TFA  Trifluoroacetic acid  
THF  Tetrahydrofuran  
TLC  Thin Layer Chromatography  
TMS   Tetramethylsilane  
Tol  Tolyl (p-MeC6H4)  
Tos  Tosyl (p-MeC6H4SO2
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